| 71220 |
1,4-DPCA
|
|
331830-20-7 |
>98%
|
|
|
2007-06-22
|
33.790607734807
|
1-4-dpca
|
1,4-dihydrophenonthrolin-4-one-3-Carboxylic acid
|
HIF-1.alpha. normoxic HIF-.alpha. prolyl HIF-PH inhibitors collagen fibrosis 4-hydroxylase normoxia hypoxic hypoxia-inducible factor HIF1.alpha. HIF1alpha HIFPH inhibition inhibits |
| 12700 |
15-deoxy-Δ12,14-Prostaglandin D2
|
|
85235-11-6 |
>95%
|
|
|
|
123.459419889503
|
15-deoxy-12-14-prostaglandin-d2
|
15-deoxy-Δ12,14-PGD2
|
PPARs prostaglandins peroxisome proliferator-activated receptors 15-deoxy-DELTA12,14-PGD2 15-deoxy-.DELTA.12,14-PGD2 15-deoxy-d12,14-PGD2 leukemia cells cancer |
| 10009742 |
15-hydroxy Prostaglandin Dehydrogenase Western Ready Control
|
|
- |
|
|
|
2007-04-03
|
52.442751381215
|
15-hydroxy-prostaglandin-dehydrogenase-western-ready-control
|
15-hydroxy PGDH
|
blotting blots western WB oxidation enzymes tumors suppression cells proliferation |
| 10011263 |
15-Lipoxygenase-2 (human recombinant)
|
|
- |
>95%
|
|
|
2008-03-25
|
53.562584407612
|
15-lipoxygenase-2-human-recombinant
|
15-LO-2; 15-LOX-2
|
arachidonic acids recombinant proteins 15-HETE 15-HpETE |
| 10011500 |
15-Lipoxygenase-2 Western Ready Control
|
|
- |
|
|
|
2008-06-25
|
23.694447513812
|
15-lipoxygenase-2-western-ready-control
|
15-LO-2; 15-LOX-2
|
WBs lipoxygenases 15LOX 15LO arachidonic acid AA 15(S)-hydroxyeicosatetraenoic acid 15(S)-HETE 15S-HETE western blots immunoblotting blotting |
| 34720 |
15(S)-HETE
|
|
54845-95-3 |
≥98%
|
|
|
|
41.036397000789
|
15-s-hete
|
|
soybean 15-LOs asthma airway 15-lipoxygenases monohydroxy fatty acids 15S-HETES 15-HETES arachidonic 15(S)-HETEs 15(S)HETEs potato polyunsaturated 15HETEs |
| 334720 |
15(S)-HETE-d8
|
|
84807-87-4 |
≥99% deuterated product
|
|
|
|
44.654696132596
|
15-s-hete-d8
|
|
GC/MS deuterium isotopes 15-HETE-d8 standards 15S-HETE-d8 15(S)HETE-d8 deuterated GC-MS LC/MS LC-MS 15-HETEs 15(S)-HETEs 15S-HETEs 15(S)HETEs hydroxy fatty acids mass spectrometry 15HETE |
| 534721 |
15(S)-HETE EIA Kit
|
|
- |
|
|
|
|
81.124019337016
|
15-s-hete-eia-kit
|
15(S)-HETE ELISA Kit
|
15(S)-HETEs 15S-HETEs measures kits eias enzyme immunoassays ELISAs 15(S)HETEs 15HETEs assays |
| 10007251 |
15(S)-HETE Lipid Maps MS Standard
|
|
54845-95-3 |
≥98%
|
|
|
2009-02-17
|
19.556098597535
|
15-s-hete-lipid-maps-ms-standard
|
|
soybean 15-LOs asthma airway 15-lipoxygenases monohydroxy fatty acids 15S-HETES 15-HETES arachidonic 15(S)-HETEs 15(S)HETEs potato polyunsaturated MS mass spectrometry standards 15HETE |
| 10009799 |
17(S)-HDoHE
|
|
- |
>98%
|
|
|
2007-03-12
|
69.213922651933
|
17-s-hdohe
|
17(S)-hydroxy Docosahexaenoic Acid
|
resolvins 17-HDHA docosahexaenoic acid COX-2 .omega.-3 w-3 aspirin hydroxylated metabolites oxygenation aspirin-inhibited cyclooxygenase-2 polyhydroxylated TNFa TNF.alpha. IL-1b IL-1.beta. glioma cells COX2 PGHS2 PGHS-2 prostaglandin synthases neurochemistry |
| 13812 |
17β-hydroxy Wortmannin
Exclusive New |
|
- |
≥98%
|
|
✓ |
2010-05-18
|
8.609447513812
|
17-hydroxy-wortmannin
|
|
phosphoinositide 3-kinase PI3K mTOR inhibitors inhibits inhibition inhibitory cancers 17-hydroxywortmannins 17-hydroxy wortmannins hydroxywortmannins PI3-K HWT phosphatidylinositol |
| 10010093 |
1-Oleoyl Lysophosphatidic Acid
Exclusive |
|
65528-98-5 |
>95%
|
|
✓ |
2007-08-29
|
24.772044198895
|
1-oleoyl-lysophosphatidic-acid
|
Oleoyl-sn-3-Glycerophosphate; 1-Oleoyl LPA
|
LPAS 1-oleoyl-LPAS agonists GPCR G-proteins cell proliferation smooth muscle contraction platelet aggregation reurite retraction |
| 10010290 |
1-Palmitoyl Lysophosphatidic Acid (sodium salt)
Exclusive |
|
- |
>98%
|
|
✓ |
2007-09-05
|
15.661767955801
|
1-palmitoyl-lysophosphatidic-acid-sodium-salt
|
1-Palmitoyl LPA (sodium salt)
|
1-palmitoyl-2-hydroxy-sn-glycero-3-phosphate monopalmitoylphosphatidic acid MPPA LPAS GPCRs biological responses |
| 10009962 |
2-(14,15-Epoxyeicosatrienoyl) Glycerol
|
|
848667-56-1 |
>95%
|
|
|
2008-04-03
|
63.758158379374
|
2-14-15-epoxyeicosatrienoyl-glycerol
|
2-14,15-EG
|
2-AG CYP450 metabolism mitogens cancers kidneys endocannabinoids |
| 13373 |
2',3',5'-triacetyl-5-Azacytidine
New |
|
10302-78-0 |
≥95%
|
|
|
2010-08-05
|
0E-12
|
2-3-5-triacetyl-5-azacytidine
|
|
inhibitors inhibits inhibition DNA methyltransferases epigenetics methylation myelodysplastic syndromes cancers prodrugs 5-azacytidine 5-azacitidine vidaza azacytidine azacitidine |
| 10005229 |
2,3-DCPE (hydrochloride)
|
|
- |
>98%
|
|
|
2006-09-15
|
17.579861878452
|
2-3-dcpe-hydrochloride
|
|
apoptosis Bcl-XL p21 ERK cancers cells cycles proapoptotic in vitro S-phase arrest upregulate activates activation |
| 71200 |
2,4-DPD
|
|
41438-38-4 |
>98%
|
|
|
|
25.104944751381
|
2-4-dpd
|
2,4-Diethylpyridine dicarboxylate
|
inhibits inhibition inhibitors proline-hydroxylases P564 HIF-PH HIF-1alpha HIF-1.alpha. alpha-keto glutarate .alpha.-keto a-keto cancer |
| 10008887 |
(+)-2,5-epi Goniothalesdiol
Exclusive |
|
- |
≥98%
|
|
✓ |
2009-03-02
|
2.801933701657
|
-2-5-epi-goniothalesdiol
|
|
tetrahydrofuran cytotoxic pesticide anticancers drugs antitumor styryl lactone |
| 13019 |
2-Hydroxyestradiol
|
|
362-05-0 |
≥95%
|
|
|
2009-01-20
|
9.563563535911
|
2-hydroxyestradiol
|
2-HE2; NSC 61711
|
estradiols steroids metabolism catechol-O-methyltransferase COMT pre-eclampsia preeclampsia angiogenesis cancers anticancer HIF-1α HIF1α |
| 13021 |
2-Methoxyestradiol
|
|
362-07-2 |
≥98%
|
|
|
2009-01-06
|
105.709079189687
|
2-methoxyestradiol
|
Panzem; NSC 659853; 2-ME2; 2-Hydroxyestradiol 2-methyl ether
|
estradiol steroids catechol-O-methyltransferase COMT pre-eclampsia preeclampsia angiogenesis cancers anticaner HIF-1α HIF1α 2-methoxyestradiol |
| 10010494 |
2-PCPA (hydrochloride)
|
|
- |
>98%
|
|
|
2008-05-09
|
0.127071823204
|
2-pcpa-hydrochloride
|
trans-2-Phenylcyclopropylamine (hydrochloride); Tranylcypromine (hydrochloride)
|
2 PCPA 2PCPA LSD1 histones chromatin nucleosomes post-translational modifications posttranslational methylation demethylation inhibitors inhibits inhibition MAO A B I MAOA MAOB MAOI MAO-A MAO-B MAO-I depression anxiety parkinsons disease epigenetics monoamine oxidases lysine-specific demethylase |
| 10009651 |
2-thio-Acetyl MAGE
|
|
112014-15-0 |
≥97%
|
|
|
2007-02-22
|
43.886666666666
|
2-thio-acetyl-mage
|
|
KIAA1363 cancers colorimetric substrates activity inhibition inhibits inhibitory enzymatic activity |
| 10004185 |
3,4',5-Trismethoxybenzophenone
Exclusive |
|
94709-12-3 |
>95%
|
|
✓ |
2004-07-21
|
20.571178637200
|
3-4-5-trismethoxybenzophenone
|
|
antimitotics antimitosis resveratrol analogs phenolic antioxidants antiproliferative antiproliferatory inhibits inhibition inhibitors cell growth |
| 13574 |
3-bromo-5-phenyl-Salicylic Acid
Exclusive New |
|
4906-68-7 |
≥95%
|
|
✓ |
2010-08-10
|
0E-12
|
3-bromo-5-phenyl-salicylic-acid
|
NSC 109116
|
Aldo-keto reductases AKR, oxidoreductases hydroxysteroid dehydrogenases HSDs 20α-HSD progesterones cancers steroids brain functions AKR1C1 AKR1C2 AKR1C3 AKR1C4 endothelial cells |
| 13265 |
4-hydroxy Nonenal Alkyne
Exclusive New |
|
1011268-23-7 |
≥98%
|
|
✓ |
2010-06-16
|
0E-12
|
4-hydroxy-nonenal-alkyne
|
Click Tag™ 4-HNE alkyne
|
lipids peroxidation inflammation neurodegeneration atherosclerosis diabetes cancers click chemistry Click Tag™ 4-HNEs alkynes IT |
| 10185 |
4-oxo-2-Nonenal
|
|
103560-62-9 |
>98%
|
|
|
2004-01-21
|
59.851837016574
|
4-oxo-2-nonenal
|
4-ONE
|
ROS Alkenals aldehydes free radicals peroxidation lipid autoxidation reactive oxygen species |
| 10004174 |
4-oxo 2-Nonenal-d3
|
|
- |
≥99% deuterated product
|
|
|
2004-03-10
|
34.416077348066
|
4-oxo-2-nonenal-d3
|
4-ONE-d3
|
ROS Alkenals aldehydes free radicals peroxidation lipid autoxidation reactive oxygen species 4-OH-2-nonenal-d3 4-hydroxy2nonenald3 internal standards mass spectrometry GC/MS LC/MS gc-ms ic-ms deuterium deuterateds |
| 10011049 |
4-phenyl-5-methyl-1,2,3-Thiadiazole
|
|
64273-28-5 |
≥98%
|
|
|
2009-03-14
|
0.094889502762
|
4-phenyl-5-methyl-1-2-3-thiadiazole
|
NSC 358739
|
cytochrome P450 CYP450 CYP2B4 CYP2E1 CYP1A2 inhibitors inhibits inhibition thiadiazoles fungicide herbicide plant growth regulator |
| 13379 |
5-bromo-3-phenyl-Salicylic Acid
New |
|
99514-99-5 |
≥95%
|
|
|
2010-08-10
|
0E-12
|
5-bromo-3-phenyl-salicylic-acid
|
|
Aldo-keto reductases AKR oxidoreductases hydroxysteroid dehydrogenases HSD 20α-HSD progesterone cancers steroids brain functions AKR1C1 AKR1C2 AKR1C3 AKR1C4 endothelial cells |
| 10009315 |
6-Aminonicotinamide
|
|
329-89-5 |
≥98%
|
|
|
2008-11-21
|
0.472375690608
|
6-aminonicotinamide
|
6-AN; NSC 21206; SR 4388
|
inhibitors inhibits inhibition 6-phosphoguconate dehydrogenase cancers ATPs oxidative injury neurodegeneration cardiovascular |
| 10009856 |
7-AAD Cell Viability Assay Kit
|
|
- |
|
|
|
2008-10-29
|
14.545303867403
|
7-aad-cell-viability-assay-kit
|
7-Amino Actinomycin D Cell Viability Kit
|
kits 7AAD measurement cells fixation blocking cytoxicity effects environmental toxins drug fluorescence fluorescent cell-based assays cell based assay cba |
| 600120 |
7-AAD/CFSE Cell-Mediated Cytotoxicity Assay Kit
|
|
- |
|
|
|
2009-08-05
|
35.546281767956
|
7-aad-cfse-cell-mediated-cytotoxicity-assay-kit
|
7-Amino Actinomycin D; 5-(6)-Carboxyfluorescein Diacetate Succinimidyl Ester
|
7-amino actinomycin D/5-(6)-carboxyfluorescein diacetates succinimidyls esters assays kits measuring measurement kits 5-(6) 5,6 5-6 7AAD cells cytoxicity cell-based cba cytolysis target effector T lymphocytes NK natural killer autoimmune systems pathological cancers multiple sclerosis granule exocytosis pathways Fas diseases graft host 51chromium 51Cr green fluorescent fluorescence probes red propidium iodide dead effector carboxyfluorescein succinimidyl esters dyes damaged DNA deoxyribonucleic acids quantify quantification single staining |
| 89300 |
8-hydroxy Guanosine
|
|
- |
>98%
|
|
|
|
11.989834254143
|
8-hydroxy-guanosine
|
|
oxidative injury RNA stress damage 7,8-dihydro-8-oxo-guanosine markers inhibitors growth 3868-31-3 |
| 10008051 |
Acid Phosphatase Assay Kit
|
|
- |
|
|
|
2006-09-20
|
6.141528545119
|
acid-phosphatase-assay-kit
|
|
aps hydrolase eznymes prostate pap tartrate resistant assays |
| 10006908 |
Adipogenesis Assay Kit
|
|
- |
|
|
|
2006-08-18
|
79.845113008538
|
adipogenesis-assay-kit
|
|
obese obesity cells cycle differentiation inhibits inhibitors inhibition adipocytes cancers origin 3T3-L1 model drug screening adipokines endocrinology cell-based assays
cell based assay cba |
| 10009381 |
Adipolysis Assay Kit
|
|
- |
|
|
|
2007-07-30
|
41.588784530386
|
adipolysis-assay-kit
|
|
obese obesity cells cycle differentiation inhibits inhibitors inhibition adipocytes cancers origin 3T3-L1 model drug screening adipokines lipolysis 3T3L1 kits assays FFA adipocytes endocrinology cell-based assay
cell based assay cba |
| 10010129 |
AG-041R
|
|
199800-49-2 |
≥98%
|
|
|
2008-12-16
|
87.188011049723
|
ag-041r
|
|
CCKs gastrin receptors antagonist cancers proliferations apoptosis NS-398 NS398 NS 398 |
| 10010314 |
AG-123
|
|
122520-86-9 |
>97%
|
|
|
2008-02-05
|
2.578370165745
|
ag-123
|
Tyrphostin AG-123; Tyrphostin 47
|
protein tyrosine kinases PTKs inhibitors inhibits inhibition antiproliferative epidermal growth factors EGFs receptors proliferation carcinomas A431 epidermal AG123 Ag 123 |
| 10010592 |
AG-1296
|
|
146535-11-7 |
>98%
|
|
|
2008-05-09
|
5.404488950275
|
ag-1296
|
Tyrphostin AG-1296
|
tyrphostins AG1296 PDGFR PTK SCF inhibitors inhibits inhibition receptors kinases proteins platelet-derived platelet derived growth factors in vitro cancer glioma athrosclerosis restenosis AG1296 AG 1296 |
| 10010244 |
AG-1478
|
|
153436-53-4 |
>98%
|
|
|
2008-04-22
|
10.538691032723
|
ag-1478
|
NSC 693255; Tyrphostin AG-1478
|
NSC 693255 EGFR PTK inhibitors inhibits inhibition kinases receptors cancers antitumor leioyoma myometrium 175178-82-2 AG1478 AG 1478 |
| 10010248 |
AG-17
|
|
10537-47-0 |
>98%
|
|
|
2007-09-18
|
1.688674033149
|
ag-17
|
NSC 242557; Tyrphostin 9; Malonoben; Tyrphostin AG-17; SF 6847; GCP 5126; RG 50872
|
proteins tyrosine kinases PTK inhibitors inhibits antiproliferative epidermal growth factor EGF receptors proliferations carcinomas AG17 AG 17 SF6847 SF-6847 GCP-5126 GCP5126 |
| 10010300 |
AG-18
|
|
118409-57-7 |
>98%
|
|
|
2007-12-20
|
1.628913443830
|
ag-18
|
RG-50810; Tyrphostin AG-18; Tyrphostin 23; TX 825; RG-50858
|
proteins tyrosines kinases PTKs inhibitors inhibition inhibits antiproliferative epidermal growth factors EGF receptors proliferations carcinoma cancers epidermoid cell lines A431 AG18 AG 18 A23 A-23 A23 RG50810 RG 50810 RG50858 RG 50858 TX-825 TX825 |
| 10010315 |
AG-183
|
|
122520-90-5 |
>98%
|
|
|
2007-09-07
|
1.931928679055
|
ag-183
|
Tyrphostin 51
|
proteins tyrosine kinases PTKs inhibitors inhibition inhibits inhibition antiproliferative epidermal growth factors EGFs receptors proliferation carcinomas cancers epidermoid AG183 AG 183 |
| 10010568 |
AG-370
|
|
134036-53-6 |
>95% (cis/trans mixture)
|
|
|
2009-01-09
|
4.299696132596
|
ag-370
|
NSC 651712
|
PTK inhibitor tyrphostin tyrosine PDGF receptor kinase EGF receptor antiproliferative |
| 10010311 |
AG-490
|
|
133550-30-8 |
>98%
|
|
|
2007-12-01
|
4.547441988950
|
ag-490
|
|
PTK tyrosine kinase inhibitors inhibition inhibits antiproliferatives tyrphostins leukemia Jak-2 Jak2 AG490 |
| 10010242 |
AG-494
|
|
133550-35-3 |
>98%
|
|
|
2008-02-08
|
1.640561694290
|
ag-494
|
|
protein tyrosine kinases PTKs inhibitors inhibits inhibition antiproliferative RG-13022 epidermal growth factors EGFs receptrors cancers proliferation |
| 10010312 |
AG-82
|
|
118409-58-8 |
>95%
|
|
|
2008-03-14
|
1.949625098658
|
ag-82
|
Tyrphostin AG-82; NSC 676484; RG-50875; Tyrphostin 25
|
proteins tyrosines kinases PTKs inhibitors inhibits inhibition antiproliferative epidermal growth factors EGFs receptors proliferation carcinomas blockers A431 AG82 AG 82 RG-50875 RG50875 A25 A-25 |
| 10010243 |
AG-825
|
|
149092-50-2 |
>98%
|
|
|
2008-01-24
|
3.442991925201
|
ag-825
|
Tyrphostin AG-825
|
Her-2 Her-2/neu erbB tyrosine kinases EGF EGFR cancers anti-cancer prostate breast signal transduction inhibitors inhibition inhibits AG825 AG 825 |
| 10010313 |
AG-99
|
|
122520-85-8 |
>98%
|
|
|
2007-12-19
|
1.541170266197
|
ag-99
|
Tyrphostin 46
|
protein tyrosine kinase PTKs inhibitor inhibits inhibition antiproliferatives epidermal growth factors EGFs receptors proliferation carcinoma cancers blochers EGF-dependent A431 cell lines AG99 AG 99 |
| 13145 |
AGK2
|
|
304896-28-4 |
≥98%
|
|
|
2009-10-22
|
10.069288267793
|
agk2
|
|
sirtuins SIRT2 histones deacetylase HDAC cells cycle progression tumorigenesis cancers SIRT1 SIRT3 dopamine neurons α-synuclein Parkinson's diseases neurodegeneration |
| 19023 |
AH 23848 (calcium salt, hydrate)
|
|
- |
≥90%
|
|
|
2009-02-26
|
109.787279005524
|
ah-23848-calcium-salt-hydrate
|
|
AH23848B AH 23848 TXBs thromboxane PGEs PGE2 receptors prostanoids TPs EP4 antagonist blockers inhibitors inhibits inhibition TXA2 platelets smooth muscle bronchial U-46619 U46619 fibroblasts cancers metastasis 81739-45-9 AH-23848 |
| 10010241 |
AICAR
|
|
2627-69-2 |
>98%
|
|
|
2008-02-25
|
245.893950276243
|
aicar
|
NSC 105823; Acadesine; AICA Riboside
|
AMPK lipids metabolism glucose fatty acids sterol HMG-CoA reductases inflammation cytokine iNOS COX-2 MnSOD glia macrophages TNF-.alpha. IL-1.beta. IL-6 aminoimidazole carboxamide ribonucleotide |
| 160773 |
AIF Polyclonal Antibody
|
|
- |
|
|
|
|
0E-12
|
aif-polyclonal-antibody
|
Programmed Cell Death Protein 8; Apoptosis-Inducing Factor Polyclonal Antibody
|
apoptosis antibodies western blots blotting WB antisera antiserum factors cancers immunoblotting |
| 13733 |
Akt1 (Phospho-Ser473) Monoclonal Antibody (Clone 104A282)
|
|
- |
|
|
|
2010-01-11
|
43.094799614136
|
akt1-phospho-ser473-monoclonal-antibody-clone-104a282
|
|
antibodies Akts PKBs peptides Akt-1 Akt 1 protein kinase B serine threonine western blots blotting immunoblotting WB IP Immunoprecipitation IP |
| 13732 |
Akt1 Polyclonal Antibody
|
|
- |
|
|
|
2010-01-11
|
43.094799614136
|
akt1-polyclonal-antibody
|
|
antibodies Akts PKBs peptides Akt-1 Akt 1 protein kinase B serine threonine western blots blotting immunoblotting WB |
| 13735 |
Akt2/3 Polyclonal Antibody
|
|
- |
|
|
|
2010-01-12
|
44.047180566517
|
akt2-3-polyclonal-antibody
|
|
Akt-2 Akt 2 PKB proteins kinase B serine threonine signaling PI3-kinase cancers Western blots blotting immunoblotting WB Akt-3 Akt 3 2-3 |
| 13734 |
Akt2 Monoclonal Antibody (Clone 95C567.1.2)
|
|
- |
|
|
|
2010-01-12
|
44.047180566517
|
akt2-monoclonal-antibody-clone-95c567-1-2
|
|
Akt-2 Akt 2 PKB proteins kinase B serine threonine signaling PI#-kinase cancers Western blots blotting immunoblotting WB |
| 13736 |
Akt3 Monoclonal Antibody (Clone 66C1247.1)
|
|
- |
|
|
|
2010-01-19
|
50.713847233184
|
akt3-monoclonal-antibody-clone-66c1247-1
|
|
Akt-3 Akt 3 western blot blotting immunoblotting WB Akts protein kinase B PKB serin threonine signaling proteins |
| 10010079 |
Akt (human recombinant) Western Ready Control
Exclusive |
|
- |
|
|
✓ |
2008-08-26
|
17.033922651933
|
akt-human-recombinant-western-ready-control
|
Protein Kinase B; PKB; AKT1
|
western blots proteins antibodies antiserum antisera WB kinases serine threonine hexahistidine his-tag his-tagged N-terminal immunoblotting blotting |
| 10009350 |
Aldehyde Reactive Probe
|
|
139585-03-8 |
≥98%
|
|
|
2008-08-26
|
7.327900552486
|
aldehyde-reactive-probe
|
O-(Biotinylcarbazoylmethyl) Hydroxylamine; ARP
|
DNA damages AP sites synthesis mutations ROS biotin oxidative stress detection detecting |
| 13144 |
Anacardic Acid
|
|
16611-84-0 |
≥98%
|
|
|
2010-02-12
|
66.665942909761
|
anacardic-acid
|
6-pentadecyl Salicylic Acid
|
HAT histones acetylation P300 pCAF transcription NF-κB IκBα p65 6-pentadecyl salicyclic acids NSC 623096 cyclogallipharic 229596 333857 |
| 600300 |
Annexin V FITC Assay Kit
New |
|
- |
|
|
|
2010-05-11
|
35.555555555556
|
annexin-v-fitc-assay-kit
|
|
assays kits measures measurements apoptosis cells death cycles tissues homeostasis dysregulation neurodegenerative diseases ischemic damages autoimmune disorders cancers drugs discovery signaling pathways membranes phospholipids phosphatidylserines phosphatidylethanolamines leaflets bilayers externalizations residues plasma phospholipids binding proteins fluorochrome-labeled fluorochromes fluorescence microscopy flow cytometry FC plate readers TUNEL TdT-mediated dUTP Nick-End Labeling analysis ISEL in situ end labeling DNA laddering detection fragmentation FITC-conjugated fluoresceins |
| 160780 |
Apaf-1 Polyclonal Antibody
|
|
- |
|
|
|
|
1.519576427256
|
apaf-1-polyclonal-antibody
|
Apoptosis Protease-Activating Factor 1
|
apoptosis cell death caspases CED-4 Apaf2 Apaf3 Apaf-2 Apaf-3 Apafs antibodies Apaf1 CED4 western blots blotting WB protease-activating factors proteases antisera antiserum cancers immunoblotting |
| 10006797 |
Araguspongin B
|
|
123000-02-2 |
>90%
|
|
|
2005-09-09
|
64.020527931246
|
araguspongin-b
|
|
membrane-permeable antagonists inositols inositol-1,4,5-triphosphates receptors marine products Pacific basin sponges vasodilatory properties signal transductions messengers IP3 promotes mobilization calcium Ca2+ intracellular stores antagonizes calcium-releasing actions cerebral microsomes Xestospongin C neuroscience |
| 160737 |
ARC Polyclonal Antibody
|
|
- |
|
|
|
|
9.948480662983
|
arc-polyclonal-antibody
|
Apoptosis Repressor with CARD
|
apoptosis cell death domain DD CARD caspase antibodies western blots blotting WB antisera antiserum cancers immunoblotting IP immunoprecipitation |
| 13250 |
(−)-AS 115
Exclusive |
|
- |
≥98%
|
|
✓ |
2009-05-18
|
9.287845303867
|
-as-115
|
|
KIAA1363 MAGE monoacylglycerol LPA LPC lysophosphatidylcholine lysophosphatidic acid lipids signaling cancers signalling |
| 10009650 |
(+)-AS 115
|
|
926657-43-4 |
≥98%
|
|
|
2009-05-19
|
9.298895027624
|
-as-115
|
|
KIAA1363 MAGE monoacylglycerol LPA LPC lysophosphatidylcholine lysophosphatidic acid lipids signaling cancer |
| 700420 |
Ascorbate Assay Kit
New |
|
- |
|
|
|
2010-09-01
|
0E-12
|
ascorbate-assay-kit
|
L-Ascorbic Acid Assay Kit; Vitamin C Assay Kit
|
kits assays measures measurements ascorbates six-carbon 6-carbon six 6 carbons lactones glucose livers mammalian species humans non-human primates guinea pigs gulonolactones oxidases acids 2-keto-1-gulonolactone diets dietary scurvy electrons donors enzymes collagen hydroxylations hydroxyls groups prolines lysines molecules carnitines fatty mitochondrias ATP adenosine triphosphates generations biosynthesis norepinephrines dopamines amides groups peptides hormones tyrosines metabolisms antioxidants chronics diseases cancers cardiovascular cataracts foods industry colors tastes odors plasmas serums urines fruits juices condensations reactions dehydroascorbic DHA o-phenylenediamines OPDA fluorescent fluorescences 4-hydroxy-2,2,6,6-tetramethylpiperidinyloxy TEMPOL condensed DFQ 3-(dihydroxyethyl)-furo[34-b]-quinoxaline-1-one OPD |
| 13375 |
Atrazine
|
|
1912-24-9 |
≥98%
|
|
|
2010-02-11
|
55.621853898097
|
atrazine
|
|
herbicides plants cancers reproductive systems reproduction homones endocrines frogs genes expressions humans animals |
| 600140 |
Autophagy/Cytotoxicity Dual Staining Kit
|
|
- |
|
|
|
2009-07-14
|
90.794762430939
|
autophagy-cytotoxicity-dual-staining-kit
|
|
assays kits measuring measurement MDC cell-based autophagy cells cytotoxicity staining autofluorescent autofluorescence substances multilamellar body bodies ions trapping mechanisms membranes lipids probes autophagic vacuoles cultured degradation digestion intracellular lysosomes organelles misfolded proteins microorganisms cytoplasms double membranes autophagosomes autolysosomes homeostasis dysregulation cancers infections aging degenerative diseases stress death apoptosis |
| 13813 |
Axitinib
New |
|
319460-85-0 |
98%
|
|
|
2010-08-09
|
0E-12
|
axitinib
|
AG 013736
|
tyrosine kinases inhibitors inhibition inhibits VEGF VEGFR-1 VEGFR-2 VEGFR-3 c-kit PDGFR-β angiogenesis cancers tumors 790713-39-2 receptors RTKs |
| 10011385 |
Bim/BOD (IN) Polyclonal Antibody
|
|
- |
|
|
|
2008-04-10
|
1.782872928176
|
bim-bod-in-polyclonal-antibody
|
|
apotosis BH3 Bcl-2 Bcl-XL cancer immunoblotting WB IHC antibodies western blotting antiserum blots immunohistochemistry |
| 10005270 |
C75
|
|
191282-48-1 |
>98%
|
|
|
2004-09-22
|
29.944714548802
|
c75
|
|
inhibits inhibitors inhibition fatty acids synthases FAS cerulenin cytotoxicity apoptosis cancers anorexigenic stable weight loss feeding endocrinology |
| 13285 |
Cannabidiol dimethyl ether
|
|
1242-67-7 |
≥98%
|
|
|
2009-05-19
|
6.635718232043
|
cannabidiol-dimethyl-ether
|
Cannabidiol-2',6'-dimethyl ether; CBDD
|
15-lipoxygenases 15-LOs dioxygenase fatty acids inflammation thrombosis cancer LDL oxidation inhibitions inhibition inhibiting |
| 10487 |
Capecitabine
New |
|
154361-50-9 |
≥98%
|
|
|
2010-08-16
|
0E-12
|
capecitabine
|
Ro 09-1978; Xeloda®
|
Capecitibine Capecytabine Captabin 5-Fluorouracil 5-FU cancers prodrugs thymidine phosphorylase fluoropyrimidine carbamate inhibits inhibition inhibitors thymidylate synthase liver enzymes 158798-73-2 958887-39-3 |
| 89800 |
Carnosol
|
|
5957-80-2 |
>96%
|
|
|
|
96.884475138121
|
carnosol
|
|
antioxidants tumors herbs carcinogenesis rosemary Rosmarinus officinalis extracts polyphenolic inhibits inhibitors inhibition |
| 360745 |
Caspase-3 (human) Blocking Peptide
|
|
- |
|
|
|
|
0.711602209945
|
caspase-3-human-blocking-peptide
|
Yama; ICE3; CPP32; Apopain
|
control peptides blots blotting western cpp-32 ice-3 apoptosis effectors caspases cell death wb antibodies |
| 10007630 |
Caspase-8 (human recombinant)
|
|
- |
>95% by SDS-PAGE
|
|
|
2006-01-04
|
21.196236187845
|
caspase-8-human-recombinant
|
MCH5; MACH; FLICE
|
proenzymes procaspases-8 interleukins ILs IL-1b IL-1.beta. ICE family cysteines proteases cells apoptosis aspartate residues self-proteolysis cleavage large small subunits activates downstream caspase-3 caspase-6 caspase-7 cellular substrates death cancer |
| 160790 |
Caspase-9 Polyclonal Antibody
|
|
- |
|
|
|
|
45.207771639042
|
caspase-9-polyclonal-antibody
|
MCH6 Polyclonal Antibody; ICE-LAP6 Polyclonal Antibody; Apaf-3 Polyclonal Antibody
|
apoptosis cell death Apaf-1 apafs caspase-3 caspases antibodies Apaf1 western blots blotting WB an tisera antiserum cancers immunoblotting |
| 13704 |
Cav3.2 Calcium Channel Monoclonal Antibody (Clone S55-10)
|
|
- |
|
|
|
2009-11-12
|
0.369064748201
|
cav3-2-calcium-channel-monoclonal-antibody-clone-s55-10
|
|
antibodies CACNA1H genes epilepsy up-regulations up regulations upregulations prostate cancers androgen-independent androgen independent western blotting blots WB fusion protein immunohistochemistry IHC immunocytochemistry ICC |
| 89740 |
CAY10398
Exclusive |
|
- |
>98%
|
|
✓ |
|
101.664604051565
|
cay10398
|
|
reversible inhibitors histone deacetylase HD1 inhibits inhibitions CAY-10398 hdacs HDAC-1 HDACs HDAC 1 HDAC1 HDACIS |
| 70635 |
CAY10416
|
|
443919-96-8 |
>95%
|
|
|
2007-07-24
|
19.453756906077
|
cay10416
|
|
COX-2 cyclooxygenases 5-LO lipoxygenases inflammation inhibitors prostates cancers PC3 LNCaP carcinomas apoptosis inhibition inhibits chemotherapy cells lines |
| 10005019 |
CAY10433
Exclusive |
|
537034-17-6 |
>98%
|
|
✓ |
2005-01-05
|
49.714043710572
|
cay10433
|
BML-210; N-phenyl-N'-(2-Aminophenyl)hexamethylenediamide
|
HDAC deacetylases histone inhibits inhibitors inhibition cancer cells differentiation gene expression regulation Trichostatin A nuclear extracts deacetylation transcription factors FOXO3 SIRT1 H2O2 hydrogen peroxides BML210 |
| 10005033 |
CAY10444
Exclusive |
|
298186-80-8 |
>98%
|
|
✓ |
2004-10-05
|
41.835755064456
|
cay10444
|
BML-241
|
receptors antagonists S1P3 EDG3 sphingosines sphingosine-1 sphingosine1 phosphates Hela cells G-proteins CAY-10444 BML241 |
| 10006546 |
CAY10465
|
|
688348-33-6 |
>98%
|
|
|
2005-09-09
|
10.871038674033
|
cay10465
|
|
resveratrol analogs analogues aryl hydrocarbons receptors agonists AhRs ligand-dependents ligands xenobiotics PDM 11 PDM11 PDM-11 estrogen dioxin poisonings stilbene xenobiotics polyaromatics soot coal tar |
| 10008872 |
CAY10503
|
|
- |
>98%
|
|
|
2007-08-02
|
49.169944751381
|
cay10503
|
|
apoptosis antiproliferation cancers differentiation HL60 cells cycles proliferative positive markers CD14 CD11b CD11c monocytic granulocytic |
| 10009078 |
CAY10505
|
|
328960-84-5 |
≥98%
|
|
|
2009-11-04
|
10.900440805051
|
cay10505
|
|
phosphoinositide 3-kinase immunity autoimmune inflammation PI3Kγ PI3Kα PI3Kβ PI3Kδ casein kinases 2 CK2 phosphorylation PKB/Akt macrophages neutrophil recruitment cancer PI3s T2Ds PI3Ks PI3K.gamma. PI3Kg |
| 10009536 |
CAY10512
|
|
139141-12-1 |
>97%
|
|
|
2007-07-18
|
12.972464088398
|
cay10512
|
|
analogs resveratrol nuclear factors NFkB NF-.kappa.B immunity inflammation stress growth apoptosis trans-stilbene activation cancers NF-kB inhibition inhibtors inhibits atherosclerosis |
| 10010301 |
CAY10554
|
|
267654-00-2 |
>95%
|
|
|
2007-12-01
|
9.965423572744
|
cay10554
|
BML-259
|
cell cycle cdk5 cdk2 inhibitors inhibits inhibition cancers BML 259 BML259 CDKs neurodegenerative diseases |
| 10010043 |
CAY10561
Exclusive |
|
933786-58-4 |
>98%
|
|
✓ |
2008-03-06
|
4.249723756906
|
cay10561
|
Pyrazolylpyrrole ERK Inhibitor
|
MEK Ras Raf ERK2 proliferation cell cycles cancers apoptosis inhibition inhibit inhibitors |
| 18218 |
CAY10572
|
|
845714-00-3 |
≥98%
|
|
|
2009-03-02
|
10.187338858195
|
cay10572
|
PHA 767491
|
inhibits inhibition inhibitors cdc7 kinases pyrrolopyridinone DNA synthesis cells death cycles apoptosis p53 cancers cdk9 antitumor agents anti-tumor |
| 10011247 |
CAY10574
|
|
140651-18-9 |
>95%
|
|
|
2008-09-04
|
14.638066298342
|
cay10574
|
|
CDK2 cyclin E CDK9 inhibitors inhibits inhibition anticancer cell cycle CAN508 |
| 10011256 |
CAY10577
|
|
300675-28-9 |
≥95%
|
|
|
2008-09-02
|
0.397790055249
|
cay10577
|
|
inhibitors inhibits inhibition CK2 kinase cell signaling apoptosis cancers |
| 10011264 |
CAY10578
|
|
19231-60-8 |
≥95%
|
|
|
2008-08-26
|
0.397790055249
|
cay10578
|
|
inhibitors inhibits inhibition kinase cell signaling CK2 apoptosis cancers isoindolineacetic acids |
| 16835 |
CAY10580
Exclusive |
|
64054-40-6 |
≥96%
|
|
✓ |
2009-03-16
|
191.022872928176
|
cay10580
|
|
PGEs PGE2 receptors inhibitors inhibits inhibition antagonist blockers EP4 cAMPs bones fromation resorption cancers atherosclerosis |
| 16838 |
CAY10581
Exclusive |
|
1018340-07-2 |
≥97%
|
|
✓ |
2009-05-08
|
4.807182320442
|
cay10581
|
|
indoleamine 2,3-dioxygenase IDO cancers inhibitors tumors inhibition inhibited naphthoquinones |
| 10012682 |
CAY10585
|
|
934593-90-5 |
≥97%
|
|
|
2008-11-06
|
40.265179558011
|
cay10585
|
Hypoxia Inducible Factor-1α Inhibitor
|
HIF-1α HIF1α hypoxia cancers transcriptions factors VEGFs erythropoietin inhibitors inhibits inhibition |
| 10009797 |
CAY10591
Exclusive |
|
839699-72-8 |
>98%
|
|
✓ |
2008-04-21
|
21.326034849128
|
cay10591
|
Sirtuin 1 Activator 3; SIRT1 Activator 3
|
p53 HDACs inhibits inhibitors inhibitions SIRTs sirtuins class III TNFalpha TNF.alpha. THP-1 cells anti-obesity anti-diabetic |
| 13206 |
CAY10593
Exclusive |
|
- |
≥95%
|
|
✓ |
2009-09-03
|
18.976316758748
|
cay10593
|
VU0155069
|
inhibitors inhibits inhibitions phospholipases D PLD PLD1 PLD2 phosphatidic acids PAs chemotaxis cells migration cancers breast lines tumors trans well assays 1130067-06-9 |
| 13281 |
CAY10598
Exclusive New |
|
346673-06-1 |
≥98%
|
|
✓ |
2010-05-07
|
28.830165745856
|
cay10598
|
|
Prostaglandins E2 PGE2 receptors EP4 bone formation cancers atherosclerosis agonists EP1 EP2 EP3 DP FP IP TP neuroprotection renal dysfunction inflammation neuro-protection |
| 10009796 |
CAY10602
|
|
374922-43-7 |
≥95%
|
|
|
2009-07-15
|
11.461740331491
|
cay10602
|
|
SIRT1 Activator 1 SIRTs sirtuins inflammation deacetylase NF-kB NFkB NF-κB NFκB |
| 13146 |
CAY10603
|
|
1045792-66-2 |
≥98%
|
|
|
2009-06-18
|
79.086497237569
|
cay10603
|
|
HDAC 6 inhibitors inhibits inhibition tubulin microtubule pancreatic cancers SAHA HDAC6 HDAC-6 HDACs HDACIs potent selective cells |
| 13321 |
CAY10609
|
|
704888-90-4 |
≥98%
|
|
|
2009-10-07
|
2.344711917916
|
cay10609
|
|
matrix metalloproteinases MMP-2 MMP2 MMP 2 ECM cancers cells migration inhibitors gelatinase A MMPs proteases HT1080 tumors invasive |
| 13291 |
CAY10616
Exclusive |
|
586410-08-4 |
≥98%
|
|
✓ |
2009-12-01
|
15.154834303036
|
cay10616
|
|
resveratrols apoptosis cancers leukemia HL-60 cells HL60 HL 60 multidrug-resistance multidrug resistance multi-drug multi-drug-resistant daunorubicin etoposides citarabines phenols cytarabines HL60R |
| 13371 |
CAY10621
Exclusive |
|
120005-55-2 |
≥98%
|
|
✓ |
2010-02-16
|
84.225160374463
|
cay10621
|
SPHK 1 Inhibitor 5C
|
sphingosines kinases Sphk sphingosine-1-phosphates S1P SphK1 SphK2 cancers inhibitors inhibits U937 cells proteins kinase C PKC |
| 13836 |
CAY10625
Exclusive New |
|
137346-42-0 |
≥95%
|
|
✓ |
2010-06-23
|
0E-12
|
cay10625
|
|
apoptosis Smac Diablo Survivin cancers antagonists INCENP doxorubicin caspase-3 caspase-7 Aurora B kinases Borealin caspases cell-permeable antagonists smac/diable smac-diablo |
| 13838 |
CAY10626
Exclusive New |
|
1202884-94-3 |
≥98%
|
|
✓ |
2010-08-23
|
0E-12
|
cay10626
|
|
PI3Kα mTOR cancers signal transduction inhibitors inhibits inhibition phosphatidylinositol 3-kinase PtdIns PIs |
| 10004985 |
Caylin-1
|
|
- |
>98%
|
|
|
2005-09-09
|
24.657108655616
|
caylin-1
|
|
caylin1 mdm-2 cancer Nutlin-3 analogs p53 inhibits inhibitors inhibition interaction Mdm2 negative regulators activity chlorine substituents phenyl rings growth HCT-116 cells promotes |
| 10005002 |
Caylin-2
|
|
- |
>98%
|
|
|
2004-07-12
|
21.455698500394
|
caylin-2
|
|
apoptosis cancer p53 inhibits inhibitors induces apoptotic re-activation reactivation antioncogenic tumors xenografts HCT-116 caylin2 |
| 13172 |
CBHA
|
|
174664-65-4 |
≥98%
|
|
|
2009-06-24
|
39.813042620363
|
cbha
|
Histone Deacetylase Inhibitor II; m-Carboxycinnamic Acid bis-Hydroxamide
|
histones deacetylase HDACs HDAC1 HDAC3 apoptosis cancers neuroblastoma tumors retinoic acids inhibitors inhibits inhibition |
| 10010350 |
CCG-1423
Exclusive |
|
285986-88-1 |
>98%
|
|
✓ |
2007-09-20
|
7.144751381215
|
ccg-1423
|
|
Rho signaling transduction cancers proliferations anti-proliferation anti-tumor serum response factor GTPase inhibits inhibitors inhibition signalling |
| 10012591 |
CCT018159
|
|
171009-07-7 |
≥98%
|
|
|
2008-12-09
|
0.584072612470
|
cct018159
|
|
inhibitors inhibits inhibition cancers Hsp90s Hsp72 kinases tumor cells 17-AAG 17AAG CCT 018159 CCT-018159 |
| 10004804 |
CD150 Monoclonal Antibody (Clone IPO-3)
|
|
- |
|
|
|
2005-03-21
|
0.320810313075
|
cd150-monoclonal-antibody-clone-ipo-3
|
SLAM; IPO-3; CDw150
|
type transmembrane glycoproteins signals signalling transduction neoplastic cells antibodies antisera antiserum antioncogenic immunohistochemistry IHC flow cytometry immunoprecipitation IP immunocytochemistry ICC receptors ligation Hodgkins lymphoma leukemia tumors cancer ipo3 cd-150 b-cells t-cells tonsils cancers FC |
| 10004837 |
CD27 Monoclonal Antibody (Clone 203.6)
|
|
- |
|
|
|
2005-09-16
|
4.521180311401
|
cd27-monoclonal-antibody-clone-203-6
|
|
antibodies antisera antiserum IHC immunohistochemistry ICC immunocytochemistry FACS flow cytometry type II transmembranes glycoproteins leukocytes proteins tetraspanin superfamily antigens alternative splicing isoforms human B cells pro-B plasma T macrophages neutrophils platelets erythrocytes Anti-CD37 immunophenotyping neoplasia hairy chronic lymphocytic non-Hodgkin's lymphoma expression lymphocytes T cells NK activated memory monocytes granulocytes dendritic B anti-CD45 mAB lymphoid malignancies malignant cancer FC |
| 10004835 |
CD34 Monoclonal Antibody (Clone ICO-115)
|
|
- |
|
|
|
2005-09-16
|
4.827484062898
|
cd34-monoclonal-antibody-clone-ico-115
|
|
antibodies antisera antiserum ICC immunocytochemistry FACS flow cytometry type I transmembranes glycoproteins proteins antigens isoforms stem cells embryonic fibroblasts neurons Anti-CD34 differential staining acute leukemias cancers malignant malignancies ICO115 FC |
| 10208 |
CD34 Monoclonal FITC Antibody (Clone ICO-115)
|
|
- |
|
|
|
2008-07-23
|
45.700322283609
|
cd34-monoclonal-fitc-antibody-clone-ico-115
|
|
antibodies antiserum antisera flow cytometry immunofluorescence FC IF transmembranes glycoproteins leukemias stem cell lines |
| 10004718 |
CD37 Monoclonal Antibody (Clone IPO-24)
|
|
- |
|
|
|
2005-09-16
|
4.521180311401
|
cd37-monoclonal-antibody-clone-ipo-24
|
|
antibodies antisera antiserum IHC immunohistochemistry ICC immunocytochemistry FACS flow cytometry type III transmembranes glycoproteins leukocytes proteins tetraspanin superfamily antigens alternative splicing isoforms human B cells pro-B plasma T macrophages neutrophils platelets erythrocytes Anti-CD37 immunophenotyping neoplasia hairy chronic lymphocytic non-Hodgkin's lymphoma expression lymphocytes T cells NK activated memory monocytes granulocytes dendritic B anti-CD45 mAB lymphoid malignancies malignant cancer FC |
| 10004597 |
CD45 Monoclonal Antibody (Clone BRA-55)
|
|
- |
|
|
|
2005-08-23
|
5.046042189854
|
cd45-monoclonal-antibody-clone-bra-55
|
|
antibodies antisera antiserum WB western blots blotting IHC immunohistochemistry ICC immunocytochemistry FACS flow cytometry type transmembranes glycoproteins leukocytes antigens alternative splicing isoforms CD45RA CD45RB CD45RC CD45RO expression lymphocytes cells NK activated memory monocytes granulocytes dendritic anti-CD45 mAB lymphoid malignancies malignant cancer BRA55 immunoblotting FC |
| 10009852 |
CD4/CD8 Monoclonal FITC/PE Antibody (Clone RIV7/OKT-8)
|
|
- |
|
|
|
2008-09-03
|
3.397790055249
|
cd4-cd8-monoclonal-fitc-pe-antibody-clone-riv7-okt-8
|
|
antibodies antisera antiserum FC flow cytometry human whole blood cells lysis white CD4-CD8 CD4+CD8 |
| 10004604 |
CD95 Monoclonal Antibody (Clone IPO-4)
|
|
- |
|
|
|
2004-06-17
|
0.625675874769
|
cd95-monoclonal-antibody-clone-ipo-4
|
APO-1; Fas; Tumor Necrosis Factor Receptor Superfamily, Member 6; TNFRSF6; Apoptosis Antigen; APT
|
glycoproteins blots blotting antibodies antisera antiserum DNA binding anti-oncogenic apoptosis cancers p53 re-activator reactivator induces apoptotic re-activation reactivation antioncogenic immunocytochemistry immunohistochemistry IHC icc FC flow cytometry |
| 10009349 |
Cell Cycle Phase Determination Kit
|
|
- |
|
|
|
2007-04-20
|
40.741099984653
|
cell-cycle-phase-determination-kit
|
|
assays kits measures measurements microscopy flow cytometry plate readers regulators cells transcription factors DNA proteins division proliferation induction inhibition fixation permeabilization staining sub-G1 G0 G2 S propidium iodide apoptosis cancer cell-based assay
cell based assay cba |
| 10005647 |
Cerulenin
|
|
17397-89-6 |
>98%
|
|
|
2004-09-01
|
27.366878453038
|
cerulenin
|
|
tumor cells fatty acid synthases FAS inhibits inhibitors inhibition cytotoxicity apoptosis cancer diet obesity |
| 10009853 |
CFSE Cell Division Assay Kit
|
|
- |
|
|
|
2010-01-15
|
64.210537139349
|
cfse-cell-division-assay-kit
|
|
derivative carboxyfluorescein diacetate, succinimidyl ester CFDA-SE cells proliferation growth factors receptors surfaces signaling molecules transcription factors DNA deoxyribonucleases proteins divisions cascades human pathological diseases cancers cell-tracing fluorescent fluorescence dyes proliferative activity parent generations daughter acetate groups molecules cleaved background unstained staining CFSE-labeled radioactivity radioactive labeling divisions inductions inhibitors inhibits inhibitions in vitro models flow cytometry fluorochromes fluorescein |
| 10011286 |
Chenodeoxycholic Acid
|
|
474-25-9 |
≥95%
|
|
|
2009-02-25
|
0.099447513812
|
chenodeoxycholic-acid
|
Ulmenide; Kebilis; Anthropodeoxycholic Acid; Hekbilin; Fluibil; CDCA
|
FXR biles acids cholesterol oxidative stress glutathione cancers atherosclerosis diabetes hyperlipidemia CDA |
| 13686 |
Chidamide
New |
|
743420-02-2 |
≥98%
|
|
|
2010-08-10
|
105.360761291519
|
chidamide
|
|
HDACs histones deacetylase H3 acetylation colon cancers cells inhibitors inhibits inhibiton LoVo HT-29 HT29 HT 29 |
| 70930 |
Chlorogenic Acid
|
|
327-97-9 |
>95%
|
|
|
|
11.711316758747
|
chlorogenic-acid
|
NSC 407296; Heriguard; 3-O-Caffeoylquinic acid
|
antioxidants acids plants metabolism polyphenolic |
| 13501 |
Chromosome Associated Protein-C Polyclonal Antibody (aa 281-297)
|
|
- |
|
|
|
2009-09-22
|
0E-12
|
chromosome-associated-protein-c-polyclonal-antibody-aa-281-297
|
CAP-C
|
antibodies SMC WB western blots immunoblotting blotting hCAP-C hCAPC hCAP C hSMC1 hCAP-E hCAP E hCAPE hSMC3 chromosomes structured maintenance |
| 13503 |
Chromosome Associated Protein-C Polyclonal Antibody (aa 47-61)
|
|
- |
|
|
|
2009-09-22
|
0E-12
|
chromosome-associated-protein-c-polyclonal-antibody-aa-47-61
|
CAP-C
|
antibodies SMC WB western blots immunoblotting blotting hCAP-C hCAPC hCAP C hSMC1 hCAP-E hCAP E hCAPE hSMC3 structural maintenance chromosomes |
| 10012583 |
cis-ACCP
|
|
777075-44-2 |
≥95%
|
|
|
2009-02-10
|
3.591160220994
|
cis-accp
|
|
MMP2 MMPs MMP 2 MMP9 MMP-9 9 tumors cancers extracellular matrix type IV collagen cell migration artritis osteoprosis |
| 13199 |
cis-trismethoxy Resveratrol
|
|
94608-23-8 |
≥98%
|
|
|
2009-03-25
|
15.415883977901
|
cis-trismethoxy-resveratrol
|
cis-Trimethoxy Stilbene
|
resveratrol anti-mitotic growth inhibitors colon cancers tubulin polymerization polyamines putrescine spermidine cis-Trimethoxy resveratrol 3,5,4'-trimethoxystilbene 3,5,4'-trimethoxy-cis-stilbene trismethoxy inhibitor inhibition caco-2 caco 2 cells |
| 10007412 |
Combrestatin A4
|
|
117048-59-6 |
>98%
|
|
|
2007-07-26
|
29.914254143646
|
combrestatin-a4
|
CRC 87-09; Combretastatin A4; CA4
|
inhibitors inhibition inhibits tubulin polymerization tumors CSA4 CSA-4 IMR32 neuroblastomas Hs746T carcinomas CFPAC-1 CFPAC1 MCF-7 MCF7 cancers inhibitory CA4 cells growth pancreatic breast gastric CA-4 combretastin |
| 360107 |
COX-2 (human) Blocking Peptide
|
|
- |
|
|
|
|
55.374571823204
|
cox-2-human-blocking-peptide
|
Prostaglandin H Synthase 2; Cyclooxygenase 2; PGHS-2
|
peptides prostaglandins PGHS-2 COX2 PGHS2 western blots blotting synthases controls immunohistochemistry IHC cyclooxygenases WB antibodies |
| 160112 |
COX-2 Monoclonal Antibody (Clone CX229)
|
|
- |
|
|
|
|
206.474262036305
|
cox-2-monoclonal-antibody-clone-cx229
|
PGHS-2; Prostaglandin H Synthase 2; Cyclooxygenase 2
|
prostaglandins inflammation cancers arthritis western blots blotting immunohistochemistry IHC WB immunocytochemistry ICC antibodies cox2 pghs2 pghs-2 synthases cyclooxygenases antisera antiserum cyclooxygenase immunoblotting |
| 160126 |
COX-2 (murine) Affinity-Purified Polyclonal Antibody
|
|
- |
|
|
|
|
129.754347375690
|
cox-2-murine-affinity-purified-polyclonal-antibody
|
PGHS-2; Prostaglandin H Synthase 2; Cyclooxygenase 2
|
immunohistochemistry IHC Western blotting WB antibodies blots cox2 PGHS2 PGHS-2 synthases prostaglandins mouse cyclooxygenases antisera antiserum cancers immunoblotting |
| 10010096 |
COX-2 (murine) Polyclonal FITC Antibody
Exclusive |
|
- |
|
|
✓ |
2008-04-23
|
55.464410681399
|
cox-2-murine-polyclonal-fitc-antibody
|
Prostaglandin H Synthase 2; PGHS2; Cyclooxygenase 2
|
antibodies prostaglandins thromboxanes prostacyclins arachidonic acids FC flow cytometry ICC immmunocytochemistry WB western blots blotting immunoblotting |
| 700200 |
COX Fluorescent Activity Assay Kit
|
|
- |
|
|
|
2008-07-24
|
109.092569060773
|
cox-fluorescent-activity-assay-kit
|
Cyclooxygenase Fluorescent Activity Assay Kit
|
cyclooxygenases synthases enzymes cox-1 cox1 cox-2 cox2 prostaglandins PGs synthase-1 synthase-2 pghs-1 pghs1 pghs-2 pghs2 assays kits peroxidase activity cellular homeostasis antiinflammatory NSAIDs nonsteroidal anti-inflammatory drugs fluorescence human recombinant ovine isozyme-specific inhibits inhibitors inhibition ADHP 10-acetyl-3,7-dihydroxyphenoxazine resorufin |
| 81025 |
Curcumin
|
|
458-37-7 |
>90%
|
|
|
|
27.155653775321
|
curcumin
|
Turmeric Yellow; Indian Saffron
|
anti-oxidant anti-imflammatory NOS nitric oxide synthase |
| 81025.1 |
Curcumin (technical grade)
|
|
458-37-7 |
>65%
|
|
|
|
7.006243093922
|
curcumin-technical-grade
|
Turmeric Yellow; Indian Saffron
|
anti-oxidant anti-imflammatory NOS nitric oxide synthase |
| 10011388 |
Cu/Zn SOD (human) Polyclonal Antibody
|
|
- |
23 kDa
|
|
|
2008-04-03
|
136.142270718232
|
cu-zn-sod-human-polyclonal-antibody
|
SOD1; Cu/Zn Superoxide Dimutase
|
SOD1 SOD2 SOD3 EC-SOD oxidative stress ROS superoxide antibodies antiserum WB western blots immunoblotting IP EIA IHC immunohistochemistry neurochemistry immunoprecipitation enzyme immunoassays neurochemistry blotting |
| 10004600 |
Cytokeratin Monoclonal Antibody (Clone C-11)
|
|
- |
|
|
|
2008-06-05
|
12.407665745856
|
cytokeratin-monoclonal-antibody-clone-c-11
|
pan-Cytokeratin
|
cytokeratins pan-cytokeratins antibodies antiserum antisera isoforms western blots WB flow cytometry FC immunocytochemistry ICC immunohistochemistry IHC immunoblotting proteins blotting |
| 10349 |
Cytokeratin Monoclonal FITC Antibody (Clone C-11)
New |
|
- |
|
|
|
2010-04-14
|
14.650000000000
|
cytokeratin-monoclonal-fitc-antibody-clone-c-11
|
pan-Cytokeratin
|
cytokeratins pan-cytokeratins antibodies antiserum antisera isoforms western blots WB flow cytometry FC immunofluorescence IF immunoblotting proteins blotting |
| 63500 |
Cytotrienin A
|
|
189010-85-3 |
≥95%
|
|
|
2009-07-06
|
22.458552486187
|
cytotrienin-a
|
|
anti-tumor anti-cancer apoptosis ROS caspace-3 p36 MBP kinase JNK |
| 13305 |
D 4476
|
|
301836-43-1 |
≥98%
|
|
|
2009-07-29
|
22.899686924493
|
d-4476
|
Casein Kinase I Inhibitor
|
inhibitors inhibits inhibition casein kinases 1 CK1 Ck1δ TGF-β TGFβ type-1 receptors ALK5 PKD1 p38α MAPK kinases phosphorylation FOXO1a RhoB p53 Smad3 D4476 |
| 160755 |
DcR2 Polyclonal Antibody
|
|
- |
|
|
|
|
1.483977900552
|
dcr2-polyclonal-antibody
|
TRUNDD Polyclonal Antibody; TRAIL-R4 Polyclonal Antibody
|
apoptosis cell death TNF DR4 DR5 DcR1 TRID TRAIL antibodies western blots blotting WB antisera antiserum immunoblotting |
| 10005432 |
DDA
|
|
25152-84-5 |
>98%
|
|
|
2004-07-22
|
21.122555248619
|
dda
|
trans-2,4-Decadien-1-al; Decadienealdehyde
|
lipoxygenases diatoms alkyls linoleic acids dihomo-gamma-linolenic dihomo-g-linolenic arachidonic dihomo-.gamma.-linolenic carcinoma Caco2 apoptosis |
| 10010706 |
(−)-Deguelin
|
|
522-17-8 |
>98%
|
|
|
2008-09-18
|
1.759668508287
|
-deguelin
|
(-)-cis-Deguelin
|
rotenoids flavonids cancers antiproliferative chemoprevention parkinsons diseases Akt PKB PI3K COX-2 COX2 apoptosis PI3-K |
| 700390 |
Demethylase (Jumonji-type) Activity Assay Kit
New |
|
- |
|
|
|
2010-05-26
|
0E-12
|
demethylase-jumonji-type-activity-assay-kit
|
|
kits assays measures measurements histones nucleoproteins chromatins DNA deoxynucleic acids eukaryotic nucleus nucleosomal H3 H4 H2B H2A octamers amino termini acetylation phosphorylation ubiquitination methylation replication repair transcriptional activation repression dysregulation tumors suppressor genes cancers inhibitors enzymes catalyzes epigenetic marks methyls lysines arginines residues demethylases 1 JMJC JHDM1 JHDM2 JHDM3 JARID1 UTX/UTY cupin 2-oxoglutarate 2OG iron Fe(II) oxygenases hydroxylation JMJD2A JMJD2B JMJD2C JMJD2D JMJD2E JMJD2F fluorescence-based fluorescent cells lysates formaldehydes peptides substrates oxidation/decarboxylation acetoacetanilides ammonia H3K9(Me)3 |
| 700400 |
Demethylase (LSD-type) Activity Assay Kit
New |
|
- |
|
|
|
2010-08-05
|
0E-12
|
demethylase-lsd-type-activity-assay-kit
|
|
kits assays measures measurements histones proteins nucleoproteins chromatins structures DNA deoxyribonuclease eukaryotics nucleus nucleosomals core particles H3 H4 H2B H2A octamers amino termini post-translationally acetylation phosphorylations ubiquitination methylations replication repair transcriptional activation repression dysregulation tumor suppressor genes cancers enzymes catalyze epigenetic marks therapeutics drugs development lysine-specific demethylases LSD1 KDM1 p110b BHC110 NPAO LSD2 flavin adenines dinucleotides FAD-dependent amines oxidases monoamines MAOs polyamines PAOs demethylates monomethylateds dimethylateds lysines 4 K4 repression deacetylases co-repressor complexes 1/2 CtBP neuronal CoREST p53 LYS370 53BP1 apoptosis C-terminal domains CW-type zinc finger motif zince-binding sites chromatin-remodeling fluorescence-based formaldehyde N-terminal tail acetoacetanilides ammonia |
| 10165 |
D-erythro-MAPP
|
|
143492-38-0 |
>98%
|
|
|
2004-02-23
|
17.747691835482
|
d-erythro-mapp
|
(1S,2R-D-erythro-2-N-myristoylamino)-1-phenyl-1-propanol
|
ceramides inhibitors sphingolipids HL60 HL-60 cancer cells G0/G1 G0-G1 inhibits ceramidase |
| 10012577 |
Diallyl Trisulfide
|
|
2050-87-5 |
≥98%
|
|
|
2009-04-07
|
2.760220994474
|
diallyl-trisulfide
|
DATS; NSC 651936
|
garlic hydrogen sulfides H2S cancers tumors smooth muscle cholesterol atherosclerosis donors supresses colon synthesis genes expression adenocarcinomas HCT-15 cells PC-3 xenografts |
| 10009081 |
Didox
Exclusive |
|
69839-83-4 |
>98%
|
|
✓ |
2007-01-16
|
13.587292817679
|
didox
|
|
antioxidants hydroxamic acids apoptosis cancers cells polyhydroxylated aromatic ocidative injury brains HIV dementia bcl-2 |
| 10006876 |
Diethylstilbestrol
|
|
56-53-1 |
≥98%
|
|
|
2005-10-03
|
11.576850828729
|
diethylstilbestrol
|
|
synthetics receptors agonists pregnant pregnancies linked breasts cancers congenital abnormalities abnormality offspring 3H-estradiols binding affinities affinity sexes hormones globulins SHBG estrogens |
| 10009986 |
dimethoxy Curcumin
|
|
160096-59-3 |
≥90%
|
|
|
2007-08-03
|
35.433591160220
|
dimethoxy-curcumin
|
|
curcumins cancers ASCJ9 antitumors anti-tumor phytochemicals turmeric inhibits inhibition inhibitory growth expression cells ASC-J9 |
| 62237 |
Diphenyl-1-pyrenylphosphine
|
|
110231-30-6 |
>98%
|
|
|
2006-07-25
|
62.428694751381
|
diphenyl-1-pyrenylphosphine
|
DPPP
|
hydroperoxides oxidative stress injury fluorescence fluorescent lipids cholesterols LDL oxidation DPPPO DPPP=O atherosclerosis |
| 10005276 |
DL-threo-PDMP (hydrochloride)
|
|
80938-69-8 |
>98%
|
|
|
2004-08-10
|
3.208766114180
|
dl-threo-pdmp-hydrochloride
|
|
analogs analogues inhibits inhibitors inhibition cytotoxicity glucosylceramides synthases chirality stereoisomers sphingosine |
| 71210 |
DMOG
|
|
89464-63-1 |
>98%
|
|
|
|
66.565635359116
|
dmog
|
Dimethyloxallyl Glycine
|
nuclear receptors cancer hypoxia HIF-1alpha Hif1α HIF-1α HIF1α Pro-angiogenic proangiogenic factors HIF-PH HIFPH prolyl hydroxylase inhibits inhibitors inhibition |
| 10009851 |
D-myo-Inositol-1,3,4,5,6-pentaphosphate (ammonium salt)
|
|
- |
>98%
|
|
|
2007-06-04
|
6.977237569061
|
d-myo-inositol-1-3-4-5-6-pentaphosphate-ammonium-salt
|
1,2,4,5,6-IP5 (sodium salt); Ins(,1,3,4,5,6)P5
|
inositols phosphate IP5 signal transduction InsP phosphitidylinositol phospholipase C PLC phosphioinositide 3-kinase PI3-K Akt cancer angiogenesis PKB protein kinase B |
| 660990 |
DNA Laddering Kit
|
|
- |
|
|
|
|
0.117845303867
|
dna-laddering-kit
|
|
kits assays apoptosis |
| 589324 |
DNA Methylation EIA Kit
|
|
- |
|
|
|
2009-04-23
|
105.261629834254
|
dna-methylation-eia-kit
|
5-methyl-2-deoxy Cytidine ELISA Kit
|
DNA deoxyribonucleic acids CpG islands dinucleotides genes genomes cancers genomic hypomethylation hypermethylation tumors suppressors malignancy carcinogenesis plasma blood urine leukemia tissues differentiation aging methyltransferases DNMTs DNMT1 DNMT3a DNMT3b nucleosides analogs azacitidine decitabine zebularine drugs suppression competitive assays EIAs ELISAs culture supernatants sample matrices |
| 589325 |
DNA Methylation EIA Kit (Solid Plate)
|
|
- |
|
|
|
2009-04-23
|
30.255049723757
|
dna-methylation-eia-kit-solid-plate
|
5-methyl-2-deoxy Cytidine ELISA Kit (Solid Plate)
|
DNA deoxyribonucleic acids CpG islands dinucleotides genes genomes cancers genomic hypomethylation hypermethylation tumors suppressors malignancy carcinogenesis plasma blood urine leukemia tissues differentiation aging methyltransferases DNMTs DNMT1 DNMT3a DNMT3b nucleosides analogs azacitidine decitabine zebularine drugs suppression competitive assays EIAs ELISAs culture supernatants sample matrices |
| 13479 |
DNA Methyltransferase 1 Monoclonal Antibody (Clone 60B1220.1)
|
|
- |
|
|
|
2009-06-29
|
1.420678768745
|
dna-methyltransferase-1-monoclonal-antibody-clone-60b1220-1
|
DNMT1
|
WB Western blots immunoblotting IHC ChIP IP DNMT 1 blotting immunohistochemistry immunoprecipitation |
| 13481 |
DNA Methyltransferase 2 Monoclonal Antibody (Clone 102B1259.2)
|
|
- |
|
|
|
2009-07-13
|
0.414364640884
|
dna-methyltransferase-2-monoclonal-antibody-clone-102b1259-2
|
DNMT2
|
WB Western blots immunoblotting DNMT-2 monoclonals blotting DNMT 2 blotting |
| 13480 |
DNA Methyltransferase 2 Polyclonal Antibody
|
|
- |
|
|
|
2009-07-13
|
0.414364640884
|
dna-methyltransferase-2-polyclonal-antibody
|
DNMT2
|
WB Western blots immunoblotting DNMT 2 blotting DNMT-2 |
| 13483 |
DNA Methyltransferase 3a Monoclonal Antibody - Biotinylated (Clone 64B814.1)
|
|
- |
|
|
|
2009-07-15
|
0.414364640884
|
dna-methyltransferase-3a-monoclonal-antibody-biotinylated-clone-64b814-1
|
DNMT3a
|
ELISA DNMT3a Enzyme-linked immunosorbent assays |
| 13484 |
DNA Methyltransferase 3a Monoclonal Antibody (Clone 64B1446)
|
|
- |
|
|
|
2009-07-15
|
0.414364640884
|
dna-methyltransferase-3a-monoclonal-antibody-clone-64b1446
|
DNMT3a
|
WB Western blots immunoblotting DNMT3a blotting ICC immunocytochemistry IHC immunohistochemistry |
| 13482 |
DNA Methyltransferase 3a Monoclonal Antibody (Clone 64B814.1)
|
|
- |
|
|
|
2009-07-01
|
0.414364640884
|
dna-methyltransferase-3a-monoclonal-antibody-clone-64b814-1
|
DNMT3a
|
WB Western blots immunoblotting DNMT3a blotting ICC immunocytochemistry |
| 13485 |
DNA Methyltransferase 3b Monoclonal Antibody (Clone 52A1018)
|
|
- |
|
|
|
2009-07-01
|
1.450276243094
|
dna-methyltransferase-3b-monoclonal-antibody-clone-52a1018
|
DNMT3b
|
WB Western blots immunoblotting DNMT3b immunoprecipitation immunofluorescence immunocytochemistry ChIP immunohistochemistry IHC IP ICC IF blotting |
| 10006305 |
D-NMAPPD
Exclusive |
|
35922-06-6 |
>98%
|
|
✓ |
2005-02-23
|
8.559337016575
|
d-nmappd
|
CAY10466; (1R,2R)-B13
|
ceramides inhibitors cancers cells inhibits inhibition ceramidase apoptosis colorectal keratinocytes melanoma lines viability inducers induces |
| 700210 |
DPP (IV) Inhibitor Screening Assay Kit
|
|
- |
|
|
|
2009-05-27
|
115.718314917126
|
dpp-iv-inhibitor-screening-assay-kit
|
|
Dipeptidyl exopeptidases IV DPPIV DPP4 enzymes CD26 cluster of differentiation T-cells activation antigens adenosine deaminase complexing 2 membrane-bound glycoproteins immune regulation signal transduction apoptosis kidneys small intestines placentas humans serums seminal fluids proteolytic derivatives serines X-prolines X-alanines dipeptides N-terminus N-terminal polypeptides growth factors chemokines neuropeptides vasoactive inhibitors inhibits inhibition oral antidiabetic agents glucose homeostasis glucoregulatory hormones glucose-dependent insulinotropics GIP glucagon-like peptide-1 GLP-1 gastric therapeutics Type 2 tumors cancers markers neoplasms assays kits measures measurements fluorescences fluorescent fluorogenics substrates Gly-Pro-Aminomethylcoumarin AMC |
| 10010302 |
DRB
|
|
53-85-0 |
>98%
|
|
|
2008-01-21
|
4.171823204420
|
drb
|
Benzimidazole; NSC 401575
|
cancers HIV P53 apoptosis CDK7 CDK9 CTD CKI CKII adenosine inhibitors inhibits inhibition transcription RNA polymerase cell cycles adenocarcinoma transactivator tat |
| 10007963 |
E-64
|
|
66701-25-5 |
≥98%
|
|
|
2009-11-12
|
40.678851916959
|
e-64
|
|
inhibitors cysteine proteases cathepsins papain calpain irreversible inhibition inhibited E64 E 64 |
| 10007964 |
E-64c
|
|
76684-89-4 |
>98%
|
|
|
2006-08-02
|
40.311616022099
|
e-64c
|
EP 475; Loxistatin Acid; NSC 694279
|
E-64 cysteine protease cell cycle inhibitor E-64d |
| 13533 |
E-64d
New |
|
88321-09-9 |
≥98%
|
|
|
2010-08-16
|
1.376988113176
|
e-64d
|
EP 453; EST; NSC 694281; Loxistatin; E-64c ethyl ester; Aloxistatin
|
cysteine protease proteins degradation lysosome inhibitors inhibits inhibition calpain cathepsin E64d E 64d 64 207396-71-2 cells cancers carcinomas A431 |
| 10011192 |
Elesclomol
Exclusive |
|
488832-69-5 |
≥98%
|
|
✓ |
2009-04-23
|
6.298637200736
|
elesclomol
|
STA 4783; NSC 174939
|
cancer apoptosis melanoma ROS oxidative stress Hsp70 metallothionein STA-4783 874477-56-2 |
| 10112 |
(±)-Enterolactone
|
|
78473-71-9 |
>98%
|
|
|
|
9.935303867403
|
-enterolactone
|
HPMF
|
lignans plants antioxidants cancer oxidative injury stress enterobacterial |
| 500520 |
Enterolactone EIA Kit
|
|
- |
|
|
|
2005-03-15
|
95.737371086556
|
enterolactone-eia-kit
|
|
steroids measures kits eias enzyme immunoassays ELISAs endocrinology assays |
| 10006647 |
Enterolactone EIA Kit (Solid Plate)
|
|
- |
|
|
|
2005-03-15
|
84.918661283467
|
enterolactone-eia-kit-solid-plate
|
|
steroids measures kits eias enzyme immunoassays ELISAs assays |
| 10477 |
EP2 Receptor Polyclonal PE Antibody
New |
|
- |
|
|
|
2010-07-07
|
300.437306629834
|
ep2-receptor-polyclonal-pe-antibody
|
Prostaglandin E2 Receptor 2; PGE2 Receptor 2
|
R-phycoerythrin immunofluorescent FL-2 FL2 FL 2 channels G-protein coupled G protein flow cytometry FC immunofluorescence IF EP1 EP2 EP3 EP4 cAMP smooth muscles mRNA tissues lungs placenta placenta spleen intestines kidneys sensory neurons |
| 10007806 |
Epoxomicin
|
|
134381-21-8 |
≥98%
|
|
|
2008-12-09
|
54.929240331491
|
epoxomicin
|
BU 4061T
|
inhibitors inhibits inhibition proteins degradation 20S proteasomes antitumors bones formation Parkinsons diseases anti-tumors |
| 13184 |
(±)-Equol
|
|
94105-90-5 |
≥98%
|
|
|
2009-09-03
|
6.145171270718
|
-equol
|
|
phytoestrogens estrogens daidzen genistein receptors cancers nonsteroidal ERα ERβ ERalpha ER.alpha. ERbeta ER.beta. breast cells proliferation 7,4'-homoisoflavone NV 07α 07alpha 66036-38-2 |
| 10010238 |
Erbstatin Analog
|
|
63177-57-1 |
≥98%
|
|
|
2008-06-06
|
0.198895027624
|
erbstatin-analog
|
Methyl 2,5-dihydoxycinnamate
|
analogs EGF EGFR inhibitors inhibits inhibition tyrosine kinase DNA synthesis cell cycle proliferation cancers |
| 10483 |
Erlotinib
New |
|
183321-74-6 |
≥98%
|
|
|
2010-08-11
|
0E-12
|
erlotinib
|
Tarceva™; CP 358,774; NSC 718781
|
tyrosine kinase inhibitor inhibits inhibiting epidermal growth factor receptors EGFR cancers tumor cyclin-dependent cyclin dependent kinase 2 CDK-2 CDK 2 CDK2 JAK-2 JAK2 JAK JAK2V617F CP-358,774 CP-358774 CP 358774 CP358774 CP358,774 NSC-718781 NSC718781 OSI-744 OSI744 R-1415 R1415 R 1415 OSI 744 |
| 10006329 |
EUK 134
|
|
81065-76-1 |
>98%
|
|
|
2005-03-02
|
34.260773480662
|
euk-134
|
|
salen manganese SOD ROS catalse stroke oxidative injury porphyrin scavengers peroxynitrites superoxides hydrogen peroxides arteries artery cerebral H2O2 infarct volumes EUK 134 EUK-134 EUK134 |
| 13487 |
EZH1 Polyclonal Antibody
|
|
- |
|
|
|
2009-07-14
|
0E-12
|
ezh1-polyclonal-antibody
|
|
Western blots WB immunoblotting blotting |
| 10022 |
F16
|
|
36098-33-6 |
>98%
|
|
|
|
6.659171270718
|
f16
|
|
apoptosis induces apoptotic mitochodrial membranes tumors inhibitors fluorescent F-16 cancer inhibits fluorescence lipophilic binding HER-1/EGFR-expressing inhibition cells breast |
| 10010019 |
FABP2 Polyclonal Antibody
|
|
- |
|
|
|
2007-10-02
|
16.696056098597
|
fabp2-polyclonal-antibody
|
Intestinal Fatty Acid Binding Protein; Fatty Acid Binding Protein 2; I-FABP
|
WB western blots fatty acids FABPs lipophilic ligands metabolism polymorphism FABP2 IFABP obesity diabetes antibodies antiserum diabetic antisera atherosclerosis endocrinology blotting immunoblotting |
| 10010364 |
FABP5 (human recombinant)
|
|
- |
>95%
|
|
|
2007-08-08
|
54.029042357274
|
fabp5-human-recombinant
|
Keratinocyte FABP; Psoriasis-Associated FABP; Fatty Acid Binding Protein 5; Epidermal-FABP; E-FABP; DA11 FABP
|
proteins lipophilic ligands uptake metabolism cellular membranes FABP-5 FABPs cytosolic fatty acids bladders carcinoma prostates atherosclerosis endocrinology |
| 10010501 |
Farnesyl Thiosalicylic Acid
|
|
162520-00-5 |
≥96%
|
|
|
2008-06-02
|
21.547403314917
|
farnesyl-thiosalicylic-acid
|
Salirasib; FTS
|
ras inhibitors inhibition inhibits cancer anti-cancer anticancer prenylation farnesylation signal transduction oncogene atherosclerosis farnesylthiosalicylic acid |
| 13175 |
Farnesyl Thiosalicylic Acid Amide
Exclusive |
|
1092521-74-8 |
≥96%
|
|
✓ |
2009-02-26
|
10.863149171270
|
farnesyl-thiosalicylic-acid-amide
|
Salirasib Amide; FTS Amide
|
Ras degradation cells signaling signalling tumors glioblastoma cancers inhibitors inhibits inhibition |
| 13287 |
FK-866
|
|
658084-64-1 |
≥98%
|
|
|
2009-07-21
|
55.106187845304
|
fk-866
|
K 22.175
|
nicotinamides phosphoribosyltransferase NAMPT NamPRT PBEF visfatin mononucleotides adenine dinucleotide NAD+ inhibitors inhibitis inhibition cancers apoptosis SIRT1 autophagy FK866 FK 866 K22.175 K 22175 K22175 NamPRT PBEF visfatin carcinoma cells autophagy |
| 700380 |
Formaldehyde Assay Kit
New |
|
- |
|
|
|
2010-05-14
|
0E-12
|
formaldehyde-assay-kit
|
CH2O; Methanal
|
HCHO kits assays measures measurements formaldehydes resins cells tissues fluids demethylation/methylation methionine-homocysteines cycles microsomal cytochromes CYP450-dependent oxidations xenobiotics oxidative deamination methylamines semicarbazides amines oxidases SSAO-mediated diabetes diabetic wood kerosene gas cigarettes emissions leukemia nasopharyngeal cancers quantification urine prostate bladder breath breast fluorescence-based acetoacetanilides ammonia fluorescent |
| 10011269 |
Fulvestrant
|
|
129453-61-8 |
≥98%
|
|
|
2009-02-24
|
37.433453038674
|
fulvestrant
|
ICI 182,780; Faslodex®
|
estrogen receptors ER ERα agonist antagonist activator breast cancers hippocampus neurons ICI182780 ZD182780 ZD9238 ZM182780 |
| 10008346 |
Gabapentin
|
|
60142-96-3 |
>98%
|
|
|
2006-04-20
|
3.560193370165
|
gabapentin
|
Neurontin®
|
antiepileptic drugs Gamma-aminobutyric acids GABA neurotransmitters receptors spinal cord analogs anticonvulsants analgeics neuropathics pain syndromes Complex Regional types CRPS1 multiple sclerosis dysesthesias cancers HIV infections CNS central nervous systems calcium channels .gamma.-aminobutyric g-aminobutyric neurochemistry |
| 13166 |
Gefitinib
|
|
184475-35-2 |
≥98%
|
|
|
2010-02-11
|
60.844250764133
|
gefitinib
|
Iressa™; ZD1839
|
EGFR-TK EGFRs TKs epidermal growth factors inhibitors cancers signal transduction tyrosine kinases inhibits inhibited NSCLC |
| 13355 |
Geldanamycin
New |
|
30562-34-6 |
98%
|
|
|
2010-07-29
|
3.207182320442
|
geldanamycin
|
NSC 122750
|
NSC 212518 antibiotics heat shock proteins 90 Hsp90 GRP94 gp96 genes expression cells proliferation apoptosis angiogenesis c-jun adenocarcinoma cancers AP-1 steroids receptors |
| 10005167 |
Genistein
|
|
446-72-0 |
>98%
|
|
|
2004-08-04
|
14.062975532754
|
genistein
|
|
isoflavonoids phytoestrogenics legumes glycosides carcinogenic tumors inhibits inhibition inhibitors estrogenic isoflavones uterine DES diethylstilbestrol histones H2B endocrine tyrosine chemopreventitive |
| 13332 |
Glycyl-H-1152 (hydrochloride)
|
|
913844-45-8 |
≥98%
|
|
|
2010-01-27
|
81.578635739133
|
glycyl-h-1152-hydrochloride
|
Rho Kinase Inhibitor IV
|
Rho kinases ROCK-I p160ROCK ROCK-II G protein Rho cytoskeletons adhesions proliferation smooth muscles contraction stem cells inhibitors inhibition inhibited Fasudil hydrochloride ROCK IV |
| 10008886 |
(+)-Goniothalesdiol
Exclusive |
|
204975-45-1 |
≥98%
|
|
✓ |
2009-03-02
|
2.801933701657
|
-goniothalesdiol
|
|
antitumor gonoiothalaus borneensis leukemia P338 cells tetrahydrofuran |
| 10007206 |
GPR40 Blocking Peptide
|
|
- |
|
|
|
2007-04-12
|
2.448784530387
|
gpr40-blocking-peptide
|
|
immunohistochemistry peptide insulin diabetes breast cancer |
| 10007205 |
GPR40 Polyclonal Antibody
|
|
- |
|
|
|
2007-04-04
|
9.710902394107
|
gpr40-polyclonal-antibody
|
Free Fatty Acid Receptor; FFAR1; G Protein-Coupled Receptor 40
|
immunohistochemistry antibody insulin diabetes breast cancer endocrinology IHC |
| 10008313 |
GW 610
|
|
872726-44-8 |
>98%
|
|
|
2006-05-10
|
28.267204419889
|
gw-610
|
NSC 721648
|
antitumors benzothiazoles inhibits inhibitors inhibition cancers antiproliferative isoflavones quercetin genistein cells MCF-7 MDA 468 NCI 60 |
| 10010556 |
H-89
|
|
127243-85-0 |
≥98%
|
|
|
2008-07-08
|
14.637790055249
|
h-89
|
5-Isoquinolinesulfonamide; Protein Kinase Inhibitor H-89
|
inhibitors inhibits inhibition PKA cAMP cell signaling protein kinase S6K1 MSK1 ROCK-II ROCKII PKB.alpha. PKBalpha PKBa MAPKAP-K1b MAPKAPK1b H89 H 89 |
| 10010249 |
H-8 (hydrochloride)
|
|
113276-94-1 |
≥98%
|
|
|
2008-07-17
|
10.317513812155
|
h-8-hydrochloride
|
Protein Kinase Inhibitor H-8
|
PKA PKG PKC MLCK cyclin C CDK8 cyclin H CDK7 p36 signal transduction inhibitor inhibits inhibition transcription 84478-11-5 |
| 10010559 |
HA-1077 (hydrochloride)
|
|
203911-27-7 |
≥98%
|
|
|
2008-09-03
|
30.874281767956
|
ha-1077-hydrochloride
|
Eril; Fasudil (hydrochloride)
|
protein kinase inhibitors inhibits inhibition ROCK-II ROCKII PRK2 MSK1 MAPKAP-K1b vasodilation hypertension diabetes renal nephropathy cancers |
| 10006515 |
HAT Inhibitor Screening Assay Kit
|
|
- |
|
|
|
2006-12-06
|
14.707366482504
|
hat-inhibitor-screening-assay-kit
|
Histone Acetyltransferase Inhibitor Screening Assay Kit
|
therapeutics histones p300/CBP-Associated Factors pCAF GNAT GCN5-related N-acetyltransferases acetylates lysines N-terminal terminus tails H3 H4 tumors suppressor genes PTEN human cancers apoptosis fluorescence fluorescent inhibitors fluorometric assays |
| 13504 |
HDAC11 Polyclonal Antibody
|
|
- |
|
|
|
2009-07-31
|
1.154696132596
|
hdac11-polyclonal-antibody
|
Histone Deacetylase 11
|
wb western immunoblotting HDACs HAT histones antibodies peptides blots blotting |
| 10009231 |
HDAC1 (human recombinant)
|
|
- |
>10% by SDS-PAGE
|
|
|
2006-12-06
|
30.516778580535
|
hdac1-human-recombinant
|
Histone Deacetylase 1
|
HDAC 1 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 retinoblastoma Rb proteins Class I yeast Rpd3 cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus GST-tagged baculovirus Sf9 |
| 10011564 |
HDAC1 Inhibitor Screening Assay Kit
|
|
- |
|
|
|
2008-04-10
|
27.379171270718
|
hdac1-inhibitor-screening-assay-kit
|
|
HDAC 1 histones deacetylases lysines residues chromatin condensation transcriptional repression fluorescence deacetylation fluorescent inhibits inhibition enzymes license:cyclex fluorometric assays cancer |
| 13491 |
HDAC1 Polyclonal Antibody
|
|
- |
|
|
|
2009-07-24
|
0.701657458563
|
hdac1-polyclonal-antibody
|
Histone Deactylase 1
|
HDAC-1 HDACs HDAC 1 antibodies WB western blots HATs immunoblotting blotting |
| 10009377 |
HDAC2 (human recombinant)
|
|
- |
>70% by SDS-PAGE
|
|
|
2006-12-06
|
37.937950480867
|
hdac2-human-recombinant
|
Histone Deacetylase 2
|
HDAC 2 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 retinoblastoma Rb proteins Class I yeast Rpd3 cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus his-tagged baculovirus Sf9 |
| 10009232 |
HDAC3/NCOR2 (human recombinant)
|
|
- |
≥50%
|
|
|
2006-12-06
|
32.067298956414
|
hdac3-ncor2-human-recombinant
|
Histone Deacetylase 3
|
HDAC 3 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 retinoblastoma Rb proteins Class I yeast Rpd3 cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus his-tagged baculovirus Sf9 |
| 13493 |
HDAC3 Polyclonal Antibody
|
|
- |
|
|
|
2009-07-19
|
2.060773480663
|
hdac3-polyclonal-antibody
|
Histone Deacetylase 3
|
HDACs antibodies HATs histones acetyltransferase deacetylases western blotting WB IP immunoprecipation ChIP immunoblots immunoblotting blots |
| 13494 |
HDAC4 Polyclonal Antibody
|
|
- |
|
|
|
2009-07-17
|
2.060773480663
|
hdac4-polyclonal-antibody
|
Histone Deacetylase 4
|
WB Western blots immunoblotting IP ChIP antibodies HDACs HATs histones immunoprecipitation blotting |
| 10009379 |
HDAC5 (human recombinant)
|
|
- |
>90% by SDS-PAGE
|
|
|
2006-12-06
|
26.793871653208
|
hdac5-human-recombinant
|
Histone Deacetylase 5
|
HDAC 5 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators extranuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 retinoblastoma Rb proteins Class IIa yeast Hda 1 catalytic domains amino acids N-terminal N-terminus nucleus cytoplasm cells chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus his-tagged baculovirus Sf9 |
| 10009465 |
HDAC6 (human recombinant)
|
|
- |
>80%
|
|
|
2007-06-14
|
48.280118310173
|
hdac6-human-recombinant
|
GenBank Accession No. BC069243; Histone Deacetylase 6
|
HDAC 6 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways proteins Class II cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers N-terminal N-terminus GST-tagged Sf9 |
| 13499 |
HDAC6 Polyclonal Antibody
|
|
- |
|
|
|
2009-07-14
|
6.414825046040
|
hdac6-polyclonal-antibody
|
Histone Deacetylase 6
|
HDAC-6 HDACs HDAC 6 antibodies WB western blots IP ChIP immunoblotting blotting immunoprecipitation |
| 13500 |
HDAC7 (Phospho-Ser155) Polyclonal Antibody
|
|
- |
|
|
|
2009-07-29
|
2.717348855564
|
hdac7-phospho-ser155-polyclonal-antibody
|
Histone Deacetylase 7
|
antibodies MMP AR receptors matrix metalloproteinase androgens Nur77 histones deacetylases N-terminal immunoblotting blots western blotting WB |
| 700230 |
HDAC8 Inhibitor Screening Assay Kit
|
|
- |
|
|
|
2009-05-15
|
11.367403314917
|
hdac8-inhibitor-screening-assay-kit
|
Histone Deacetylase 8 Inhibitor Screening Assay Kit
|
histone deacetylases inhibits inhibitors inhibition angiogenesis cycling apoptosis differentiation tumors proliferation anticancers genes epigenetic trichostatin A human class I tissues nucleus cytosolic smooth muscle neuroblastoma pathogenesis kits assays measures measurement fluorescent fluorescence-based |
| 10009466 |
HDAC9 (human recombinant)
|
|
- |
>95%
|
|
|
2007-06-14
|
28.578684078352
|
hdac9-human-recombinant
|
GenBank Accession No. NM 178423; Histone Deacetylase 9
|
histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 HDAC 9 retinoblastoma Rb proteins Class I yeast Rpd3 cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus his-tagged baculovirus Sf9 |
| 10011563 |
HDAC Activity Assay Kit
|
|
- |
|
|
|
2008-04-10
|
36.537918968692
|
hdac-activity-assay-kit
|
|
histones deacetylases lysines residues chromatin condensation transcriptional repression fluorescence deacetylation fluorescent inhibits inhibition enzymes license:cyclex fluorometric assays cancer |
| 600150 |
HDAC Cell-Based Activity Assay Kit
|
|
- |
|
|
|
2009-11-09
|
19.212996260952
|
hdac-cell-based-activity-assay-kit
|
Histone Deacetylase Cell-Based Activity Assay Kit
|
assays kits measuring measurement histones deacetylases lysines residues chromatin condensation transcriptional repression fluorescence deacetylation fluorescent inhibits inhibition enzymes fluorometric assays cancer modulators whole cells proteins lysine-specific HDAC1 homogenous inhibitor/activator TSA |
| 10010329 |
HDBA
|
|
125697-93-0 |
≥98%
|
|
|
2008-07-08
|
0E-12
|
hdba
|
Lavendustin C; NSC 666251
|
EGFR kinases tyrosine pp60c-src pp60csrc CamKII SOD neutrophil activation erbstatin inhibitor inhibits inhibition |
| 100024 |
Hepsin Blocking Peptide (aa 241-260)
|
|
- |
|
|
|
|
10.699631675874
|
hepsin-blocking-peptide-aa-241-260
|
|
antibodies western blots blotting WB antisera antiserum ICC IHC protease immunohistochemistry immunocytochemistry apoptosis cancer peptides controls |
| 100022 |
Hepsin Polyclonal Antibody (aa 241-260)
|
|
- |
|
|
|
|
17.937016574585
|
hepsin-polyclonal-antibody-aa-241-260
|
|
antibodies western blots blotting WB antisera antiserum protease immunohistochemistry apoptosis IHC cancer formalin fixed paraffin embedded immunoblotting |
| 10006084 |
Hesperetin
|
|
520-33-2 |
>98%
|
|
|
2005-02-16
|
17.510257826887
|
hesperetin
|
|
hesperitin hesperidin atherosclerosis citrus nutraceuticals flavonoids flavanoids hypocholesterolemic ACAT2 ACAT-2 mRNA transcription inhibits inhibition inhibitors ApoB proteins histamines azelastine atherosclerosis |
| 16834 |
Hexadecanal-d5
|
|
- |
≥99% deuterated compound
|
|
|
2009-03-02
|
56.942607602475
|
hexadecanal-d5
|
Palmitaldehyde; 16-Hexadecanal
|
deuterated deuterium sphingosine-1-phosphate S1P palmitic acids S1P lyase 1 plasmalogen cell proliferation GC/MS GC-MS LC/MS LC-MS mass spectrometry |
| 300003 |
HIF-1α (C-Term) Blocking Peptide
|
|
- |
|
|
|
2005-04-15
|
45.022375690608
|
hif-1-c-term-blocking-peptide
|
Hypoxia Inducible Factor 1α
|
HIF-1alpha factors HIF1.alpha. antibodies peptides cancer hypoxia transcription factors low-oxygen hypoxic stimulus cytoplasmic accumulation cells nucleus stress-adaptive proteins oxidative physiology tumors EPAS-1 family phosphorylation prolyl hydroxylases western blotting blots signaling signalling WB controls proteins |
| 10006421 |
HIF-1α (C-Term) Polyclonal Antibody
|
|
- |
|
|
|
2005-04-15
|
51.982517758484
|
hif-1-c-term-polyclonal-antibody
|
Hypoxia Inducible Factor-1α
|
HIF-1alpha factors antibodies western blots blotting WB antisera antiserum cancers hypoxia transcription
factors low-oxygen hypoxic stimulus cytoplasmic accumulation cells nucleus stress-adaptive proteins oxidative physiology tumors EPAS-1 family phosphorylation prolyl hydroxylases immunoblotting HIF1 HIF1alpha HIF1 alpha HIF-1 alpha |
| 10006910 |
HIF-1α Transcription Factor Assay Kit
|
|
- |
|
|
|
2007-10-31
|
65.679592541436
|
hif-1-transcription-factor-assay-kit
|
Hypoxia-inducible Factor-1α
|
tf HIF-1alpha factors HIF1.alpha. cancers basic-helix-loop-helix bHLH cellular oxygen homeostasis cells tissues ischemia infections embryos tumors drugs target breast prostate cardiovascular diseases nuclear extracts whole lysates assays kits ELISAs enzyme-linked immunosorbent double stranded dsDNA HIF1
HIF1alpha HIF1 alpha HIF-1 alpha
|
| 13535 |
Histone H2A Polyclonal Antibody
|
|
- |
|
|
|
2009-07-31
|
0.338397790055
|
histone-h2a-polyclonal-antibody
|
|
H1 H2B H3 H4 histones antibodies DNA WB western blots immunoblotting ELISA enzyme-linked immunosorbent assays blotting |
| 13538 |
Histone H2B (C-Term) Polyclonal Antibody
|
|
- |
|
|
|
2009-08-04
|
0.338397790055
|
histone-h2b-c-term-polyclonal-antibody
|
|
histones antibodiesarginine lysine DNA WB western blots immunoblotting blotting |
| 13539 |
Histone H2B (N-Term) Polyclonal Antibody
|
|
- |
|
|
|
2009-08-04
|
0.338397790055
|
histone-h2b-n-term-polyclonal-antibody
|
|
histones antibodies WB western blots immunoblotting DNA arginine lysine blotting |
| 13540 |
Histone H3 (Phospho-Ser28) Monoclonal Antibody (Clone 117C826)
|
|
- |
|
|
|
2009-08-10
|
1.353591160221
|
histone-h3-phospho-ser28-monoclonal-antibody-clone-117c826
|
PHH3
|
H1 H2B H3 H4 histones antibodies WB western blots immunoblotting serine phosphos phosphorylation blotting |
| 10530 |
Histone H3 Trimethyl Lys9 Peptide
New |
|
- |
|
|
|
2010-06-29
|
300.437306629834
|
histone-h3-trimethyl-lys9-peptide
|
H3K9(Me)3 Peptide
|
JMJD2A JMJC JMJD2D acetylation methylation phosphorylation genes transcription substances regulation H3K9Me3 |
| 13543 |
Histone H4 Polyclonal Antibody
|
|
- |
|
|
|
2009-08-10
|
0.338397790055
|
histone-h4-polyclonal-antibody
|
|
antibodies H1 H2A H2B H3 amino acids WB western blots immunblotting blotting |
| 13295 |
HNHA
|
|
926908-04-5 |
≥98%
|
|
|
2009-09-03
|
77.672412523020
|
hnha
|
Histone Deacetylase Inhibitor VI
|
inhibitors inhibits inhibition histones deacetylase HDACs cancers fibrosarcoma HT1080 cells hyperacetylation p21 genes expressions transcription cycles arrest tumor growth murine xenograph human umbilical vein endothelial HUVECs tubes formation migration vascular endothelial factors VEGF retinal neovascularization angiogenesis |
| 10011384 |
Hsc70 (Hsp73) Polyclonal Antibody
|
|
- |
|
|
|
2008-03-26
|
2.549907918968
|
hsc70-hsp73-polyclonal-antibody
|
Heat Shock Cognate 70
|
heat shock stress protein antibodies antiserum WB immunoblotting western blots immunoprecipation immunofluorscence IP IF blotting |
| 10011383 |
Hsp40 Polyclonal Antibody
|
|
- |
40 kDa
|
|
|
2008-03-26
|
2.618784530386
|
hsp40-polyclonal-antibody
|
Heat Shock Protein 40; HDJ1
|
DnaJ WB translation folding unfolding translocation degradation heat shock stress chaperone antibodies antiserum Hsps immunoblotting western blots blotting |
| 10202 |
Hsp90α (human recombinant)
New |
|
- |
≥80%
|
|
|
2010-03-16
|
93.359453652547
|
hsp90-human-recombinant
|
Hsp84; Heat Shock Protein 90α
|
heat shock proteins molecular chaperones Hsp90.alpha. Hsp90AA1 HspCAL4 HspN 90kDa cytosolic class A member 2 heat-shock 1 Hsp90AA2 Hsp86 Hsp90a |
| 10342 |
Hsp90β (human recombinant)
New |
|
- |
≥85%
|
|
|
2010-03-16
|
99.888095238095
|
hsp90-human-recombinant
|
Hsc90; Hsp90 AB1; Heat Shock Protein 90β
|
heat shock proteins molecular chaperones Hsp90.beta. 90kDa alpha cytosolic class B member 1 Hsp90beta Hsp90AB1 Hsp90b |
| 10005673 |
HU-331
|
|
137252-25-6 |
>95%
|
|
|
2005-09-09
|
29.442098572670
|
hu-331
|
|
cannabidiols analogs antiproliferative activity endocannabinoids central CB1 peripheral CB2 non-CB receptor-mediated pharmacology receptors memory weight loss appetite neurodegeneration tumor surveillance analgesia inflammation hydroxylquinone antineoplastic human cancer cells lines inhibits inhibitors inhibition growth Raji Jurkat lymphomas in vitro HT-29 colon carcinomas neuroscience neurochemistry cannabinoids |
| 13624 |
Icariin
|
|
489-32-7 |
≥97%
|
|
|
2010-02-11
|
62.642659719415
|
icariin
|
|
PDE5 inhibitors flavonoids differentiation cancers proliferation flavonols E brevicornum horny goat weed BMP2 ED erectile dysfunction |
| 10008207 |
IGFBP5 Polyclonal Antibody
|
|
- |
|
|
|
2007-07-19
|
31.501896869244
|
igfbp5-polyclonal-antibody
|
IGF-Binding Protein 5; IBP-5; Insulin-like Growth Factor Binding Protein 5
|
IGF-1 cell growth differentiation apoptosis receptors kidney heart placenta skeletal cancers amino acids neuroblastoma mammary glands antibodies wb western blots immunocytochemistry IGF1 IGFBP-5 endocrinology blotting immunoblotting |
| 13139 |
Imatinib (mesylate)
|
|
220127-57-1 |
≥98%
|
|
|
2009-04-21
|
16.523608607154
|
imatinib-mesylate
|
CGP57148B; Glivec; Gleevec; STI-571
|
inhibitors tyrosine kinase cancer chronic myelogenous leukemia CML c-ABL kits c-kit platelet-derived growth factor receptors imatinib mesilate 152459-95-5 75-75-2 gleevec |
| 13659 |
IWR-1-endo
Exclusive New |
|
1127442-82-3 |
≥98%
|
|
✓ |
2010-03-23
|
200.000000000000
|
iwr-1-endo
|
|
Wnt cancers embryonic developments tissues homeostasis embryogenesis tumorigenesis stem cells β-catenin genes expression transcription inhibitors inhibits inhibition proteasomes Apc Axin2 Ck1 Gsk3β IWR-1-exo |
| 13598 |
IWR-1-exo
Exclusive New |
|
1127442-87-8 |
≥98%
|
|
✓ |
2010-03-23
|
200.000000000000
|
iwr-1-exo
|
|
Wnt cancers embryonic developments tissues homeostasis embryogenesis tumorigenesis stem cells β-catenin genes expression transcription inhibitors inhibits inhibition controls |
| 10011246 |
Janex-1
|
|
202475-60-3 |
≥98%
|
|
|
2008-12-17
|
6.428950276243
|
janex-1
|
WHI-P131
|
inhibitors inhibits inhibition JAK3 apoptosis leukemias anti-inflammatory antiinflammatory lymphocytes WHIP131 Janex 1 |
| 9000059 |
(±)-Jasmonic Acid methyl ester
|
|
39924-52-2 |
>95% (mixture of isomers)
|
|
|
2009-04-01
|
5.095994475137
|
-jasmonic-acid-methyl-ester
|
(±)-Methyl Jasmonate
|
cancers plants apoptosis survival inflammation hexokinase jasmonic acids jasmonates stress hormones proteins inhibitors inhibition inhibited mitochondrial hexokinase anti-inflammatory |
| 10009172 |
JC-1 Mitochondrial Membrane Potential Assay Kit
|
|
- |
|
|
|
2007-04-12
|
177.854206787687
|
jc-1-mitochondrial-membrane-potential-assay-kit
|
|
apoptosis cells mitochondria caspases cytochrome C electrons transport transmembranes Dym DELTApsim .DELTA..psi.m fluorscence fluorescent cationic dyes rhodamine-123 Rh123 DiOC6 cytofluorimetric lipophilic tetrachloro-1,1',3,3'-tetraethylbenzimidazoylcarbocyanine iodide green red J-aggregates monomeric assays kits measures measurements microscopy flow cytometry plate readers fluorometric cancer JC1 cell-based assays
cell based assay cba JC 1 |
| 700360 |
JMJD2A Inhibitor Screening Assay Kit
New |
|
- |
|
|
|
2010-05-25
|
0E-12
|
jmjd2a-inhibitor-screening-assay-kit
|
Jumonji Domain Containing 2A Inhibitor Screening Assay Kit
|
kits assays measures measurements histones nucleoproteins chromatins DNA deoxynucleic acids eukaryotic nucleus nucleosomal H3 H4 H2B H2A octamers amino termini acetylation phosphorylation ubiquitination methylation replication repair transcriptional activation repression dysregulation tumors suppressor genes cancers inhibitors enzymes catalyzes epigenetic marks methyls lysines arginines residues demethylases 1 JMJC JHDM1 JHDM2 JHDM3 JARID1 UTX/UTY cupin 2-oxoglutarate 2OG iron Fe(II) oxygenases hydroxylation JMJD2A JMJD2B JMJD2C JMJD2D JMJD2E JMJD2F fluorescence-based fluorescent cells lysates formaldehydes peptides substrates oxidation/decarboxylation acetoacetanilides ammonia H3K9(Me)3 trimethylated |
| 700370 |
JMJD2D Inhibitor Screening Assay Kit
New |
|
- |
|
|
|
2010-05-25
|
0E-12
|
jmjd2d-inhibitor-screening-assay-kit
|
Jumonji Domain Containing 2D Inhibitor Screening Assay Kit
|
kits assays measures measurements histones nucleoproteins chromatins DNA deoxynucleic acids eukaryotic nucleus nucleosomal H3 H4 H2B H2A octamers amino termini acetylation phosphorylation ubiquitination methylation FLJ10251 replication repair transcriptional activation repression dysregulation tumors suppressor genes cancers inhibitors enzymes catalyzes epigenetic marks methyls lysines arginines residues demethylases 1 JMJC cupin 2-oxoglutarate 2OG iron Fe(II) oxygenases hydroxylation JMJD2A JMJD2B JMJD2C JMJD2D JMJD2E JMJD2F fluorescence-based fluorescent cells lysates formaldehydes peptides substrates oxidation/decarboxylation acetoacetanilides ammonia H3K9(Me)3 trimethylated |
| 10008131 |
JNJ-10198409
|
|
627512-69-0 |
>98%
|
|
|
2006-10-18
|
14.805897790055
|
jnj-10198409
|
|
PDGF-BB tyrosine kinases inhibits inhibition inhibitors growth factors receptors platelet-derived antiangiogenic antiproliferative coronary artery smooth muscle cells antagonists ATP binding hydrolysis tumors angiogenesis |
| 10009458 |
JTE-013
|
|
383150-41-2 |
>98%
|
|
|
2007-01-18
|
87.972562154695
|
jte-013
|
|
reverses inhibition inhibits coronary artery smooth muscles lipids cells proliferation cytoskeletal morphogenesis GPCRs protein-coupled receptors antagonists S1P2 humans rats EDG5 sphingosines sphingosine-1-phosphates sphingosine1 inhibitors JTE013 FDG-5 cancers |
| 10010239 |
Kenpaullone
|
|
142273-20-9 |
>98%
|
|
|
2007-09-04
|
18.745782688766
|
kenpaullone
|
NSC 664704; 9-Bromopaullone
|
GSK-3.beta. cyclin-dependent kinase cyclin CDK inhibitors inhibits inhibition proliferations cell cycle cancers |
| 10012659 |
Ki16425
|
|
355025-24-0 |
≥95%
|
|
|
2008-11-06
|
97.890527931246
|
ki16425
|
|
LPA1 LPA2 LPA3 LPA4 LPA5 lysophosphatidic acids cancers antagonist receptors selective |
| 10010427 |
KRP 203-phosphate
|
|
- |
≥98%
|
|
|
2009-01-30
|
105.814548802946
|
krp-203-phosphate
|
|
immune modulators S1P receptors transplants allograft FTY720 SEW2871 lymphocyte immunosuppression KRP203 KRP-203 KRP203-P KRP-203-P |
| 10011011 |
KT 5720
|
|
108068-98-0 |
≥98%
|
|
|
2009-01-20
|
119.441215469613
|
kt-5720
|
|
PKAs cAMPs signaling proteins kinase inhibitors inhibits inhibition phosphorylase kinase PDK1 MEK MSK1 PKα GSK3β KT5720 KT-5720 |
| 10008882 |
LDH Cytotoxicity Assay Kit
|
|
- |
|
|
|
2006-12-15
|
125.354493554327
|
ldh-cytotoxicity-assay-kit
|
Lactate Dehydrogenase Cytotoxicity Assay Kit
|
cells death apoptosis necrosis measuring measurement cystolic enzymes cells membranes integrity cancer cell-based assays
cell based assay cba |
| 10010265 |
LFM-A13
|
|
244240-24-2 |
>98%
|
|
|
2008-01-23
|
22.811933701657
|
lfm-a13
|
|
BTK Bruton's Tyrosine kinases signal transduction leukemia cancers polo-like anti-cancer chemosensitivity apoptosis CD95 |
| 10245 |
LSD1 (human recombinant)
|
|
- |
≥50%
|
|
|
2009-06-03
|
3.140055248618
|
lsd1-human-recombinant
|
AOF2; NPAO; Lysine-specific demethylase-1; BHC110; p110b; KDM1
|
recombinant humans E.coli histones tumors suppressor CoREST lysine specific demethylase 1 proteins enzymes |
| 700120 |
LSD1 Inhibitor Screening Assay Kit
|
|
- |
|
|
|
2008-10-16
|
7.456837016574
|
lsd1-inhibitor-screening-assay-kit
|
Lysine-Specific Demethylase 1
|
lysines 4 demethylases histones residues repression transcription chromosomal DNA chromosomes inhibits inhibitors inhibition tumors suppressors activity cells cycles progression cancers fluorescent fluorescence enzymes enzymatic reactions H2O2 hydrogens peroxides peptides N-terminal tails H3 horseradish peroxidases ADHP resorufins assays |
| 13554 |
LSD1 Polyclonal Antibody (aa 100-150)
|
|
- |
|
|
|
2009-08-10
|
0.255524861878
|
lsd1-polyclonal-antibody-aa-100-150
|
Amine Oxidase (flavin containing) Domain 2
|
WIRM N-terminal antibodies WB western blots immunoblotting CoREST histones HDACs LSD1 AOF2 amine oxidase flavin containing domain 2 peptide affinity blotting |
| 13553 |
LSD1 Polyclonal Antibody (aa 400-450)
|
|
- |
|
|
|
2009-08-10
|
0.255524861878
|
lsd1-polyclonal-antibody-aa-400-450
|
|
antibodies WB western blots immunoblotting lysine histones demethylase FAD-binding SWIRM domains blotting |
| 13486 |
LSD1 Polyclonal Antibody (aa 450-500)
|
|
- |
|
|
|
2009-08-11
|
0.212937384898
|
lsd1-polyclonal-antibody-aa-450-500
|
|
WIRM N-terminal antibodies WB western blots immunoblotting CoREST histones HDACs LSD1 blotting |
| 13555 |
LSD1 Polyclonal Antibody (aa 800-850)
|
|
- |
|
|
|
2009-08-13
|
0.255524861878
|
lsd1-polyclonal-antibody-aa-800-850
|
|
WIRM N-terminal antibodies WB western blots immunoblotting CoREST histones HDACs LSD1 immunohistochemistry IHC paraffin AOF2 amine oxidase flavin containing domain 2 blotting |
| 10007502 |
Luminex® Thromboxane B2 Kit
|
|
- |
|
|
|
2009-07-13
|
27.665414364640
|
luminex-thromboxane-b2-kit
|
Luminex® TXB2 Kit
|
thromboxanes thromboxane A2 TXA2 metabolites urine in vivo measures kits luminex xMAP beads assays |
| 10009768 |
LY293111
Exclusive |
|
161172-51-6 |
≥98%
|
|
✓ |
2009-02-09
|
136.559668508287
|
ly293111
|
Etalocib; VML 295
|
LTBs LTB4 receptors inflammation antagonist benzophenone neutrophil chemotaxis pancreatic cancers |
| 13341 |
LY364947
|
|
396129-53-6 |
≥98%
|
|
|
2009-07-23
|
23.928784530386
|
ly364947
|
TGF-β RI Kinase Inhibitor; HTS 466284
|
TGF-β receptor inhibitors antagonists Smad p38 MAPK MLK-7 cells growth fibroblasts NIH 3T3 cells phosphorylation fibronectin PAI-1 uPA matrigel invasion MDA-MB-231 cells transforming factors LY 364947 LY-364947 HTS-466284 HTS466284 HTS 466284 ALK5 Inhibitor I TβR-I inhibitor Transforming Growth Factor-β Type I Receptor Kinase Inhbitor [3-(Pyridin-2-yl)-4-(4-quinoynyl)]-1H-pyrazole |
| 600310 |
Lysosome/Cytotoxicity Dual Staining Kit
New |
|
- |
|
|
|
2010-06-15
|
5.555555555556
|
lysosome-cytotoxicity-dual-staining-kit
|
|
lysosomes membrane-bound acidic intracellular compartments cells waste products fats carbohydrates proteins macromolecules mobilize recycle organelles microorganisms animals leukocytes degradative enzymes hydrolases pH 5 cytoplasm homeostasis Tay-Sachs diseases arthritis neurodegeneratives Parkinson's brains cathepsin D genes therapeutics kits assays measures measurements 4-Nitro-7-(1-piperazinyl)-2,1,3-benzoxadiazole NBD-PZ membranes permeable carboxylic acids luminal cultured propidium iodides death chloroquine inhibitors positive controls fluorescence fluorescent microscopy plates reader detections flow cytometry |
| 13174 |
M 344
|
|
251456-60-7 |
≥98%
|
|
|
2009-07-24
|
101.376243093923
|
m-344
|
D237; Histone Deacetylase Inhibitor III; MS 344
|
HDACs inhibitors inhibits inhibitions histones deacetylases HDAC1 HDAC6 cancers squamous carcinoma radiation cells cycles arrest apoptosis endometrial ovarian M344 MS344 M-344 MS-344 |
| 10010497 |
Manumycin A
|
|
52665-74-4 |
≥98%
|
|
|
2008-06-25
|
13.340000000000
|
manumycin-a
|
UCF 1C; NSC 622141
|
farnesyltransferase inhibitors inhibits inhibition cancer antitumor anti-tumor signal transduction Ras farnesylation NF-.kappa.B NF-kB NF-kappaB |
| 10009645 |
Maslinic Acid
Exclusive |
|
4373-41-5 |
>98%
|
|
✓ |
2007-11-02
|
9.663535911602
|
maslinic-acid
|
2α-Hydroxyoleanoic Acid; Crategolic Acid
|
cancer apoptosis antiproliferative antioxidant HIV inhibition inhibitor inhibits leukemia cells astrocytoma CaCo-2 colon HIV-1 aids |
| 10005174 |
Matairesinol
|
|
580-72-3 |
>95%
|
|
|
2004-07-28
|
162.081012891344
|
matairesinol
|
|
lignans plants antioxidants cancer oxidative injury stress enterobacterial fiber dietary enteric isoprostanes enterolactone |
| 13778 |
Metastasis Associated 1 Family Member 2 Polyclonal Antibody
New |
|
- |
|
|
|
2010-05-04
|
300.437306629834
|
metastasis-associated-1-family-member-2-polyclonal-antibody
|
p53 Target Protein in Deacetylase Complex; MTA2; MTA-L1 Protein; PID
|
WB IHC western blotting blots immunoblotting immunohistochemistry MTA-2 MTA 2 MTA-1 MTA 1 MTA-3 MTA 3 HDAC2 HDAC-2 HDAC 2 HDAC1 HDAC-1 HDAC 1 proteins chromatin deacetylase activity activities northern p53 |
| 9000332 |
Methylcarbamyl PAF C-8
Exclusive |
|
- |
≥98%
|
|
✓ |
2009-02-25
|
10.842071823204
|
methylcarbamyl-paf-c-8
|
|
Methylcamyl PAF Methylcamyl PAF C-8 Methylcamyl PAF C-16 PAF C-16 PAF-AH Platelet aggregation c-myc c-fos MAP kinase Mitogen-activated kinase G1 Cell cycle PAF |
| 700140 |
Methyltransferase Colorimetric Assay Kit
|
|
- |
|
|
|
2009-04-07
|
23.015653775321
|
methyltransferase-colorimetric-assay-kit
|
MT Colorimetric Assay Kit
|
assays kits measures measuring monitoring monitors MTs methylation signal transduction biosynthesis repair gene silencing chromatin regulation S-adenosylmethionine SAM-dependent methyltransferases enzymatic cofactors AdoMet donor modifications DNA Alzheimer's diseases depression Parkinson's multiple sclerosis liver failure cancers enzyme-coupled AdoHcy positive control S-adenosylhomocysteine |
| 700150 |
Methyltransferase Fluorometric Assay Kit
|
|
- |
|
|
|
2009-04-08
|
22.094267955800
|
methyltransferase-fluorometric-assay-kit
|
MT Fluorometric Assay Kit
|
assays kits measures measuring monitoring monitors MTs methylation signal transduction biosynthesis proteins repair gene silencing chromatin regulation S-adenosylmethionine SAM-dependent methyltransferases enzymes enzymatic cofactors AdoMet donor proteins modifications DNA Alzheimer's diseases depression Parkinson's multiple sclerosis liver failure cancers enzyme-coupled AdoHcy positive control S-adenosylhomocysteine |
| 10007188 |
Microcystin-LR
|
|
101043-37-2 |
>95%
|
|
|
2005-07-20
|
96.460883977900
|
microcystin-lr
|
Cyanoginosin-LR
|
proteins phosphatases inhibitors microcystins toxins hepatotoxic cyclics heptapeptides cyanobacteria poisonings humans livestock fresh water blue-green algae endemic PP-2A inhibits enzymes PP-1 serine/threonine nodularins okadaic acids |
| 10006317 |
Mifepristone
|
|
84371-65-3 |
>98%
|
|
|
2005-01-25
|
90.582671665350
|
mifepristone
|
RU-486
|
progesterones estrogens estradiol cancers apoptosis RU486 uterine uterus pregnancy hormones receptors glucocorticoids steroids PR GR HRE response elements binding endocrinology |
| 63280 |
Miltefosine
|
|
58066-85-6 |
>98%
|
|
|
|
15.348637200736
|
miltefosine
|
HePC
|
CTP:phosphocholines cytidylyl transferases antimetastatic ceramides apoptosis inhibits inhibitors inhibition cancers |
| 13208 |
Mirin
|
|
299953-00-7 |
≥95%
|
|
|
2009-04-15
|
69.098425414364
|
mirin
|
|
DNA damage ATM histone nuclease MRN Mre11 Rad50 Nbs1 repair |
| 13600 |
MK 0457
New |
|
639089-54-6 |
≥98%
|
|
|
2010-08-16
|
0E-12
|
mk-0457
|
Tozasertib; VX 680
|
mitosis aurora kinase inhibitors inhibits inhibition MK0457 MK-0457 MK-457 MK457 cells cycles cancers apoptosis tumor A B C |
| 10011389 |
Mn SOD (rat) Polyclonal Antibody
|
|
- |
|
|
|
2008-03-27
|
128.212712204921
|
mn-sod-rat-polyclonal-antibody
|
Manganese Superoxide Dismutase
|
SOD1 SOD2 SOD3 EC-SOD oxidative stress superoxide ROS WB IP IHC EIA western blots immunoprecipitation immunohistochemistry immunoblotting blotting enzyme immunoassays |
| 10212 |
Monoacylglycerol Lipase (FL) Polyclonal Antibody
New |
|
- |
|
|
|
2010-03-23
|
122.169116022099
|
monoacylglycerol-lipase-fl-polyclonal-antibody
|
MAGL
|
WB western blots hydrolases antibodies antiserum antisera hydrolysis immunohistochemistry IHC immunoblotting MGL monoacylglycerol neuroscience neurochemistry MAGL monoglycerol blotting |
| 13284 |
MS-275
|
|
209783-80-2 |
≥98%
|
|
|
2009-11-05
|
105.667495660930
|
ms-275
|
Entinostat; SNDX 275
|
inhibitors histone deacetylases HDACs HDAC1 HDAC3 HDAC8 cyclin-dependent kinase inhibitor 1A p21 CIP1 WAF1 cell growth differentiation tumors cancers apoptosis adriamycin PARP Hsp90 ms275 MS 27-275 SNDX-275 SNDX275 MS27275 |
| 10009365 |
MTT Cell Proliferation Assay Kit
|
|
- |
|
|
|
2007-02-15
|
85.536528545120
|
mtt-cell-proliferation-assay-kit
|
|
assays kits screen measures measurements cells cellular growth factors signaling signalling molecules transcription DNA pathological cancers aging cycles progression regulatory cytokines mitogens drugs inductions inhibitors inhibits inhibitions in vitro plasma membranes formazan intracellular NAD(P)H-oxidoreductases NADPH-oxidoreductases proteins enzymes enzymatic cleavage microtiter plates tertrazolium salts mitochondrial dehydrogenases cancer cell-based assay
cell based assay cba |
| 600330 |
Multi-Parameter Apoptosis Assay Kit
New |
|
- |
|
|
|
2010-08-18
|
5.555555555556
|
multi-parameter-apoptosis-assay-kit
|
|
assays kits measures measurements apoptosis cells death cycles tissues homeostasis dysregulation neurodegenerative diseases ischemic damages autoimmune disorders cancers drugs discovery signaling pathways membranes phospholipids phosphatidylserines phosphatidylethanolamines leaflets bilayers externalizations residues plasma phospholipids binding proteins fluorochrome-labeled fluorochromes annexin V fluorescence microscopy flow cytometry FC plate readers TUNEL TdT-mediated dUTP Nick-End Labeling analysis ISEL in situ end labeling DNA deoxyribonucleic acids mitochondrial transmembranes tetramethylrhodamines ethyls esters TMRE lipophilics probes laddering detection fragmentation FITC-conjugated fluoresceins |
| 10004910 |
Murine Macrophage Microsomal Immunoblot Control
|
|
- |
|
|
|
2004-11-09
|
39.194751381215
|
murine-macrophage-microsomal-immunoblot-control
|
Mouse Macrophage Microsomes Protein
|
western blots blotting microsomes immunoblots immunoblotting positive controls COX-2 COX2 PGHS-2 PGHS2 cyclooxygenases prostaglandins synthases cultures SDS-PAGE |
| 13779 |
MutL Protein Homolog 1 Monoclonal Antibody (Clone 164C819)
New |
|
- |
|
|
|
2010-04-29
|
300.437306629834
|
mutl-protein-homolog-1-monoclonal-antibody-clone-164c819
|
HNPCC; MLH1
|
antibodies western blots bloting immunobloting WB Mut-L Mut L MLH 1 MLH-1 DNA genes cancers colons |
| 10012600 |
Myricetin
|
|
529-44-2 |
>98%
|
|
|
2009-02-20
|
13.802596685083
|
myricetin
|
NSC 407290; Cannabiscetin
|
flavonoid antioxidant oxLDL CD36 atherosclerosis cancers JAK1 STAT3 MEK1 |
| 10008581 |
Myristoleic Acid methyl ester
|
|
56219-06-8 |
>98%
|
|
|
2007-04-17
|
0.791325966851
|
myristoleic-acid-methyl-ester
|
|
cytotoxic Serenoa S. repens apoptosis necrosis prostate cancers cheese whey fatty acids Candida C. albicans MIC minimal inhibitory concentration in vivo esters hydrophobic |
| 13055 |
Naphthofluorescein
|
|
61419-02-1 |
≥98%
|
|
|
2009-03-20
|
2.733129439620
|
naphthofluorescein
|
CCG 8295
|
furin matrix metalloproteinase MTA-MMP MMP2 motility invasion cancer metastasis MMP inhibitors naphthafluorescein |
| 10387 |
Naringenin-4'-O-β-D-Glucuronide
New |
|
158196-35-1 |
≥88%
|
|
|
2010-04-23
|
0E-12
|
naringenin-4-o-d-glucuronide
|
|
flavanone inhibits inhibition inhibitor CYP1A2 CYP 1A2 cytochrome P450 158196-35-1 |
| 10388 |
Naringenin-7-O-β-D-Glucuronide
|
|
- |
≥98%
|
|
|
|
0E-12
|
naringenin-7-o-d-glucuronide
|
|
158196-34-0 inhibits inhibition cytochrome P450 inhibitor CYP1A2 |
| 13755 |
NF-κB (p50) Monoclonal Antibody (Clone 2J10D7)
|
|
- |
|
|
|
2010-02-05
|
73.552164518109
|
nf-b-p50-monoclonal-antibody-clone-2j10d7
|
|
NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB nuclear transcription factors cytokines UV radiations stress injury bacterial viral cells growth differentiation proliferation apoptosis inflammation DNA AIDS cancers arthritis western blots blotting immunoblotting IHC WB immunohistochemistry |
| 13754 |
NF-κB (p50) Polyclonal Antibody
New |
|
- |
|
|
|
2010-04-27
|
34.441053406998
|
nf-b-p50-polyclonal-antibody
|
|
NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB nuclear transcription factors DNA p65 N-terminal binding western blots blotting immunoblotting WB antibodies |
| 10010184 |
NF-κB (p50) Western Ready Control
|
|
- |
74.5 kDa (GST-tagged), 48.5 kDa (native)
|
|
|
2007-07-19
|
35.445745856353
|
nf-b-p50-western-ready-control
|
Nuclear Factor-κB (p50); NF-κB1
|
western blot WB transcription factors p50 p105 p52 p100 regulating cytokines chemokines immunoreceptors cell adhesion molecules mammals |
| 13756 |
NF-κB (p65) Monoclonal Antibody-biotin (Clone 112A1021)
|
|
- |
|
|
|
2010-02-11
|
111.440352698253
|
nf-b-p65-monoclonal-antibody-biotin-clone-112a1021
|
|
NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB genes apoptosis viral replications tumorigenesis diseases inflammations N-terminal DNA DNA-binding binding western blots blotting WB biotins biotinylated biontinylation 112A1021 clones |
| 13752 |
NF-κB (p65) Monoclonal Antibody (Clone 112A1021)
|
|
- |
|
|
|
2010-02-11
|
111.440352698253
|
nf-b-p65-monoclonal-antibody-clone-112a1021
|
|
NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB genes apoptosis viral replications tumorigenesis diseases inflammations N-terminal DNA DNA-binding binding western blots blotting flow cytometry FC WB immunohistochemistry IHC |
| 13751 |
NF-κB (p65) NLS Polyclonal Antibody
|
|
- |
|
|
|
2010-02-11
|
111.440352698253
|
nf-b-p65-nls-polyclonal-antibody
|
Nuclear Factor-κB (p65) Nuclear Localization Signal
|
NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB transcription factors N-terminal C-terminal terminals terminus signals tissues nuclear receptors western blots blotting immunoblotting WB immunocytochemistry ICC antibodies |
| 13757 |
NF-κB (p65) Polyclonal Antibody (aa 2-17)
|
|
- |
|
|
|
2010-02-11
|
108.489855460684
|
nf-b-p65-polyclonal-antibody-aa-2-17
|
|
NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB genes apoptosis viral replications tumorigenesis diseases inflammations N-terminal DNA DNA-binding binding western blots blotting WB amino acids 2 7 |
| 13753 |
NF-κB (p65) Polyclonal Antibody (aa 538-546)
|
|
- |
|
|
|
2010-02-11
|
111.440352698253
|
nf-b-p65-polyclonal-antibody-aa-538-546
|
|
NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB genes apoptosis viral replications tumorigenesis diseases inflammations N-terminal DNA DNA-binding binding western blots blotting WB amino acids 538 546 |
| 10011250 |
NH125
|
|
278603-08-0 |
≥95%
|
|
|
2008-11-21
|
3.098066298342
|
nh125
|
|
antibacterial histidine kinase cancer cell cycle eEF-2K drug resistance imidazoles |
| 10010422 |
Nilotinib
|
|
641571-10-0 |
≥98%
|
|
|
2009-10-23
|
16.523608607154
|
nilotinib
|
AMN107
|
tyrosine kinases inhibitors therapy cancer Bcr/Abl chronic myeloid leukemia MLL philadelphia chromosomes acute lymphoblastic ALL imatinib gleevec genes expression DNA helicase complex cyclins cyclin-dependent cells proliferation |
| 10006966 |
Nitrotyrosine Monoclonal Antibody - Biotinylated
|
|
- |
|
|
|
2005-04-15
|
21.941546961326
|
nitrotyrosine-monoclonal-antibody-biotinylated
|
|
antibodies western blots blotting WB antisera antiserum peroxynitrite western blots blotting nitric oxide nitration proteins NO superoxide alzheimer's diseases oxidative injury stress IHC immunohistochemistry IP immunoprecipitation EIA enzyme immunoassay species independent detection immunoblotting Enzyme-linked immunosorbent assays |
| 10005705 |
NO-Indomethacin
|
|
301838-28-8 |
>98%
|
|
|
2004-10-20
|
1.558625690607
|
no-indomethacin
|
NCX 2121
|
inhibition inhibitors NSAIDs non-steroidal anti-inflammatory drugs inhibits nitric oxides cancer chemopreventative donor gastrointestinal NOs PaCa-2 PaCa2 pancreatic analgesic |
| 10011255 |
NSC 210902
|
|
51726-83-1 |
≥95%
|
|
|
2008-09-15
|
1.672375690607
|
nsc-210902
|
|
Inhibitor inhibits inhibition CK2 kinase cell signaling apoptosis cancers NSC210902 |
| 13196 |
NSC 23766 (hydrochloride)
New |
|
1177865-17-6 |
≥98%
|
|
|
2010-07-20
|
0E-12
|
nsc-23766-hydrochloride
|
|
733767-34-5 GTPases cells cycles growth proliferations cell-cell adhesions motility differentiation guanine nucleotides exchange factors GEFs inhibitors inhibits inhibition cell migration angiogenesis leukemia cancers gene expression Rac1 Inhibitor |
| 13303 |
NSC 663284
New |
|
383907-43-5 |
≥98%
|
|
|
2010-04-01
|
0E-12
|
nsc-663284
|
Cdc25 Phosphatase Inhibitor II; DA-3003-1
|
dual specificity phosphatases CDC25 Cdc25A Cdc25B Cdc25C proto-oncogenes cancers inhibitors VHR PTP1B MKP-1 Cdk1 Cdk2 cells proliferation tumors inhibits inhibition Cdcs potent cell-permeable irreversible |
| 13308 |
NU 7026
|
|
154447-35-5 |
≥95%
|
|
|
2009-09-21
|
60.650994475138
|
nu-7026
|
DNA-PK Inhibitor II; LY293646
|
DNA-dependent proteins kinase DNA-PK strand breaks ionizing radiation DNA repair inhibitors inhibitis inhibitions PI3K ATM ATR PAPR-1 PARP1 cytotoxicity topoisomerase II leukemia mitoxantrone NU-7026 NU 7026 ataxia telangiectasia mutated Rad3 related Rad3-related Rad 3 Rad-3 DNA-Dependent Protein Kinase |
| 18585 |
(−)-Nutlin-3
Exclusive |
|
- |
≥98%
|
|
✓ |
2008-08-06
|
143.446160220994
|
-nutlin-3
|
Nutlin 3a
|
P53 cellular stress proliferation cells cycle apoptosis tumor suppressor MDM2 agents Nutlin-3 enantiomer a |
| 10009816 |
(+)-Nutlin-3
Exclusive |
|
- |
≥98%
|
|
✓ |
2008-08-11
|
99.996270718231
|
-nutlin-3
|
Nutlin 3b
|
p53 cellular stress proliferation cells cycle apoptosis tumer suppressor MDM2 inactive inhibitors inhibits inhibition Nutlin-3 enantiomer b |
| 10004372 |
(±)-Nutlin-3
|
|
548472-68-0 |
>98%
|
|
|
2004-04-06
|
108.302491210446
|
-nutlin-3
|
|
apoptosis cancers p53 inhibits inhibitors induces apoptotic re-activation reactivation antioncogenic tumors xenografts license:hoffmanlaroche Nutlin3 nutlins |
| 13641 |
NVP-AEW541 (hydrochloride)
New |
|
- |
98%
|
|
|
2010-07-28
|
34.935248618785
|
nvp-aew541-hydrochloride
|
|
475488-34-7 IGF-1R Insulin-like growth factor I receptors tyrosine kinases angiogenesis cells proliferation cancers inhibitors inhibition inhibits 701294-63-5 Ins-R NWT-21 |
| 10010547 |
O-Arachidonoyl Glycidol
Exclusive |
|
439146-24-4 |
>98%
|
|
✓ |
2008-03-31
|
43.893867403314
|
o-arachidonoyl-glycidol
|
|
2-AG 2-arachidonoyl glycerol 2-oleoylglycerol N-arachidonoylethanolamine anandamide AEA FAAH endocannabinoid obesity pain neurodegenerative diseases monoacylglycerol lipase inhibits inhibitors inhibitions MAGL MGL |
| 10010299 |
Oleoyl 3-carbacyclic Phosphatidic Acid
Exclusive |
|
- |
≥95%
|
|
✓ |
2009-10-14
|
13.700418310970
|
oleoyl-3-carbacyclic-phosphatidic-acid
|
3-ccPA 18:1
|
cyclic phosphatidic acids cPAs lysophosphatidic LPA ccPA 3ccPA oleate transcellular migration MM1 cells mesothelial autotoxin cancer survival growth migration invasion metastasis antagonist LPA1 LPA2 LPA3 476310-24-4 |
| 10010240 |
Olomoucine
|
|
101622-51-9 |
>98%
|
|
|
2007-09-13
|
13.512863720074
|
olomoucine
|
|
inhibitors inhibits inhibition cyclin-dependent kinases cdks spinal cord injury SCI G1 cell cycle |
| 600008 |
p53 Cell-Based Activation/Translocation Assay Kit
|
|
- |
|
|
|
2009-03-10
|
2.083885819521
|
p53-cell-based-activation-translocation-assay-kit
|
|
p53 dsDNA double-stranded tumors suppressors proteins guardians of the genomes cells cellular responses genotoxic stresses activity cycles arrests apoptosis senescence humans cancers mutations inactivated binding ubiquitination acetylation phosphorylation sumoylation neddylation methylation glycosylation damages oncogenes ribosomal cell-matrix matrices adhesion hypoxia p21 WAF1 Cip1 MDM2 GADD45 Cyclin G Bax IGF-BP3 bcl-2 Bcl-XL cyclins B1 MAP4 survivin HPV16 PARP-1 WT1 E1b/E4 degradation nucleus cytoplasms proteasomes promoter carcinogenesis endogenous wild-type heterogenous autosomal dominant disorders Li Fraumeni Syndromes nuclear extracts assays cell-based assay
cell based assay cba |
| 600030 |
p53 Designer Transcription Factor Assay Kit
|
|
- |
|
|
|
2009-01-08
|
19.413275453827
|
p53-designer-transcription-factor-assay-kit
|
|
dsDNA double-stranded tumors suppressors proteins guardians of the genomes cells cellular responses genotoxic stresses activity cycles arrests apoptosis senescence humans cancers mutations inactivated binding ubiquitination acetylation phosphorylation sumoylation neddylation methylation glycosylation damages oncogenes ribosomal cell-matrix matrices adhesion hypoxia p21 WAF1 Cip1 MDM2 GADD45 Cyclin G Bax IGF-BP3 bcl-2 Bcl-XL cyclins B1 MAP4 survivin HPV16 PARP-1 WT1 E1b/E4 degradation nucleus cytoplasms proteasomes promoter carcinogenesis endogenous wild-type heterogenous autosomal dominant disorders Li Fraumeni Syndromes nuclear extracts ELISAs assays enzyme-linked immunosorbent TFs T.F. factors assays |
| 10004806 |
p53 Monoclonal Antibody (Clone BP53-12)
|
|
- |
|
|
|
2004-06-17
|
2.126921862667
|
p53-monoclonal-antibody-clone-bp53-12
|
|
proteins WB western blots blotting antibodies antisera antiserum DNA anti-oncogenic apoptosis cancers p53 apoptotic antioncogenic flow cytometry immunocytochemistry ICC IHC immunohistochemistry transcription factors cellular stress damage hypoxia shock guardian of the genome special:month specialdiscount:15 specialstart:2008-01-01 specialend:2008-01-31 immunoblotting FC |
| 10004807 |
p53 (Phospho-Ser392) Polyclonal Antibody
|
|
- |
Affinity-purified
|
|
|
2004-05-18
|
12.307262124002
|
p53-phospho-ser392-polyclonal-antibody
|
|
phosphorylateds proteins WB western blots blotting antibodies antisera antiserum DNA binding anti-oncogenic apoptosis cancer p53 re-activator reactivator induces apoptotic re-activation reactivation antioncogenic phospho-specific immunoblotting |
| 10005291 |
p53 Product Pack
|
|
- |
|
|
|
2004-09-08
|
25.525317679558
|
p53-product-pack
|
|
DNA binding anti-oncogenic apoptosis cancer p53 re-activators reactivators induces apoptotic re-activation reactivation antioncogenic packs |
| 600060 |
p53 Total and p53 (Phospho-Ser392) Dual Staining Assay Kit
|
|
- |
|
|
|
2009-03-10
|
3.367311233886
|
p53-total-and-p53-phospho-ser392-dual-staining-assay-kit
|
|
kits assays measuring measurements tumors treatments DyLightTM (-)-Nutlin-3 positive ontrols p53(Phospho-Ser392) dsDNA double-stranded suppressors proteins guardians of the genomes cells cellular responses genotoxic stresses activity cycles arrests apoptosis senescence cancers mutations inactivated binding ubiquitination acetylation phosphorylation sumoylation neddylation methylation glycosylation damages oncogenes ribosomal cell-matrix matrices adhesion hypoxia p21 WAF1 Cip1 MDM2 GADD45 Cyclin G Bax IGF-BP3 bcl-2 Bcl-XL cyclins B1 MAP4 survivin HPV16 PARP-1 WT1 E1b/E4 degradation nucleus cytoplasms proteasomes promoter carcinogenesis endogenous autosomal Li Fraumeni Syndromes nuclear extracts cell-based assays
cell based assay cba |
| 600020 |
p53 Transcription Factor Assay Kit
|
|
- |
|
|
|
2008-10-27
|
20.701883714811
|
p53-transcription-factor-assay-kit
|
|
dsDNA double-stranded tumors suppressors proteins guardians of the genomes cells cellular responses genotoxic stresses activity cycles arrests apoptosis senescence humans cancers mutations inactivated binding ubiquitination acetylation phosphorylation sumoylation neddylation methylation glycosylation damages oncogenes ribosomal cell-matrix matrices adhesion hypoxia p21 WAF1 Cip1 MDM2 GADD45 Cyclin G Bax IGF-BP3 bcl-2 bcl-X cyclins B1 MAP4 survivin HPV16 PARP-1 WT1 E1b/E4 degradation nucleus cytoplasms proteasomes promoter carcinogenesis endogenous wild-type heterogenous autosomal dominant disorders Li Fraumeni Syndromes nuclear extracts ELISAs assays enzyme-linked immunosorbent TFs T.F. factors assays |
| 10009317 |
PAC-1
|
|
315183-21-2 |
>98%
|
|
|
2007-07-12
|
8.565745856354
|
pac-1
|
Procaspase-activating Compound 1
|
in vitro procaspase-3 apoptosis cancers cells death drugs treatment acivators procaspases PAC1 |
| 10461 |
Paclitaxel
New |
|
33069-62-4 |
≥98%
|
|
|
2010-08-23
|
0E-12
|
paclitaxel
|
Taxol®; NSC 125973
|
Microtubules cancers cervical HeLa lung A549 breast MCF-7 colon HT-29 ovarian OVG-1 pancreatic PC-Sh carcinomas chemotherapy mitotic arrest apoptosis JNK BCL-2 p53 Pacific yew tree c-Jun cyclin-dependent kinases multipolar spindle formation Abraxane Capxol Mitotax Onxal QW 8184 Yewtaxan Tocosol Taxus Liberte Genexol-PM Genetaxyl EndoTAG 1 Ebetaxwl DHP 107 ABI 007 |
| 10007358 |
Palmitic Acid methyl ester
|
|
112-39-0 |
>99%
|
|
|
2006-02-17
|
1.746484178804
|
palmitic-acid-methyl-ester
|
MP; Methyl Palmitate
|
esters saturated fatty acids synthesized synthesis plants animals acetyl coenzymes CoA energy storage 16-carbon dietary fats plasma lipoproteins expression COX-2 cyclooxygenase-2 cyclooxygenases proteins acylation lipids anchoring signaling signalling molecules |
| 10010298 |
Palmitoleoyl 3-carbacyclic Phosphatidic Acid
Exclusive |
|
910228-13-6 |
≥95%
|
|
✓ |
2009-11-03
|
8.451954509578
|
palmitoleoyl-3-carbacyclic-phosphatidic-acid
|
3-carbacyclic PA; 3-ccPA 16:1
|
cyclic phosphatidic acids cPAs lysophosphatidic LPA ccPA 3ccPA palmitoleate transcellular migration MM1 cells mesothelial autotoxins cancer survival growth migration invasion metastasis NPP2 ENPP2 ectonucleotide pyro phosphatase/phosphodiesterase 2 |
| 10010293 |
Palmitoyl 3-carbacyclic Phosphatidic Acid
Exclusive |
|
476310-22-2 |
≥95%
|
|
✓ |
2009-10-07
|
13.564666315881
|
palmitoyl-3-carbacyclic-phosphatidic-acid
|
3-ccPA 16:0; 3-carbacyclic PA
|
cyclic acids cPAs lysophosphatidic LPA ccPA 3ccPA palmitate transcellular migration MM1 cells mesothelial autotoxins cancers survival growth migration invasion metastasis |
| 13557 |
PARP (Cleaved) Monoclonal Antibody
|
|
- |
|
|
|
2009-08-11
|
0E-12
|
parp-cleaved-monoclonal-antibody
|
|
poly ADP ribose polymerase ADP-ribose DNA western blots immunoblotting WB flow cytometry intracellular antibodies FC blotting |
| 10009115 |
pCAF Histone Acetyltransferase
|
|
- |
>95%
|
|
|
2006-10-18
|
13.228915745856
|
pcaf-histone-acetyltransferase
|
HAT; p300/(CREB binding protein) Associated Factor
|
proteins binding GCN5 nuclear acetyltransferases C-terminal C-terminus acetyl-lysine N-terminal N-terminus histones H3 H4 transcriptional activators MyoD E2F1 p53 acetylates PTEN K125 K128 catalytic cleft in vivo enzymes cancers |
| 10004805 |
PCNA Monoclonal Antibody (Clone IPO-38)
|
|
- |
|
|
|
2004-08-27
|
3.157524861878
|
pcna-monoclonal-antibody-clone-ipo-38
|
Nuclear Antigen of Proliferating Cells; Proliferating Cell Nuclear Antigen
|
WB western blots blotting IHC immunohistochemistry immunoblots proliferating cells nuclear antigens ipo38 flow cytometry immunocytochemistry ICC mitosis DNA polymerases holoenzymes antibodies antisera antiserum cancers immunoblotting FC |
| 10007185 |
PCSK9 (human) Polyclonal Antibody
|
|
- |
|
|
|
2005-11-30
|
23.462864204711
|
pcsk9-human-polyclonal-antibody
|
Proprotein Convertase Subtilisin Kexin 9; NARC-1
|
atherosclerosis proteins diseases antibodies antisera antiserum WB western blots blotting ICC immunocytochemistry serines proteases family lipoproteins subtilisin metabolisms mutations genes autosomal doimant dominance hypercholesterolemia low density LDLs overexpressions plasmas total cholesterols livers kidneys lungs spleens jejunums ileums colons muscles golgi tissues atherosclerosis immunoblotting |
| 10009581 |
PCSK9 (murine) Blocking Peptide
|
|
- |
|
|
|
2007-01-22
|
13.817720994475
|
pcsk9-murine-blocking-peptide
|
Proprotein Convertase Subtilisin Kexin 9; NARC-1
|
neural apoptosis regulated convertase 1 proteins antibodies antisera antiserum WB western blots blotting ICC immunocytochemistry serines proteases lipoproteins subtilisin metabolisms mutations genes autosomal doimant dominance hypercholesterolemia low density LDLs overexpressions plasmas total cholesterols cancer cells |
| 10008811 |
PCSK9 (murine) Polyclonal Antibody
|
|
- |
|
|
|
2007-01-22
|
15.063116022099
|
pcsk9-murine-polyclonal-antibody
|
Proprotein Convertase Subtilisin Kexin 9; NARC-1
|
immunoblot neural apoptosis regulated convertase 1 atherosclerosis proteins antibodies antisera antiserum WB western blots blotting ICC immunocytochemistry serines proteases lipoproteins subtilisin metabolisms mutations genes autosomal doimant dominance hypercholesterolemia low density LDLs overexpressions plasmas total cholesterols atherosclerosis PCSK-9 immunoblotting |
| 13034 |
PD 0325901
|
|
391210-10-9 |
≥98%
|
|
|
2009-03-13
|
55.542829687333
|
pd-0325901
|
|
MEK ERK RAS RAF MAPK tumors stem cells cancers differentiation signaling GSK3 kinase inhibitors inhibits inhibition pd325901 pd 325901 PD0325901
|
| 13032 |
PD 173074
|
|
219580-11-7 |
≥98%
|
|
|
2009-07-29
|
25.174872928177
|
pd-173074
|
|
fibroblast growths factors receptors FGFRs FGFR1 tyrosine kinase activity activities activation signals propagation inhibitors inhibition inhibits autophosphorylation PDGFR c-Src cSrc c Src EGFR InsR MEK PKC FGFR2 FGFR3 FGFR4 FGFR5 angiogenesis cancers tumors self-renewal self renewal stems cells ERK1/2 ERK-1/2 ERK 1/2 |
| 10012431 |
PD 184161
Exclusive |
|
212631-67-9 |
≥98%
|
|
✓ |
2009-06-09
|
18.628839779005
|
pd-184161
|
|
MEK inhibitors MAP kinase ERK signaling cancer MEK 1/2 inhibition inhibited ERK 1/2 potent selective pd184161 |
| 10006726 |
PD 98059
|
|
167869-21-8 |
>98%
|
|
|
2005-09-12
|
33.561878453039
|
pd-98059
|
|
potent selective MAPK mitogen-activated proteins kinases family serines threonines cellular PD-98059 programs cells proliferation differentiation movement death noncompetitive inhibits inhibitors inhibition pathways activation MAPKK1 Raf MEK MAPKK2 MAPKK-1 PD98059 MAPKK-2 ERK |
| 10006341 |
PDM 11
|
|
- |
>98%
|
|
|
2005-03-23
|
10.793469613259
|
pdm-11
|
|
resveratrol analogs analogues aryl hydrocarbons receptors anatagonists AhRs ligand-dependents ligands xenobiotics PDM11 PDM-11 estrogen dioxin poisonings stilbene xenobiotics polyaromatics soot coal tar |
| 10006342 |
PDM 2
|
|
688348-25-6 |
>98%
|
|
|
2005-03-29
|
11.900342541436
|
pdm-2
|
|
AhRs antagonists stilbenes dioxins aryl hydrocarbons receptors ligand-dependent transcription factors resveratrol analogs ligands xenobiotics PDM2 PDM-2 estrogen poisonings xenobiotics polyaromatics soot coal tar cancers |
| 62595 |
PDMP (hydrochloride)
|
|
73257-80-4 |
>98%
|
|
|
2004-08-10
|
1.226740331491
|
pdmp-hydrochloride
|
|
analogs analogues inhibits inhibitors inhibition cytotoxicity glucosylceramides aynthases chirality stereoisomers sphingosine |
| 10005983 |
Pentafluorobenzenesulfonyl fluorescein
|
|
728912-45-6 |
>98%
|
|
|
2005-02-22
|
15.762108655617
|
pentafluorobenzenesulfonyl-fluorescein
|
|
fluoresceins hydrogen peroxides oxidative stress fluorescents probes ROS reactive oxygen species perhydrolysis H2O2 |
| 500290 |
Phagocytosis Assay Kit (IgG FITC)
|
|
- |
|
|
|
2009-04-09
|
95.458651933702
|
phagocytosis-assay-kit-igg-fitc
|
|
kits assays measuring measurement ingestion killing phagocytic leukocytes defense pathogens microbe-innate immune cytoskeletal rearrangement membrane trafficking microbial mechanisms pro-inflammatory anti-inflammatory cytokines chemokines apoptosis antigen immune systems pathological Multiple Sclerosis Alzheimer's diseases atherosclerosis bacterial fungal infections in vitro fluorescently opsonizing latex beads fluorescently-labeled flow cytometry cytometric analysis quantification cell-based assay
cell based assay cba |
| 10007192 |
PH Domain Leucine-rich Repeat Protein Phosphatase Blocking Peptide
|
|
- |
|
|
|
2006-01-30
|
2.505925414364
|
ph-domain-leucine-rich-repeat-protein-phosphatase-blocking-peptide
|
KIAA0606 Protein; PHLPP; PLEKHE1 Protein; SCOP; Suprachiasmatic Nucleus Circadian Oscillatory Protein
|
western blotting blots signaling signalling WB IHC ICC immunohistochemistry formalin-fixed paraffin-embedded immunocytochemistry proteins kinases Akt cells growth death serine residues Ser473 C-terminal hydrophobic motifs human cancers dephosphorylates dephosphorylation reduces activity apoptosis apoptotic colon glioblastomas lines tumors brain |
| 10007191 |
PH Domain Leucine-rich Repeat Protein Phosphatase Polyclonal Antibody
|
|
- |
|
|
|
2006-01-04
|
3.757658839778
|
ph-domain-leucine-rich-repeat-protein-phosphatase-polyclonal-antibody
|
Suprachiasmatic Nucleus Circadian Oscillatory Protein; SCOP; PLEKHE1 Protein; PHLPP; KIAA0606 Protein
|
proteins diseases antibodies antisera antiserum western blots blotting immunocytochemistry ICC immunohistochemistry IHC cancers WB immunoblotting |
| 700240 |
Phosphatidic Acid Assay Kit
|
|
- |
|
|
|
2009-08-24
|
60.175303867403
|
phosphatidic-acid-assay-kit
|
PA Assay Kit
|
assays kits measures fluorescence-based cells cellular phospholipids phosphatidate membranes storage de novo synthesis phospholipases PLD PLA hydrolysis phosphodiesters phosphatidylcholines PC phosphorylation diacylglycerol DAG DAGK lysophosphatidic LPA lysoPA-acyltransferase LPAAT phosphates phosphohydrolases LPPs intracellular signal transduction mammalian rapamycin mTOR signaling cycle progression growth disregulation human diseases cancers bacterial FKBP12 Raf-1 kinases sphingosines cAMP Adenosines 3',5' cyclic mononucleotides phosphodiesterases 4A1 translocation proteins PKC tyrosines SHP-1 guanine nucleotides Son of sevenless glycerol-3-phosphate oxidized oxidases hydrogen peroxides H2O2 peroxidases ADHP 10-acetyl-3,7-dihydroxyphenoxazines resorufin |
| 10009209 |
PI-103
|
|
371935-74-9 |
>98%
|
|
|
2007-01-19
|
81.993030781373
|
pi-103
|
|
phosphoinositides PI3-kinases Phosphatidylinositols cancers Glioma DNA-PK mTOR inhibitors inhibits inhibition anti-proliferatives proliferation PI103 |
| 10010177 |
PI3-Kinase α Inhibitor 2
Exclusive |
|
371943-05-4 |
>98%
|
|
✓ |
2007-08-02
|
65.905497237568
|
pi3-kinase-inhibitor-2
|
PI3Kα Inhibitor 2; Phosphatidylinositol 3-Kinase α Inhibitor 2
|
phosphoinositides 3-kinases PI3-kinase phosphatidylinositols cancers proliferations inhibits inhibitors inhibition PI3-K PI3K inhibitory A375 melanoma cell proliferation |
| 13326 |
Pifithrin-α
|
|
63208-82-2 |
≥95%
|
|
|
2009-07-16
|
22.042012628255
|
pifithrin
|
|
p53 apoptosis DNA damage cyclin D1 C8 cells HUVECs endothelial cells dependent independent inactivator |
| 10009210 |
PIK-75
New |
|
372196-67-3 |
≥98%
|
|
|
2010-03-10
|
93.284757903622
|
pik-75
|
|
p110α PI3K insulin signaling signals cancers inhibitors inhibits inhibition signalling p110a phosphatidylinositol 3-kinase phosphorylation Akt activation mTORC1 PIP2 PIP3 p110β p110α p110γ p110beta p110 alpha p110.beta. p110.alpha. p110gamma p110.gamma.p110g |
| 89130 |
Pimonidazole
|
|
70132-50-2 |
>98%
|
|
|
2008-04-23
|
7.666850828729
|
pimonidazole
|
NSC 380540; Ro 03-8799
|
hypoxia hypoxic cells radiosensitizer tumors marker hypoxia hypoxyprobe |
| 10006284 |
PINK1 Blocking Peptide
|
|
- |
|
|
|
2005-01-18
|
8.655911602210
|
pink1-blocking-peptide
|
PTEN Induced Putative Kinase 1; PARK6; BRPK
|
antibodies western blotting blots signaling signalling IHC WB formalin immunohistochemistry controls peptides phosphatases tensin homolog dephosphorylates lipids human cancers tumor-suppressive pathway mRNA mitochondria C-terminus Parkinson's diseases phosphatidylinositols phosphates |
| 10006283 |
PINK1 Polyclonal Antibody
|
|
- |
|
|
|
2004-12-28
|
31.904486187845
|
pink1-polyclonal-antibody
|
PTEN Induced Putative Kinase 1; PARK6; BRPK
|
proteins antibodies antisera antiserum wb western blots blotting IHC immunohistochemistry Parkinson's diseases cancers tumor-suppressive phosphatases tensin homologs dephosphorylates human signaling signalling pathway mRNA mitochondria c-terminus phosphatidyl inositols phosphates special:month specialdiscount:15 specialstart:2008-05-01 specialend:2008-05-31 immunoblotting |
| 13368 |
Piroxicam
|
|
36322-90-4 |
≥95%
|
|
|
2010-01-06
|
18.259891376272
|
piroxicam
|
NSC 666076; Larapam; Feldene
|
inflammation NSAIDs inhibitors cyclooxygenases COX-1 COX-2 analgesic pain arthritis cancers Artrooxicam Baxo Bruxicam CP 16171 Geldene Neoxicam Reudene Roxicam Roxiden Sasulen Solocalm Uphaxicam Zunden inhibition inhibited inflammatory |
| 10459 |
PKC 412
New |
|
120685-11-2 |
≥98%
|
|
|
2010-07-27
|
0E-12
|
pkc-412
|
CGP 41251; N-Benzoylstaurosporine; Midostaurin; CGP 41231
|
inhibitors inhibits inhibition PKC412 PKC-412 serine/threonine serine threonine tyrosines kinases PKCα PKCβ PKCγ PKC-α PKC-β PKC-γ Syk Flk-1 Flk1 Akt PKA c-Kit cKit C-Fgr cFgr FLT3 FLT-3 PDFRβ PDFR-β VEGFR1 VEGF2 nitric oxide synthase eNOS apoptosis cancers angiogenesis signal transduction |
| 10011332 |
Plerixafor (hydrochloride hydrate)
|
|
155148-31-5 |
≥98%
|
|
|
2009-02-10
|
34.935248618785
|
plerixafor-hydrochloride-hydrate
|
Mobozil™; SID 791; JM 3100; AMD 3100
|
stem cells hematopoiesis HIV lymphocyte replication metastasis cancers growth antagonist CXCR4 SDF-1 SDF1 CXCL12 ireversible virus inhibits inhibition inhibitor |
| 13786 |
PMS2 Monoclonal Antibody (Clone 163C1251)
New |
|
- |
|
|
|
2010-05-10
|
300.437306629834
|
pms2-monoclonal-antibody-clone-163c1251
|
PMS1 Protein Homologue 2; Mismatch Repair Endonucleas PMS2; DNA Mismatch Repair Protein PMS2
|
antibodies PMS-1 PMS 1 PMS 2 PMS-2 proteins DNA cancers HNPCC hereditary nonpolyposis non-polyposis western blots blotting immunoblotting WB cancer DNA damage repair |
| 10009987 |
PPARγ FL (human recombinant from Sf21 cells)
|
|
- |
>80% by SDS-PAGE
|
|
|
2007-06-15
|
17.833683241252
|
ppar-fl-human-recombinant-from-sf21-cells
|
Peroxisome Proliferator-activated Receptor γ Full Length (human recombinant from Sf21 cells)
|
proteins binding enzymes PPAR.gamma. PPARgamma diseases obesity diabetes atherosclerosis cancers endocrinology |
| 10007451 |
PPARδ (human recombinant)
|
|
- |
>95%
|
|
|
2005-07-29
|
9.948187845304
|
ppar-human-recombinant
|
PPARβ; Peroxisome Proliferative Activated Receptor δ; Nuclear Hormone Receptor 1; NUC1; FAAR
|
peroxisomes proliferator-activated receptors PPARs proliferator activated PPARdelta PPAR.delta. PPARd PPARδ PPAR-δ PPAR-delta delta .delta. δ PPAR-.delta. PPAR-d recombinant proteins human atherosclerosis cancers EMSA electrophoretic mobility shift assays endocrinology fluorescence metabolic syndrome nuclear obese obesity biochemistry transcription factors members retionic acids genes expression developments baculovirus Sf21 heterodimerize subtypes hNUC1 FAAR ubiquitously tissues mediator embryo implantation overexpression systems gels coomassie stains staining western blots WB immunoblotting 10006914 |
| 10009568 |
PPARδ Western Ready Control
|
|
- |
|
|
|
2007-02-02
|
7.238066298342
|
ppar-western-ready-control
|
Peroxisome Proliferative Activated Receptor δ; Nuclear Hormone Receptor 1; FAAR; PPARβ; NUC1
|
peroxisome proliferative-activated receptor PPARd xenopus laevis PPARb PPAR.beta. liver intesine kidney abdominal adipose skeletal muscle lipids metabolism cholesterol homeostasis embryos cancers obesity atherosclerosis endocrinology |
| 63520 |
PRIMA-1
|
|
5608-24-2 |
>95%
|
|
|
|
12.084837707182
|
prima-1
|
|
DNA binding anti-oncogenic apoptosis cancer p53 re-activator reactivator induces apoptotic re-activation reactivation antioncogenic cancers 2,2-bis(hydroxymethyl)-1-azabicyclo[2.2.2]octan-3-one |
| 13552 |
PRMT4 Polyclonal Antibody
|
|
- |
|
|
|
2009-07-24
|
0E-12
|
prmt4-polyclonal-antibody
|
CARM1; Protein Arginine Methyltransferase 4
|
antibodies WB western immunoblotting blots coactivator associated arginine methyltransferase 1 steroids receptors SRC proteins co-activators blotting |
| 13559 |
PRMT5 Polyclonal Antibody
|
|
- |
|
|
|
2009-07-24
|
0.906077348066
|
prmt5-polyclonal-antibody
|
Protein Arginine Methyltransferase 7; Skb1HS; JBP1
|
proteins PRMTs signaling WB western immunoblotting blots ADMA blotting janus kinase-binding kinase binding fission yeast 1 |
| 13558 |
PRMT6 Polyclonal Antibody
|
|
- |
|
|
|
2009-07-24
|
0.906077348066
|
prmt6-polyclonal-antibody
|
Protein Arginine Methyltransferase 6
|
antibodies WB HeLa proteins western immunoblotting blots blotting |
| 13551 |
PRMT7 Polyclonal Antibody
|
|
- |
|
|
|
2009-07-24
|
0.906077348066
|
prmt7-polyclonal-antibody
|
Protein Arginine Methyltransferase 7
|
PRMTs antibodies proteins western blotting immunoblotting blots SRC steroid receptor co-activator coactivator GRIP-1 GRIP1 WB |
| 10009762 |
Progesterone Receptor (Phospho-Ser190) Monoclonal Antibody
|
|
- |
|
|
|
2007-04-05
|
88.433701657458
|
progesterone-receptor-phospho-ser190-monoclonal-antibody
|
|
antibodies WB western blots phospho-specific Progesterones receptors phosphorylation Ser190 cancers breast mammary glands endocrinology blotting immunoblotting IHC immunohistochemistry |
| 10009763 |
Progesterone Receptor (Phospho-Ser294) Monoclonal Antibody
|
|
- |
|
|
|
2007-04-05
|
88.433701657458
|
progesterone-receptor-phospho-ser294-monoclonal-antibody
|
|
antibodies WB western blots phospho-specific progesterone receptors cancers breast mammary glands endocrinology blotting immunoblotting IHC immunohistochemistry |
| 13365 |
Programmed Cell Death Protein 4 (C-term) Blocking Peptide
|
|
- |
|
|
|
2008-08-25
|
0E-12
|
programmed-cell-death-protein-4-c-term-blocking-peptide
|
PDCD4
|
antibodies antibody peptides antiserum antisera blocking immunoblotting WB western blots PDCD4 PCDC-4 PDCDP4 PDCDP-4 |
| 10250 |
Programmed Cell Death Protein 4 (C-Term) Polyclonal Antibody
|
|
- |
|
|
|
2008-09-15
|
0.508747697974
|
programmed-cell-death-protein-4-c-term-polyclonal-antibody
|
PDCD4; Neoplastic Transformation Inhibitor
|
western blots WB KLH genes tumors antibodies antiserum antisera PDCD4 PCDC-4 PDCDP4 PDCDP-4 blotting immunoblotting |
| 10010 |
Prostaglandin A1
|
|
14152-28-4 |
>98%
|
|
|
|
111.669352801894
|
prostaglandin-a1
|
PGA1
|
prostaglandins renal vasodilation pge1 dehydration semen antimitotic antiproliferative |
| 12010 |
Prostaglandin D2
|
|
41598-07-6 |
>99%
|
|
|
|
109.955638428484
|
prostaglandin-d2
|
PGD2
|
Vasodilation prostaglandins brain sleep platelets aggregation. H-PGDS synthases mast cells hematopoietic allergic allergy asthmatic anaphylaxis hypotension inhibits inhibitors inhibition beta-trace .beta.-trace b-trace neurochemistry |
| 512031 |
Prostaglandin D2 EIA Kit
New |
|
- |
|
|
|
2010-07-19
|
0E-12
|
prostaglandin-d2-eia-kit
|
PGD2 ELISA Kit
|
PGD2 prostaglandins measures kits eias enzyme immunoassays ELISAs measurements brains glutathione-independent lipocalin-type synthases L-PGDS cerebrospinal fluid CSF physiologic sleep rats humans mast cells leukocytes intracellular myeloid-type glutathione-dependent vascular 11β-PGF2α eicosanoids cultures lysates biosynthesis serum proteins albumin media medium methoximine derivatives PGD2-MOX competitive enzymatic reactions |
| 512041 |
Prostaglandin D2 Express EIA Kit
New |
|
- |
|
|
|
2010-07-19
|
0E-12
|
prostaglandin-d2-express-eia-kit
|
PGD2 Express ELISA Kit
|
PGD2 prostaglandins measures kits eias enzyme immunoassays ELISAs measurements brains glutathione-independent lipocalin-type synthases L-PGDS cerebrospinal fluid CSF physiologic sleep rats humans mast cells leukocytes intracellular myeloid-type glutathione-dependent vascular 11β-PGF2α eicosanoids cultures lysates biosynthesis serum proteins albumin media medium methoximine derivatives PGD2-MOX competitive enzymatic reactions |
| 10007202 |
Prostaglandin D2 Lipid Maps MS Standard
|
|
41598-07-6 |
>99%
|
|
|
2008-10-27
|
28.090560985975
|
prostaglandin-d2-lipid-maps-ms-standard
|
PGD2
|
Vasodilation prostaglandins brain sleep platelets aggregation. H-PGDS synthases mast cells hematopoietic allergic allergy asthmatic anaphylaxis hypotension inhibits inhibitors inhibition beta-trace .beta.-trace b-trace neurochemistry mass spectrometry standards GC LC MS |
| 10007939 |
Prostaglandin E Synthase-1 (microsomal) (human recombinant)
|
|
- |
16,000 x g supernatant
|
|
|
2009-03-15
|
43.443563535911
|
prostaglandin-e-synthase-1-microsomal-human-recombinant
|
MGST1-L1; mPGE Synthase-1; PIG12; Prostaglandin H/E Isomerase; Membrane-Associated PGES-1
|
enzymes proteins PGs prostaglandins catalyzes conversion PGH2 PGE2 membrane-associated eicosanoids glutathiones metabolisms MAPEG expression proinflammatory stimuli stimulus IL-1.beta. IL-1b interleukins glucocorticoids synovial tissues primary synoviocytes rheumatiod arthritis fever onset drugs anti-inflammatory therapy therapies E. coli mPGES mPGES-1 mPGES1 |
| 10011210 |
Protein Phosphatase 2A C subunit (human recombinant)
Exclusive |
|
- |
≥90%
|
|
✓ |
2008-07-17
|
322.995745856353
|
protein-phosphatase-2a-c-subunit-human-recombinant
|
PP2A Cα
|
PP2AC.alpha. PP2ACalpha PP2ACa proteins phosphorylation serine threonine phosphatase cell growth cycle differentiation tumor suppressor |
| 10011237 |
Protein Phosphatase 2A C subunit (human recombinant; L309 deletion)
Exclusive |
|
- |
|
|
✓ |
2008-07-17
|
7.620110497237
|
protein-phosphatase-2a-c-subunit-human-recombinant-l309-deletion
|
PP2A Cα; PP2A Δ309; PP2A L309
|
proteins phosphatases serine threonine cellular tumors enzyme kinetics regulations substrates phosphorylasion PP2As octahistidine-tag streptactin-tag |
| 10010896 |
Protein Tyrosine Phosphatase 1b (human recombinant)
|
|
- |
≥95%
|
|
|
2008-08-25
|
13.215303867403
|
protein-tyrosine-phosphatase-1b-human-recombinant
|
PTP1B
|
proteins recombinant PTPs phosphates tyrosines pNPP enzymes diabetes insulin leptin signaling signalling |
| 13527 |
Pseudolaric Acid B
|
|
82508-31-4 |
≥98%
|
|
|
2009-12-04
|
3.927272727273
|
pseudolaric-acid-b
|
PAB
|
Pseudolarix kaempferi traditional Chinese fungal fungus infections cancers apoptosis angiogenesis tumors inhibits inhibitors inhibition P. therapy apoptosis cells |
| 10009817 |
PtdIns-(3,4,5)-P3 Binding Protein
|
|
- |
>95%
|
|
|
2008-02-14
|
5.574051565377
|
ptdins-3-4-5-p3-binding-protein
|
PI(3,4,5)P3 Binding Protein; Phosphatidylinositol-(3,4,5)-triphosphate Binding Protein; GRP1 PH Domain; PIP3 Binding Protein
|
lipids recognition proteins GST-tagged PIPs phosphatidylinositols triphosphates |
| 10009815 |
PtdIns-(4,5)-P2 Binding Protein
|
|
- |
>95%
|
|
|
2008-02-13
|
0.652375690607
|
ptdins-4-5-p2-binding-protein
|
PIP2 Binding Protein; PI(4,5)-P2 Binding Protein; Phosphatidylinositol-(4,5)-diphosphate Binding Protein; PLC-δ1-PH domain
|
lipid recognition protein human recombinant GST-tagged proteins E. coli PIPs phosphatidylinositols diphosphate PLCdelta PLCd |
| 10009241 |
PtdIns-(4)-P1 Binding Protein
|
|
- |
>90%
|
|
|
2008-02-21
|
1.056132596685
|
ptdins-4-p1-binding-protein
|
SidC; PIP Binding Protein; PI(4)-P1 Binding Protein; SidC 3C
|
GST-tagged EDTA PIPs PtdIns phosphoinositols PIP2 PIP3 PI3-kinase cancers proteins |
| 10007073 |
PTEN Blocking Peptide
|
|
- |
|
|
|
2005-06-28
|
2.385428176795
|
pten-blocking-peptide
|
Phosphatase and Tensin Homology on Chromosome 10
|
western blotting blots signaling signalling WB IHC immunohistochemistry formalin-fixed paraffin-embedded sections controls proteins dephosphorylates lipids AKT phosphatidylinositols triphosphates PIP3 tissues acids regulates cells division migrations apoptosis mutations cancers melanomas prostates carcinomas A431 HEK293 signals transductions |
| 10009746 |
PTEN (human recombinant)
|
|
- |
≥95%
|
|
|
2008-09-04
|
2.588881215469
|
pten-human-recombinant
|
TEP1; Phosphatidylinositol 3-phosphatase; MMAC1; Phosphatase and Tensin Homology on Chromosome 10
|
proteins PTENs phosphatase homology tensin chromosomes enzymes lipids Sf21 cells recombinant N-terminal tumor suppressor cancers phosphoinositide hexahistidine His-tag His-tagged |
| 10005059 |
PTEN Polyclonal Antibody
|
|
- |
|
|
|
2005-05-04
|
12.888614534636
|
pten-polyclonal-antibody
|
TEP1; Phosphoinositide 3-phosphatase; MMAC1; Phosphatase and Tensin Homology on Chromosome 10
|
proteins antibodies antisera antiserum wb western blots blotting IHC immunohistochemistry dephosphorylates lipids AKT phosphatidylinositols triphosphates PIP3 tissues acids regulates cells division migrations apoptosis mutations cancers melanomas prostates carcinomas A431 HEK293 signals transductions cancers endocrinology immunoblotting |
| 10009747 |
PTEN Western Ready Control
|
|
- |
|
|
|
2007-05-30
|
2.973342541436
|
pten-western-ready-control
|
TEP1; MMAC1; Phosphoinositide 3-Phosphatase; Phosphatase and Tensin Homology on Chromosome 10
|
western blot WB AKT phosphatidylinositol 3,4,5-triphosphate PIP3 enzyme transduction pathway endocrinology |
| 13000 |
Pterostilbene
|
|
537-42-8 |
≥98%
|
|
|
2009-09-09
|
13.886543014995
|
pterostilbene
|
3',5'-Dimethoxy-4-Stilbenol; trans-3,5-Dimethoxy-4'-Hydroxystilbene
|
resveratrol blueberries antioxidant PGE2 prostaglandins E2 cells proliferation ERK1/2 ERK 1/2 p38 MAPK PI3K/Akt NF-kB NFkB NF-κB NFκB AP-1 AP1 transcriptional activation cancers inflammation diabetes inflammatory |
| 10005169 |
Quercetin
|
|
117-39-5 |
>95%
|
|
|
2004-08-04
|
13.796331491712
|
quercetin
|
|
flavonoid plants fruits glycosides carcinogens carcinogenic inhibits inhibitors inhibition phosphodiesterases antioxidants rutin |
| 10011620 |
Raloxifene (hydrochloride)
|
|
82640-04-8 |
≥98%
|
|
|
2009-01-07
|
5.196767955801
|
raloxifene-hydrochloride
|
Evista; LY156758; Keoxifene (hydrochloride)
|
breasts cancers osteoporosis SERM estrogen evista bone remodeling formation IL-6 IL6 25-OH vitamin D parathyroid hormones cardiovascular protection |
| 13346 |
Rapamycin
|
|
53123-88-9 |
≥98%
|
|
|
2009-10-21
|
38.575802540001
|
rapamycin
|
Sirolimus
|
immunosuppresssants transplants rejection inhibitors IL-2 lymphocytes B cells T FKBP12 mTOR mTORC1 cancer adipogenesis diabetes tuberous sclerosis cardiovascular diseases |
| 10010172 |
(R)-Equol
Exclusive |
|
221054-79-1 |
≥98%
|
|
✓ |
2009-08-27
|
10.638847671665
|
-r-equol
|
Isoequol; (+)-Equol
|
phytoestrogens estrogens daidzen genistein receptors cancers R-Equol +equol + equol agonist activity R equol (R) equol |
| 10006606 |
Retreversine
|
|
- |
>98%
|
|
|
2005-09-15
|
7.876243093922
|
retreversine
|
|
inactive isomers reversine purine analogs cells stem organogenesis derivatives C2C12 myoblasts osteogenic bones adipogenic adipose de-differentiation dedifferentiation re-differentiation progenitors |
| 10004412 |
Reversine
|
|
656820-32-5 |
>98%
|
|
|
2005-03-25
|
21.648655616943
|
reversine
|
|
purine analogs cells stem organogenesis derivatives C2C12 myoblasts osteogenic bones adipogenic adipose de-differentiation dedifferentiation progenitors fate cancers |
| 10010309 |
RG-13022
|
|
149286-90-8 |
>98%
|
|
|
2008-01-24
|
3.152532936676
|
rg-13022
|
|
protein tyrosine kinase PTK inhibitors inhibits inhibition antiproliferatives tyrphostin epidermal growth factors EGFs receptors cancers |
| 10010310 |
RG-1462
|
|
136831-49-7 |
>98%
|
|
|
2008-02-08
|
1.908977900552
|
rg-1462
|
|
protein tyrosine kinases PTKs inhibitors inhibits inhibition antiproliferative tyrphostin epidermal growth factors EGFs receptors proliferation cancers |
| 13293 |
Rhapontigenin
Exclusive |
|
500-65-2 |
≥98%
|
|
✓ |
2009-11-10
|
21.877568511036
|
rhapontigenin
|
|
resveratrols antioxidants cancers cytochromes P450 CYP450 proliferation anti cancers anti-oxidants |
| 160785 |
RICK Polyclonal Antibody
|
|
- |
|
|
|
|
6.485856353591
|
rick-polyclonal-antibody
|
Ripk2; CCk; Rip2; CARDIAK
|
apoptosis antibodies kinase CARD domains RIP Fas western blots blotting WB antisera antiserum RIP-2 cancers immunoblotting |
| 10006426 |
RITA
|
|
213261-59-7 |
>98%
|
|
|
2006-01-11
|
32.044585635358
|
rita
|
NSC 652287; 2,5-bis(5-hydroxymethyl-2-thienyl) Furan
|
HDM-2 human double minute-2 MDM-2 mouse murine negative regulator p53 proteasomal degradation tumors cancers apoptosis cells reactivation molecules inhibitors wild-type DNA-protein human renal SCID mice HCT116 A-498 xenografts nude HDM2 HDM-2 MDM2 |
| 13697 |
(R)-MG132
Exclusive New |
|
- |
≥98%
|
|
✓ |
2010-06-22
|
0E-12
|
-r-mg132
|
|
ubiquitin proteasomes inhibitors proteolytic degradation inflammation cells cycle regulation cancers NF-κB apoptosis inhibition inhibited |
| 10006415 |
Ro 48-8071
|
|
161582-11-2 |
>98%
|
|
|
2005-06-01
|
30.147645027624
|
ro-48-8071
|
|
monooxidosqualenes cyclases inhibitors OSC cholesterols lowering activity microsomal enzymes catalyzes lanosterol synthetic pathway LDL low-density lipoproteins human livers microsomes HepG2 cells HDL high-desity toxicity CYP3A mRNA proteins hepatocytes cultures atherosclerosis |
| 10009569 |
(R)-Roscovitine
|
|
186692-46-6 |
>98%
|
|
|
2007-09-04
|
27.280174953960
|
-r-roscovitine
|
Seliciclib
|
cell cycle cyclin-dependent kinase cdk proliferation cancer renal disease |
| 13664 |
S32826
New |
|
1096770-84-1 |
≥98%
|
|
|
2010-06-18
|
11.863821362799
|
s32826
|
|
Autotaxins lysophospholipase D lysophosphatidylcholine lysophosphatidic acids LPAs inhibitors src phosphatase 1B adipocytes plasma inhibited inhibition inhibits |
| 13603 |
S-Adenosylhomocysteine
New |
|
979-92-0 |
≥98%
|
|
|
2010-04-22
|
0.205357142857
|
s-adenosylhomocysteine
|
SAH; AdoHcy
|
amino acids derivatives cysteine methyl cycle biosynthesis risk factors
metabolic pathways cancers by-products by products neurodegenerative diseases |
| 9000372 |
S-Adenosylhomocysteine-d4
Exclusive |
|
- |
≥99% deuterated product
|
|
✓ |
2009-12-02
|
5.971931728492
|
s-adenosylhomocysteine-d4
|
SAH-d4
|
deuteriums GC/MS LC/MS mass spectrometry GC-MS LC-MS deuterateds amino acids derivative cysteine methyl cycle biosynthesis 979-92-0 risk factors s-adenosyl-l-homocysteine-d4 |
| 10009929 |
SAHA
|
|
149647-78-9 |
>98%
|
|
|
2007-08-07
|
228.643209442490
|
saha
|
Vorinostat; Suberoylanilide Hydroamic Acid; Zolinza™
|
HDACs inhibitors cancers inhibits inhibition |
| 13178 |
Salermide
Exclusive |
|
1105698-15-4 |
≥98%
|
|
✓ |
2009-04-27
|
18.295982636148
|
salermide
|
|
Sirtuin SIRT1 SIRT2 inhibitors cancers apoptosis leukemias histone deacetylases HDACS inhibition inhibited |
| 13628 |
Salidroside
New |
|
10338-51-9 |
≥97%
|
|
|
2010-05-28
|
0E-12
|
salidroside
|
Rhodioloside
|
glycosides plants Rhodiola Chinese medicine memory infections inflammation cancers diabetes fatigue apoptosis |
| 13031 |
SB 431542
|
|
301836-41-9 |
≥98%
|
|
|
2009-08-10
|
38.333161179045
|
sb-431542
|
|
inhibitors inhibits inhibitions TGF-β1 TGFβ1 receptors ALK5 ALK4 ALK7 ALKs BMP ALK2 ALK3 ALK6 kinases Smad fibrosis cancers renewal embryonic stems cells induced pluripotent differentiation SB431542 |
| 10011561 |
SC-51089
|
|
146033-02-5 |
≥95%
|
|
|
2010-02-02
|
78.715547882136
|
sc-51089
|
CID132748
|
prostaglandins E2 PGE2 receptors EP1 pain antagonists analgesia glioma cells cancers tumors growth neuroprotection neurons oxidative stress SC51089 SC 51089 PGs |
| 10010173 |
(S)-Equol
|
|
531-95-3 |
≥98%
|
|
|
2009-08-27
|
8.512391475927
|
-s-equol
|
4',7-Isoflavandiol; 4',7-Dihydroxyisoflavan; (-)-Equol
|
phytoestrogen estrogens daidzen genistein receptors cancers (S) equol S-equol -Equol (-) Equol antagonist |
| 10005260 |
Serine Palmitoyltransferase Polyclonal Antibody
|
|
- |
|
|
|
2004-12-02
|
14.222235727440
|
serine-palmitoyltransferase-polyclonal-antibody
|
Serine-palmitoyl-CoA transferase, long chain base subunit 2; SPT
|
antibodies antisera western blots blotting WB sphingolipids SPT2 immunohistochemistry immunohistochemical analysis IHC nuclear proteins nucleus immunoblotting |
| 13780 |
SET7/9 (FL) Polyclonal Antibody
New |
|
- |
|
|
|
2010-03-08
|
88.973296500920
|
set7-9-fl-polyclonal-antibody
|
SET Domain-Containing Protein; KMT7; SETD7/9
|
antibodies SET 7/9 SET-7/9 7 9 histones H3 lysines 4 western blotting WB blots immunoblotting |
| 10320 |
SET7/9 (human recombinant)
|
|
- |
≥95%
|
|
|
2009-08-11
|
5.861878453038
|
set7-9-human-recombinant
|
KMT7; SETD7/9; SET Domain-containing Protein 7/9
|
SET-7/9 SET 7/9 7 9 recombinant His-tagged proteins SETs methylation methyltransferase |
| 700270 |
SET7/9 Methyltransferase Inhibitor Screening Assay Kit
|
|
- |
|
|
|
2009-12-04
|
8.851754409264
|
set7-9-methyltransferase-inhibitor-screening-assay-kit
|
|
methyltransferases SET Domain-containing Protein 7/9 lysines 7 KMT7 methylation signal transduction biosynthesis proteins repair genes silencing chromatins S-adenosylmethionine SAM AdoMet methyl donors Alzheimer's depression Parkinson's Diseases multiple sclerosis liver cancers substrates histones histone 3 lysine residue 4 H3K4 p53 transcription factors TAF10 mono-methylated mono-methylase DNA damage acetylation human tumorigenesis inhibitors acceptor peptides S-adenosylhomocysteine S-ribosylhomocysteine adenine nucleosidase hypoxanthine deaminase urate hydrogen peroxide H2O2 ADHP 10-acetyl-3,7-dihydroxyphenoxazine resorufin fluorescence measures measurement assays kits |
| 10319 |
SET8 (human recombinant)
|
|
- |
≥95%
|
|
|
2010-01-07
|
21.356169429097
|
set8-human-recombinant
|
SETD8; SET domain-containing (lysine methyltransferase) 8; PR-Set7
|
SET-8 SET 8 recombinant His-tagged proteins SETs methylation methyltransferase MTs domain containing |
| 700350 |
SET8 Methyltransferase Inhibitor Screening Assay Kit
New |
|
- |
|
|
|
2010-03-09
|
128.769140822226
|
set8-methyltransferase-inhibitor-screening-assay-kit
|
SET domain-containing (lysine methyltransferase) 8; PR-Set7; SETD8
|
assays kits measures measurement methyltransferases MTs inhibits inhibitors inhibition methylation signal transduction biosynthesis protein repair genes silencing chromatins regulation S-adenosylmethionine (SAM)-dependent AdoMet DNA deoxyribonucleic acids Alzheimer's diseases depression Parkinson's multiple sclerosis livers cancers KMT5A lysines PR-Set 7 methylates histones H4 residues 20 H4K20 transcriptional p53 tumors suppressors tumorigenesis inhibits inhibition inhibitors peptides S-adenosylhomocysteines S-ribosylhomocysteines adenines nucleosidases hypoxanthines deaminases hydrogen peroxides H2O2 ADHP 10-acetyl-3,7-dihydroxyphenoxazines fluorescent fluorescence resorufin |
| 13277 |
(S)-HDAC-42
Exclusive |
|
935881-37-1 |
≥95%
|
|
✓ |
2009-12-03
|
43.965914529308
|
-s-hdac-42
|
AR42
|
histones deacetylases HDACs cancers inhibitors prostate p21 Akt Bcl-XL tumors inhibition inhibits OSU-HDAC-42 |
| 10006211 |
Silybin
|
|
22888-70-6 |
>98%
|
|
|
2005-02-16
|
17.497886740331
|
silybin
|
Silymarin; Silibinin
|
flavanoids flavonoids 5-LOs 5-lipoxygenases inhibits inhibitors inhibition flavonolignans Silybum marianum superoxides Kupffer cells leukotrienes LTB4 synthesis PMA-activated milk thistle |
| 10011190 |
SIRT1 (human recombinant)
|
|
- |
≥60%
|
|
|
2008-09-24
|
12.796063535911
|
sirt1-human-recombinant
|
Silent Information Regulator 2; Sirtuin 1; Sir 2
|
SIRT 1 SIRTs sirtuins HDACs DNA p53 proteins anti-cancers GST-tags GST-tagged |
| 700280 |
SIRT2 Direct Fluorescent Screening Assay Kit
|
|
- |
|
|
|
2009-12-10
|
12.508674010897
|
sirt2-direct-fluorescent-screening-assay-kit
|
|
Nucleosomes chromosomal deoxyribonucleases DNA histones H2A H2B H3 H4 octameric cores transcription amino termini acetylation phosphorylation methylation ε-amino lysines acetyltransferases HATs chromatins genes activation deacetylases HDACs catalyzes hydrolytic acetyls sirtuins trichostatins A-insensitive lysyl-deacetylases class III catalyzes deacetylation nicotinamides O-acetyl-ADP-ribose NAD+ human SIRT1 SIRT2 SIRT3 SIRT4 SIRT5 SIRT6 SIRT7 cytoplasmic proteins H4 lysine-16 lysine-40 α-tubulin a-tubulin alpha-tubulin HDAC6 microtubules mitotic chromosomal hyperpolid cells tissues skeletal muscle heart oligodendroglia brain tumor suppressor gliomas Down-regulation gene chromosomal region diagnostic marker fluorescence-based inhibitors activators p53 Gln-Pro-Lys-Lys(ε-acetyl)-AMC recombinant NAD+ fluorescent fluorescence kits assays measures measurement |
| 700290 |
SIRT6 Direct Fluorescent Screening Assay Kit
|
|
- |
|
|
|
2010-02-18
|
80.312485243424
|
sirt6-direct-fluorescent-screening-assay-kit
|
|
SIRT 6 SIRT-6 assays kits measures sirtuins trichostatins A-intensive lysyl-deacetylases class III HDACs human mitochondrial nuclear proteins mitochondrias translocated nucleus cells cellular stress lysine deacetylation nicotinamides O-acetyl-ADP-ribose NAD+ abstracted ADP-ribosyl transferases deacetylases telomeres chromatins NF-κB NF-kappaB NF-.kappa.B signaling signalling mammalian cells Werner Syndromes aging disorders anti-cancers anti-inflammatory drugs apoptosis screening fluorescence activators Arg-His-Lys-Lys(ε-acetyl)-AMC fluorescent fluorometric |
| 10012628 |
(S)-MG132
|
|
133407-82-6 |
≥98%
|
|
|
2009-02-18
|
237.284033149171
|
-s-mg132
|
2-Leu-Leu-Leu-CHO
|
ubiquitin proteasome inhibitors inhibits inhibition proteolytic degradation inflammation cell cycle regulation cancers NF-kB NFkB apoptosis NF-κB mg 132
mg-132 2-LLL-CHO |
| 13121 |
Sodium Butyrate
|
|
156-54-7 |
≥95%
|
|
|
2009-07-31
|
97.984917127072
|
sodium-butyrate
|
Butyric Acid (sodium salt)
|
fatty acids short chains inhibitors inhibits inhibition histones deacetylases HDACs epigenetics growth arrest differentiation apoptosis cancers inflammation genes expressions pro-inflammatory proinflammatory cytokines IFN-γ IL-6 IFNγ IL6 IL-1β IL1β IFNg |
| 10010466 |
SP 600125
|
|
129-56-6 |
≥98%
|
|
|
2009-01-07
|
5.877348066298
|
sp-600125
|
1PMV; Pyrazolanthrone; NSC 75890
|
c-Jun cJun JNKs inhibitors inhibits inhibition reversible cell-permeable cells COX-2 COX2 MAP kinase MAPK genes expressions apoptosis autophagy differentiation IL-10 IL10 TNF-α TNFα IFN-γ IFNγ T-cells Tcells HeLa sp600125
|
| 10009236 |
Sphingosine Kinase 1 (human recombinant)
|
|
- |
>80% by SDS-PAGE
|
|
|
2007-01-16
|
97.468263614838
|
sphingosine-kinase-1-human-recombinant
|
SPHK 1
|
proteins enzymes GenBank Accession No AF200328 SK1 SPK1 kinases sphingolipids SPHKs D-erythro-sphingosines phosphorylates sphingosine-1-phosphates S1P isoforms SPHK 2 mammalian cells signals signaling pathways mast fibroblasts epithelial mRNA humans tumors brains oncogenic erythroleukaemic therapeutics cancers inflammation inflammatory signalling SPHK1 |
| 10006822 |
Sphingosine Kinase 1 Polyclonal Antibody
|
|
- |
|
|
|
2006-12-21
|
56.561112338858
|
sphingosine-kinase-1-polyclonal-antibody
|
SPHK 1
|
proteins diseases antibodies antisera antiserum WB western blots blotting ICC immunocytochemistry sphingosines kinases enzymes sphingolipids metabolisms catalyzes phosphorylation sphingosine-1-phosphates cells proliferation death tissues kidneys livers spleen hearts platelets tumors cytosolic membranes amino acids post translational modifications SK1 SPK1 cancers immunoblotting |
| 10012201 |
Sphingosine Kinase 1 Polyclonal FITC Antibody
Exclusive |
|
- |
|
|
✓ |
2008-06-06
|
21.789152854512
|
sphingosine-kinase-1-polyclonal-fitc-antibody
|
SPHK 1
|
SPHK-1 metabolism sphingolipids phosphorylation sphingosine-1-phosphate cell proliferation death immunofluorescence IF flow cytometry FC western blots WB SPHKs blotting immunoblotting |
| 10009237 |
Sphingosine Kinase 2 (human recombinant)
|
|
- |
>80% by SDS-PAGE
|
|
|
2007-01-18
|
85.067324388319
|
sphingosine-kinase-2-human-recombinant
|
SPHK 2
|
signalling inflammatory enzymes proteins GenBank Accession No AF245447 SK2 SPK2 kinases sphingolipids SPHKs D-erythro-sphingosines phosphorylates sphingosine-1-phosphates S1Ps isoforms mammalian cells signals signaling pathways cancers inflammation proliferation apoptosis calcium homeostasis angiogenesis vascular maturation diseases |
| 10009222 |
Sphingosine Kinase Inhibitor 2
|
|
312636-16-1 |
>95%
|
|
|
2007-01-18
|
41.904925019732
|
sphingosine-kinase-inhibitor-2
|
SKI II; SPHK 2
|
cancers Anti-proliferative Sphingosine-1-phosphates S1Ps SK1 SK2 SKI2 SPHK1 SPHK2 sphingosines sphingolipids inhibits inhibitors inhibition proliferation |
| 13084 |
STF-62247
|
|
315702-99-9 |
≥98%
|
|
|
2009-10-07
|
0.189285714286
|
stf-62247
|
|
autophagy lethality renal cells carcinoma cancers von Hippel-Lindau VHL tumors supressors genes growth rates kidneys metastasize syndrome diseases |
| 13577 |
SU 11652
|
|
326914-10-7 |
≥95%
|
|
|
2010-02-02
|
66.017581338245
|
su-11652
|
|
growth factors receptors tyrosine kinases RTK inhibitors inhibits platelet-derived PDGF PDGF-β vascular endothelial VEGF VEGFR-2 fibroblast FGF FGFR1 epidermal EGFs EGFRs cells cycling apoptosis Kit c-Kit angiogenesis estrogen SU11652 mutants SU-11652 autophosphorylation |
| 13342 |
SU 5416
|
|
204005-46-9 |
≥98%
|
|
|
2009-07-16
|
52.371675874770
|
su-5416
|
VEGFR 2 Kinase Inhibitor; Semaxinib; Sugen 5416; NSC 696819
|
inhibitors inhibits inhibition tyrosine kinases receptors vascular endothelial growth factor VDGF VEGFR-2 VEGFR2 VEGFR 2 Flk-1 Flk 1 Flk1 KDR cancers tumors vascularization PDGFR c-Kit cKit RET Flt-3 Flt3 Flt 3 ABL EGF FGF |
| 13338 |
SU 6656
|
|
330161-87-0 |
≥95%
|
|
|
2009-08-04
|
10.202058011049
|
su-6656
|
|
inhibitors Src kinases Src Yes Lyn Fyn cells growth development nervous system fibrosis cancers inhibits inhibition CNS SU6656 |
| 16860 |
Swainsonine
|
|
72741-87-8 |
≥98%
|
|
|
2009-06-12
|
194.280773480663
|
swainsonine
|
Tridolgosir
|
Alkaloid N-linked glycoside hydrolases asparagine-linked glycoproteins glycoproteins inhibitor lysosomal α-mannosidase glycosidases Golgi α-mannosidase II N-linked glycosylation antiproliferative proliferation growth antimetastatic metastasis cancer α-mannosidase lysosomes oligosaccharides glycoproteins lysosomal storage disease toxicity locoism |
| 10009911 |
Tangeritin
|
|
481-53-8 |
≥98%
|
|
|
2008-12-16
|
5.877348066298
|
tangeritin
|
Ponkanetin; NSC 618905; NSC 53909
|
flavone cancers tumors cholesterol atherosclerosis ERKs p38 MAPKs JNKs AKTs LDLs triacylglycerol estradiol MDR1 pregnane X receptors IL-1 IL1 IL 1 melanoma insulinoma |
| 13085 |
Tenovin-1
Exclusive |
|
380315-80-0 |
≥98%
|
|
✓ |
2008-09-18
|
31.963016574585
|
tenovin-1
|
|
histones sirtuins cancers p53 cell growth tumors SIRT1 SIRT2 inhibitors inhibits inhibition melonoma lymphoma |
| 13086 |
Tenovin-6
Exclusive |
|
1011557-82-6 |
≥95%
|
|
✓ |
2009-02-12
|
46.790469613259
|
tenovin-6
|
|
histones sirtuins cancers p53 cell growth tumors SIRT1 SIRT2 inhibitors inhibits inhibition SIRTs transcription factors TFs |
| 10011619 |
Terbinafine (hydrochloride)
|
|
78628-80-5 |
≥98%
|
|
|
2010-02-16
|
69.573707796194
|
terbinafine-hydrochloride
|
|
antifungals squalene epoxidase antitumor tumors antiangiogenic anticancer cancers inhibitors inhibits inhibition |
| 10007565 |
Tetradecyl Phosphonate
|
|
4671-75-4 |
>98%
|
|
|
2005-10-17
|
46.953667127072
|
tetradecyl-phosphonate
|
|
pan-antagonists LPA receptors lysophosphatic acids lipids signalling molecules hydrolysis lysophospholipase D autotoxin signals GPCRs G-protein coupled LPA1/EDG-2 LPA2/EDG-4 LPA3/EDG-7 LPA4/GPR23 activates activation PPAR.gamma. peroxisomes proliferator-activated inhibits inhibition LPA-induced calcium mobilization activates reporter |
| 70302 |
tetramethyl Nordihydroguaiaretic Acid
Exclusive |
|
24150-24-1 |
≥98%
|
|
✓ |
2008-09-24
|
9.740276243094
|
tetramethyl-nordihydroguaiaretic-acid
|
tetramethyl NDGA; TMNDGA; Tetrameprocol; M4N; EM-1421
|
tumors inhibitor inhibits inhibition cancers NDGAs survivin apoptosis Cdc2 HIV growing growth glioma brains antitumor organic melonomas |
| 10007207 |
tetranor-12(S)-HETE
|
|
121842-79-3 |
>98%
|
|
|
2005-12-07
|
35.527476979742
|
tetranor-12-s-hete
|
|
neuroscience peroxisomes metabolites arachidonic acids metabolisms 12-lipoxygenases 12-LOs platelets leukocytes smooth muscle cells tumors adhesion endothelial fibronectin subendothelial matrix b-oxidation .beta.-oxidation tissues Lewis lung carcinomas controlling inflammations inflammatory responses injured corneas Zellweger's syndromes peroxisomal abnormalities inability metabolizes symptoms diseases derivatives reasearch tools elucidations metabolic fate cancers ophthalmology |
| 10009813 |
thio-Miltefosine
|
|
- |
>98%
|
|
|
2007-08-13
|
13.420165745856
|
thio-miltefosine
|
|
analogs inhibitors inhibit inhibition CTP phosphocholine cytidylyl transerases antimetastatic antiproliferatives ceramides apoptosis antiprotazoal thiomiltefosine sulfurs thios |
| 10038 |
TMS
|
|
24144-92-1 |
>98%
|
|
|
|
32.928806629834
|
tms
|
2,3',4,5'-Tetramethoxystilbene
|
cytochromes inhibitors tetramethoxystilbene antimutagenesis CYP450-1B1 inhibits selective selectivity apoptosis cell growth |
| 160750 |
TRAIL Polyclonal Antibody
|
|
- |
|
|
|
|
1.483977900552
|
trail-polyclonal-antibody
|
Apo-2L Polyclonal Antibody
|
apoptosis cell death TNF DR4 DR5 NF-.kappa.B NF-kappab NF-kappab antisera antiserum antibodies WB western blots blotting cancers immunoblotting |
| 10188 |
trans-trismethoxy Resveratrol
|
|
22255-22-7 |
>98%
|
|
|
2004-03-03
|
12.885489703666
|
trans-trismethoxy-resveratrol
|
(E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzene diol
|
selective cyclooxygenases inhibitors COX-1 PGHS-1 COX1 PGHS Prostaglandins synthases antioxidants oxidative injury stress sirtuins 3,5,4'-trihydroxy stilbene 3,5,4'-trihydroxystilbene 3,5,4'-trimethoxy stilbene 3,5,4'-trimethoxystilbene trimethoxy |
| 13129 |
trans-trismethoxy Resveratrol-d4
|
|
- |
≥99% deuterated product
|
|
|
2009-02-09
|
12.508468106479
|
trans-trismethoxy-resveratrol-d4
|
(E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzene diol-d4
|
deuterated deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometrysirtuins |
| 13791 |
TRF2 Polyclonal Antibody
New |
|
- |
|
|
|
2010-06-24
|
300.437306629834
|
trf2-polyclonal-antibody
|
TTAGGG Repeat Binding Factor 2; TRBF2; Telomeric Repeat Binding Factor 2; TERF2
|
antibodies proteins TRF-2 TRF 2 factors repeat DNA binding cells apoptosis western blots blotting immunoblotting telomere WB ICC IP ChIP IF immunoprecipitation immunofluorescence immunocytochemistry cancers apoptosis |
| 89730 |
Trichostatin A
|
|
58880-19-6 |
>98%
|
|
|
|
115.090121546961
|
trichostatin-a
|
TSA
|
reversible inhibitors histone deacetylase nuclear receptors inhibitions inhibits hdacs TSAs cancers |
| 10010237 |
Triciribine
|
|
35943-35-2 |
>98%
|
|
|
2007-09-11
|
22.686187845304
|
triciribine
|
Tricyclic Nucleoside; NSC 154020
|
Akt cancers inhibitors inhibition inhibits Akt-1 Akt1 Akt-2 Akt2 Akt-3 Akt3 PI3-kinase PI3kinase PI3K PI-3-kinase phosphorylation activation signalling pathway signaling |
| 10009083 |
Trimidox
|
|
95933-74-7 |
>98%
|
|
|
2008-02-13
|
0.220994475138
|
trimidox
|
VF 233
|
apoptosis ribonucleotide reductases cells cycles cancers dNTP HIV caspase DNA synthesis chemotherapy dGTP HL-60 |
| 10011124 |
Trimidox (hydrochloride)
Exclusive |
|
- |
>98%
|
|
✓ |
2008-06-10
|
0.220994475138
|
trimidox-hydrochloride
|
CF 233 (hydrochloride)
|
apoptosis ribonucleotides reductases cells cycles cancers dNTP HIV caspases DNA synthesis chemotherapy dGTP HL-60 HCls |
| 10011659 |
Trolox
|
|
53188-07-1 |
≥98%
|
|
|
2008-12-02
|
339.668715469613
|
trolox
|
6-hydroxy-2,5,7,8-tetramethylchroman-2-Carboxylic Acid
|
antioxidants vitamins E oxidative injury injuries neurodegeneration aging cancers adjunctive |
| 10005732 |
U19 Blocking Peptide
|
|
- |
>75%
|
|
|
2004-09-01
|
0E-12
|
u19-blocking-peptide
|
EAF2 Blocking Peptide
|
WB western blots blotting IHC immunohistochemistry immunoblot formalin-fixed paraffin-embedded sections apoptosis inhibits ihibitors inhibition prostate tumors testosterone antibodies paraffins signaling signalling controls peptides |
| 10005190 |
U19 Polyclonal Antibody
|
|
- |
|
|
|
2004-08-12
|
1.972132596685
|
u19-polyclonal-antibody
|
ELL-Associated Factor 2; EAF2
|
WB western blots blotting IHC immunohistochemistry immunoblots formalin-fixed paraffin-embedded sections apoptosis inhibits inhibitors inhibition prostate tumors testosterone suppressive supression leukemogenesis cancers endocrinology immunoblotting |
| 13033 |
Valproic Acid (sodium salt)
|
|
1069-66-5 |
≥95%
|
|
|
2009-10-21
|
13.735750397380
|
valproic-acid-sodium-salt
|
Sodium Valproate; 2-Propylvaleric Acid
|
valeric acids anticonvulsant seizures inhibitors histones deacetylases HDAC glycogen synthase kinases GSK3 inositol-1,4,5-trisphosphate IP3 combination therapy cancers Alzheimer's diseases stem differentiation self-renewal |
| 160840 |
VE-Cadherin Polyclonal Antibody
|
|
- |
|
|
|
|
19.751436464088
|
ve-cadherin-polyclonal-antibody
|
Cadherin-5 Polyclonal Antibody; CD144 Polyclonal Antibody
|
Western blots blotting antibodies WB antisera antiserum ICC IP immunocytochemistry immunoprecipitation apoptosis cancers immunoblotting |
| 13131 |
VER-49009
Exclusive New |
|
940289-57-6 |
≥98%
|
|
✓ |
2010-07-09
|
0.138035604665
|
ver-49009
|
|
heat shock proteins Hsp90 inhibitors Hsp27 Hsp72 cells cycle arrest apoptosis inhibits inhibition isoxazole survivin C-RAF B-RAF PRMT5 molecular chaperones folding signalling signaling VER49009 VER 49009 cancers |
| 13132 |
VER-50589
New |
|
747413-08-7 |
≥98%
|
|
|
2010-04-06
|
0.138035604665
|
ver-50589
|
|
heat shock proteins Hsps Hsp90 cancers inhibitors inhibits inhibition Hsp27 Hsp72 C-RAF B-RAF survivin PRMT5 cells cylce arrest apoptosis tumors growth glioblastoma molecular chaperones protein folding signaling signalling pharma |
| 10010591 |
Wortmannin
|
|
19545-26-7 |
≥98%
|
|
|
2008-11-21
|
36.766139502762
|
wortmannin
|
KY 12420
|
phosphoinositide 3-kinase PI3K cells growth differentiations cancers motility inhibitors inhibits inhibition irreversible polo-like kinases PLK1 PLK3 mTOR DNA-PK DNAPK PL4K MLCK p38 MAPK |
| 13671 |
Wortmannin-Rapamycin Conjugate
New |
|
- |
≥98%
|
|
|
2010-05-11
|
0E-12
|
wortmannin-rapamycin-conjugate
|
|
phosphoinositides 3-kinases PI3K mammalian targets mTOR cancers inhibitors inhibits inhibition complex 1 mTORC1 tumors bevacizumab VEGF colons A498 HT29 53123-88-9 sirolimus prodrug linkers links 19545-26-7 KY 12420 renal |
| 10008883 |
WST-1 Cell Proliferation Assay Kit
|
|
- |
|
|
|
2006-09-07
|
33.206016837673
|
wst-1-cell-proliferation-assay-kit
|
|
assays cells proliferation induction inhibitors inhibition inhibits growth factors signaling signalling molecules cycles regulatory factors cytokines mitogens drugs microtiter plates in vitro enzymes enzymatic cleavage tertrazolium salts formazan cellular mitochondrial dehydrogenases screen kits measures measurements cancers cell-based assay
cell based assay cba |
| 10010199 |
WST-8 Cell Proliferation Assay Kit
|
|
- |
|
|
|
2007-09-11
|
60.442836095763
|
wst-8-cell-proliferation-assay-kit
|
|
assays cells proliferation induction inhibitors inhibition inhibits growth factors signaling signalling molecules cycles regulatory factors cytokines mitogens drugs microwell plates in vitro enzymes enzymatic cleavage tertrazolium salts formazan cellular mitochondrial dehydrogenases screen kits measures measurements special:quarterly specialdiscount:50 specialstart:2007-12-01 specialend:2008-02-29 cell-based assay
cell based assay cba |
| 13639 |
WZ811
Exclusive New |
|
55778-02-4 |
≥95%
|
|
✓ |
2010-03-22
|
123.014020871700
|
wz811
|
|
CXC chemokines receptors CXCR4 stromal cell-derived factor-1 SDF-1 CXCL12 hematopoietic stem cells chemotaxis lymphocytes growth metastasis cancers T cells HIV infection inhibitors antagonist cAMP Matrigel invasion breast cancer adenocarcinoma inhibition |
| 10010895 |
Xanthine Oxidase Assay Kit
|
|
- |
|
|
|
2008-03-13
|
241.437209944751
|
xanthine-oxidase-assay-kit
|
XO Assay Kit; Xanthine Oxidoreductase Assay Kit
|
assays kits plasma serum tissues homogenates oxidoreductases molybdoflavoenzymes human purine catabolism catalyzing catalyzes hydroxylation hypoxanthine uric acids NADH superoxides reactive oxygen species ROS hydrogen peroxides H2O2 inschemia-reperfusion injury molecular cells death degeneration apoptosis mammalian livers intestines diseases horseradish HRP ADHP fluorescence fluorescent resorufin excitation emission wavelengths special:quarterly specialdiscount:50 specialstart:2007-03-01 specialend:2008-05-31 fluorometric |
| 13596 |
XAV939
Exclusive |
|
284028-89-3 |
≥98%
|
|
✓ |
2009-12-03
|
50.151372256234
|
xav939
|
|
Wnt cancers β-catenin APC axin GSK3 poly-ADP-ribosylation tankyrases TNKS1 TNKS2 inhibitors inhibition inhibits |
| 10010200 |
XTT Cell Proliferation Assay Kit
|
|
- |
|
|
|
2007-09-11
|
41.906003683241
|
xtt-cell-proliferation-assay-kit
|
|
assays cells proliferation induction inhibitors inhibition inhibits growth factors signaling signalling molecules cycles regulatory factors cytokines mitogens drugs microtiter plates in vitro enzymes enzymatic cleavage tertrazolium salts formazan cellular mitochondrial dehydrogenases screen kits measures measurements special:quarterly specialdiscount:50 specialstart:2007-12-01 specialend:2008-02-29 cell-based assay
cell based assay cba |
| 13661 |
YK-4-279
Exclusive |
|
1037184-44-3 |
≥98%
|
|
✓ |
2010-02-05
|
48.888888888889
|
yk-4-279
|
|
ES-FLI1 oncogene Ewing's sarcomas RNA helicases A RHAs tumors cancers inhibitors apoptosis inhibition inhibited Ewings YK 4-279 YK4279 YK 4279 YK 4 279 |
| 71800 |
(Z)-Guggulsterone
|
|
39025-23-5 |
≥98%
|
|
|
2009-12-01
|
1.714984453480
|
-z-guggulsterone
|
|
anti flammatory cancers FXR bile acids LDL cholesterol tumors IL-6 STAT3 VEGF Akt |
| 10010367 |
ZM 336372
|
|
208260-29-1 |
>98%
|
|
|
2008-01-09
|
3.300121546960
|
zm-336372
|
|
Raf-1 c-raf inhibitors inhibition inhibits cancers anti-cancer MEK 1/2 MAPK signals transductions proliferations cells cycles ERK1 ERK2 ERK1/2 ATP adenosine triphosphate signaling carcinoid tumor |
| 13601 |
ZM 447439
New |
|
331771-20-1 |
|
|
|
2010-08-03
|
0E-12
|
zm-447439
|
|
auroras A B C kinases mitosis cytokinesis centromere inhibitors inhibits inhibition cancers |
| 300013 |
β-Catenin Blocking Peptide
|
|
- |
|
|
|
|
3.145653775322
|
-catenin-blocking-peptide
|
|
b-catenin beta-catenin immunoanalysis western blots immunoblotting controls peptides cancer cell .beta.-catenin wb |
| 100029 |
β-Catenin Polyclonal Antibody
|
|
- |
|
|
|
|
4.376512430939
|
-catenin-polyclonal-antibody
|
|
antibodies antisera antiserum western blots blotting wb icc immunocytochemistry b-catenin cancers cell immunoblotting IHC immunohistochemistry |
| 10009137 |
β-Gal-NONOate
|
|
357192-77-9 |
>98%
|
|
|
2007-11-10
|
39.195559392265
|
-gal-nonoate
|
|
nitric oxides NOs donors anti-cancer anticancers .beta.-galatosidases cytoxic bactericidal cell-lines genes cytotoxicity |
| 10010621 |
γ-CEHC EIA Kit (plasma and serum)
|
|
- |
|
|
|
2008-03-21
|
22.744834254144
|
-cehc-eia-kit-plasma-and-serum
|
2,7,8-trimethyl-2-(β-Carboxy-Ethyl)-6-Hydroxychroman EIA Kit
|
competitive quantification kits eias enzymes immunoassays gammaCEHC gCEHC gamma-CEHC g-CEHC tocopherol tocotrienols vitamins E g-tocopherols .gamma.-tocopherol gamma-tocopherol lipid soluble antioxidants diets metabolites livers cytochrome p450 CYP450 natriuretic acitvity nitric oxides NO radicals inhibits inhibitions inhibitors COX cyclooxygenases macrophages epithelial cells plasma serums blood cardiovascular diseases prostate cancers assays |